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I  ABBREVIATIONS
AF Allele frequency
CP Codon position
CRT Cyclic reversible termination
CSB I–III Conserved sequence blocks 1, 2 and 3
CsCl Cesium chloride
D-loop Triple-stranded  structure  at  mtDNA control
region
dsDNA Double-stranded DNA
E7.5, E14 Embryonic day 7.5 or 14
EDTA Ethylenediaminetetraacetic acid
ETAS I–II Extended termination associated sequences 1 
and 2
EtBr Ethidium bromide
ExoV DNA exonuclease V
F1 Founder mouse of a female mouse lineage, 
MKO genotype
F1 score Harmonic mean of precision and sensitivity
FP False positive variant
gDNA Genomic DNA (including both nuclear and 
mitochondrial DNA)
HSP Heavy-strand transcription promoter
H-strand Heavy-strand of mtDNA (based on GC-
content)
LSP Light-strand transcription promoter
L-strand Light-strand of mtDNA (based on GC-
content)
MKO Hemizygote mtDNA mutator mouse, 
genotype PolgAD275A/KO
mtDNA Mitochondrial DNA
mtDNA-seq The optimized mtDNA enrichment and 
sequencing approach
MTERF1 Mitochondrial transcription termination 
factor 1
IV
mtRNA Mitochondrial RNA
NCR Non-coding region, mtDNA control region
N1, N2, N3 F1 female offspring lines, carry  mtDNA 
variants, WT genotype
nDNA Nuclear DNA
NuMTs Nuclear sequences of mitochondrial origin
NZB Wild-type mouse carrying mtDNA from NZB
mouse
OriL, OriH Origin of replication of light- (L) and heavy- 
(H) strand of mtDNA
pAM1 The entire mtDNA cloned into pACYC177-
vector backbone
PCS Post-PCR cloning and sequencing
PGC Primordial germ cell
POLG Mitochondrial DNA polymerase γ
PolgA Mitochondrial DNA polymerase γ catalytic 
subunit A
POLRMT Mitochondrial RNA polymerase
pp Percentage points
PPV Positive predictive value, precision
R1, R2 Read 1 and read 2 obtained by paired-end 
sequencing
RCA Rolling circle amplification (multiple 
displacement amplification)
RMC Random mutation capture
SD Standard deviation
smPCR Single-molecule PCR
SNA Single nucleotide addition
ssDNA Single-stranded DNA
TFAM Mitochondrial transcription factor A
TFB2 Mitochondrial transcription factor B2
TP True positive variant
TPR True positive rate, recall, sensitivity
TWINKLE Replicative mitochondrial helicase
UMI Unique molecular identifier
WT Wild-type mouse, genotype PolgAWT/WT
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II ZUSAMMENFASSUNG
Pathogene  Mutationen  in  der  mitochondrialen  DNA (mtDNA)  sind
dafür  bekannt,  mehrere  Erbkrankheiten  zu  verursachen.  Aufgrund
fehlender  Methoden  zur  transgenen  Manipulation  der  mtDNA ist  es
kaum möglich, die mtDNA Sequenzen und Funktionen zu untersuchen.
Die  mtDNA-Mutator-Maus  wird  als  Sättigungsmutagenese-Modell
verwendet, um eine hohe Variantenbelastung innerhalb der mtDNA zu
erzeugen.  Bisher  wurde  bei  diesem  Modell  gezeigt,  dass  der  OriL
essentiell für die mtDNA-Replikation ist und dass eine starke negative
Selektion potentiell  schädlicher  mtDNA-Mutationen in der  Keimbahn
stattfindet. Traditionell wurden mtDNA-Mutationen anhand von Sanger-
Sequenzierung  oder  Post-PCR-Klonierung  und  Sequenzierung
nachgewiesen.  Diese  Methoden  können  allerdings  nicht  das  gesamte
mtDNA-Genom darstellen. Zudem sind sie aufwendig, teuer und nicht
sensibel  genug.  Seit  einigen  Jahren  werden  Hochdurchsatz-
Sequenzierungsverfahren als billigere Ansätze verwendet, um mtDNA-
Varianten über das gesamte Genom zu detektieren. Allerdings werden
diese, wegen ihrer hohen Fehlerrate, als ungeignet zum Detektieren von
Varianten  angesehen.  Im  Gegensatz  dazu  sind  empfindlichere
Hochdurchsatz-Sequenzierungsmethoden  wie  Duplex-Sequenzierung
mit einem hohen Arbeitsaufwand verbunden, da sie eine umfangreiche
Optimierung  und  eine  hohe  Sequenzierungstiefe  erfordern.  Dadurch
erhöhen sich die Kosten auf ein unerschwingliches Niveau.
In dieser Arbeit werden verschiedene Mitochondrienanreicherungs- und
Amplifikations-methoden  untersucht,  um  mtDNA frei  von  nuklearer
DNA-Kontamination  anzureichern.  Es  wird  eine  Standard  Illumina
HiSeq Sequenzierung genutzt. Die Datenanalyse wird sorgfältig für das
mtDNA-Genom optimiert, da dessen Eigenschaften sich von denen des
Kerngenoms unterscheiden.  Schließlich  wird  das  optimierte  mtDNA-
Anreicherungs-  und  Sequenzierungs-protokoll,  mtDNA-seq,  unter
Verwendung  einer  Titration  von  Spike-In  Proben,  welche  bekannte
mtDNA-Varianten besitzen, validiert.  Mit  mtDNA-seq ist  es  möglich,
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mtDNA-Varianten zuverlässig zu detektieren. MtDNA detektiert sogar
Mutationen  unterhalb  einer  Allelfrequenz  von  0,05%.  Dies  ist  etwa
zehnmal  niedrigerer  als  die  allgemein  angewandte  Varianten-
Nachweisgrenze.
Die  optimierte  mtDNA-seq  wird  angewendet,  um  noch  offene
mitochondriale Probleme zu adressieren. Es wird das Variantenprofil des
gesamten  mtDNA-Genoms  erzeugt,  wodurch  mehrere  komplette
Mutations-Coldspots  innerhalb  von  Kontrollbereichen  der  mtDNA
entdeckt  werden.  Diese  bisher  unbeschriebenen  Coldspots  könnten
potenzielle  Regulationsorte  für  die  mtDNA-Replikation  und  die
replikations-assoziierte  Transkription  sein.  Die  molekulare
Mechanismen  hierfür  sind  bisher  ebenfalls  unbekannt.  Zur
Untersuchung  der  Entwicklungs-stufen  und  des  Mechanismus  der
negativen  Selektion  wird  die  hemizygote  mtDNA-Mutator-Maus
verwendet, um mtDNA-Varianten in weibliche Linien zu isolieren. Da
mtDNA-seq  die  Detektion  extrem  seltener  mtDNA-Varianten
ermöglicht,  können  neue  Ergebnisse  gewonnen  werden,  welche  den
bisherigen  Wissensstand  zur  starken  negativen  Selektion  in  der  N2-
Generation von Mäusen erweitern.  Die Ergebnisse deuten darauf hin,
dass  jede  mtDNA-Variante  zufällig  auf  die  Nachkommen  übertragen
werden kann. Jedoch scheinen sich die schädlichsten Mutationen nicht
klonal auszubreiten, nicht  einmal in N1-Generation. Um die mtRNA-
Verarbeitung  zu  verstehen,  wird  in  einer  Pilotstudie  der  amplicon-
Sequenzierungsansatz  verwendet.  Ziel  dieser  Studie  ist  es,  Allel-
Mismatches  zwischen  mtDNA und  mtRNA-Varianten  zu  detektieren
und dadurch auf mögliche mtRNA-Verarbeitungsdefekte hinzuweisen.
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III ABSTRACT
Pathogenic  mutations in  mitochondrial  DNA (mtDNA) are  known to
cause  numerous  inherited  diseases.  However,  the  lack  of  methods to
transgenically  manipulate  the  mtDNA limits  the  possibilities  to  learn
about  mtDNA sequence and function.  The mtDNA mutator  mouse is
used as a saturation mutagenesis model to generate high variant load
into mtDNA. With this model, it  has been previously shown that, for
instance OriL is essential for mtDNA replication or that strong purifying
selection of potentially deleterious mtDNA mutations takes place in the
germ  line.  Traditionally,  mtDNA mutations  have  been  detected  by
Sanger  sequencing  or  post-PCR  cloning  and  sequencing,  which  are
unable  to  represent  the  entire  mtDNA genome,  and  are  laborious,
expensive,  or  of  low  sensitivity.  More  recently,  high-throughput
sequencing methods have been utilized as cheaper approaches to detect
mtDNA variants over the entire genome. However, the high error-rate of
these technologies is considered as a limiting factor regarding variant
detection sensitivity. On the other hand, high-sensitivity high-throughput
sequencing methods, such as Duplex Sequencing, are often laborious
requiring extensive optimization and high sequencing depth, ultimately
raising the costs to a prohibitive level.
In  this  thesis,  various  mitochondria  enrichment  and  amplification
methods are explored in order to enrich mtDNA free from nuclear DNA
contamination. Standard Illumina HiSeq sequencing is utilized and data
analysis steps are carefully optimized to be suitable for mtDNA genome,
which  has  characteristics  very  different  from  the  nuclear  genome.
Finally,  the  optimized  mtDNA enrichment  and  sequencing  protocol,
mtDNA-seq,  is  validated  utilizing  a  titration  of  spike-in  samples
harboring known mtDNA variants.  With mtDNA-seq it  is  possible to
detect mtDNA variants reliably even below allele frequency of 0.05 %,
which is approximately ten times lower variant detection threshold than
what has been generally applied in other studies. 
The  optimized  mtDNA-seq  is  applied  to  address  open  mitochondrial
VIII
biology research  questions.  The variant  profile  of  the  entire  mtDNA
genome is  generated,  and  several  complete  mutational  coldspots  are
discovered at the control region of the mtDNA. These novel coldspots
are hypothesized to be potential regulation sites for mtDNA replication
and  replication-associated  transcription  by  as-yet-unknown molecular
mechanisms.  To  clarify  the  developmental  stage  and  mechanism  of
purifying selection,  hemizygote  mtDNA mutator  mouse is  utilized  to
isolate mtDNA variants into female lineages. As it is possible to detect
extremely  rare  mtDNA variants  by  mtDNA-seq,  these  new  results
expand the  previous study showing strong purifying selection by N2
generation  of  mice.  The  results  suggest  that  by  chance  any  mtDNA
variant  may  be  transmitted  to  the  offspring,  however,  the  most
deleterious  mutations  do  not  seem  to  clonally  expand  even  in  N1
generation  mice.  To  understand  the  mtRNA  processing,  amplicon
sequencing approach is utilized in a preliminary study. The aim in this
study  is  to  detect  allelic  mismatches  between  mtDNA and  mtRNA
variants, which potentially indicate mtRNA processing defects.
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1 REVIEW OF THE LITERATURE
1.1 Mitochondrial genetics and disorders
1.1.1 Mitochondria
According to the widely accepted endosymbiotic theory of the origin of
mitochondria,  mitochondria  evolved  from  an  α-proteobacterium
engulfed  by  an  archaeon  (reviewed  by  Martin  et  al.  2015).  The
symbiotic  relationship was thought  to  be based  on the  ability  of  the
proteobacterium  to  efficiently  produce  ATP  in  exchange  of
carbohydrates produced by the host. Over the course of evolution, such
symbiosis lead to formation of mitochondria – cell organelles, which are
known as the powerhouses of the cell, but mitochondria also contribute
to  many  other  cell  functions  (reviewed  by  Nunnari  &  Suomalainen
2012).  Mitochondria  are  dynamic  in  nature,  forming a  fusion-fission
network, the steady state of which varies between different cell types: in
cardiomyocytes,  the network consists of connected tubular structures,
which  are  distributed  throughout  the  cell,  whereas  in  oocytes
mitochondria network is more localized as fragmented aggregates. Such
a  system requires  delicate  control  of  fusion,  fission,  positioning  and
motility, and it is enabling the cells to respond variable energy demands
(reviewed by Labbé et al. 2014). 
The energy production (i.e. oxidative phosphorylation system) is located
inside  a  double-membrane  structure,  in  the  inner  membrane  and
mitochondrial  matrix.  The  respiratory  chain  is  formed  by  four
respiratory complexes,  coenzyme Q and cytochrome  c,  which receive
electrons from the citric acid cycle. The electrons go through a series of
reduction and oxidation reactions resulting in proton transfers across the
mitochondrial  inner  membrane.  This  proton  gradient  drives  the  ATP
production and is an essential part of mitochondrial function. The key
proteins  required  for  oxidative  phosphorylation  are  encoded  in
mitochondrial  genome  (mitochondrial  DNA,  mtDNA,  reviewed  by
Larsson 2010).  During  their  evolution,  most  of  the  original  bacterial
genetic material has been  transferred to the nucleus, and novel genes
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required for mitochondrial function have evolved. Mitochondria still do
harbor their own tightly packed circular mtDNA molecules (Fig. 2.1) –
size of which varies from ~6 kb in Plasmodium falciparium to ~16 kb in
mammals or even >200 kb in some plants (reviewed by Gray 2012). 
The  DNA strands  of  the  mammalian  mitochondrial  genome  can  be
categorized into heavy- and light-strands (H- and L-strand) according to
their density separation, as H-strand is more G-rich than L-strand. H-
strand is the sense strand for 12 proteins, the core components of the
mitochondrial  respiratory  complexes,  and  the  two rRNAs  as  well  as
14 tRNAs required for mitochondrial translation machinery, whereas L-
strand is the sense strand for only one protein and 8 tRNAs. The rest of
the  >1000 proteins  required  for  oxidative  phosphorylation,  mtDNA
replication and expression, mitochondrial protein synthesis, iron-sulfur
cluster synthesis or other metabolic functions are encoded in the nuclear
genome, translated in the cytosol and transported to mitochondria (Fig.
2.1, reviewed by Larsson 2010). This bi-genomic system requires well-
coordinated expression of nuclear and mitochondrial genes.
The  mitochondria  network  harbors  thousands  of  mtDNA molecule
copies. At a given time, a proportion of mtDNA molecules are naked,
but most of them are packed into nucleoid structures (Farge et al. 2014).
The exact  nucleoid composition is still  a debated topic.  Studies  with
mouse  embryonic  fibroblasts  (MEFs)  suggest  the  nucleoid  typically
consists of mitochondrial transcription factor A (TFAM) protein and a
single copy of mtDNA (Kukat et al. 2011). Approximately 1000 TFAM
proteins coat a single mtDNA molecule (i.e. one TFAM every ~16 bp
[(Kukat  et  al.  2011]),  and  TFAM can  bind  mtDNA in  a  single,  co-
operative and cross-strand fashion in vitro (Kukat et al. 2015). Binding
of human TFAM to mtDNA is sequence specific at the promoter regions
but non-specific elsewhere (Fisher & Clayton 1988; Fisher et al. 1992),
and furthermore, human TFAM is shown to bend the mtDNA 180° (Ngo
et al. 2011; Rubio-Cosials et al. 2011). All these qualities explain the
capability of TFAM to efficiently compact the mtDNA molecule into a
nucleoid structure of ~100 nm in size (Kukat et al. 2011).
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Figure 2.1. Mitochondrial function and genome.  Mitochondria are cell organelles, which consist of outer and inner membranes
(OM and IM) enclosing inter-membrane space (IMS) and forming the inner matrix of mitochondria. Mitochondria produce ATP by
oxidative phosphorylation, which is dependent on proteins encoded in nuclear genome (nDNA) as well as in mitochondrial genome
(mtDNA). Approximately >1000 proteins are synthesized in the cell cytoplasm (pink and light green) and imported to mitochondria
not only for oxidative phosphorylation but also for other mitochondrial functions e.g. iron-sulfur cluster synthesis, cell signalling and,
of  course,  for  mtDNA maintenance,  such  as  compacting  mtDNA into  nucleoids  (orange  proteins)  or  mtDNA replication  and
transcription (light green proteins). Only 13 proteins are encoded in mtDNA, and they are essential parts of the respiratory complexes
(components of each complexes are denoted with different colors: complex I, ND1–6, purple; complex III, CYTB, orange; complex IV,
CO1–3,  green;  complex  V,  ATP6  and  8,  yellow).  Furthermore,  mtDNA encodes  the  two  rRNAs  and  22  tRNAs  required  for
mitochondrial translation. The base composition of mtDNA is biased, and the different strands are called as heavy- and light-strands
(H- and L-strands) according to their densities. Both strands harbor their own origin of replication (OriH and OriL) as well as
transcription promoters (LSP and HSP). The densly packed mtDNA contain only one major non-coding region (NCR) also known as
control region. The illustration is based on Gustafsson et al. (2016).
Others have additionally suggested the nucleoid to contain also mtDNA
replication  proteins  (e.g.  mitochondrial  DNA polymerase  γ (POLG),
mitochondrial  single-stranded  DNA  binding  protein  (mtSSB),
mitochondrial  helicase  TWINKLE  as  well  as  mitochondrial  inner
membrane proteins) (reviewed by Gilkerson 2009). This is suggested to
hold  the  nucleoid  tethered  to  the  inner  membrane  rather  than  freely
floating  nucleoids,  providing  a  possible  model  how  mtDNA  and
nucleoids are segregated between the dynamic network of mitochondria
and  to  the  daughter  organelles  (Gilkerson  2009).  In  line  with  this,
mitochondria and endoplasmic reticulum interact at certain contact sites
which direct mitochondrial division and nucleoid segregation (reviewed
by Labbé et al. 2014). Moreover, the level of mtDNA compaction into
nucleoids  may  function  as  a  regulator  for  mtDNA replication  and
transcription (Farge et al. 2014).
Different from nucleus of the same cell, mtDNA are replicated through a
relaxed replication process independent from the cell cycle.  Despite a
relatively low error rate of POLG, 5.6x10-7 mut/bp/doubling (Zheng et
al. 2006), each mtDNA molecule will go through many more rounds of
replication, which increases the probability of variant-harboring mtDNA
copies and higher per gene substitution rate in comparison to nuclear
DNA (nDNA). Different mtDNA molecules, harboring distinct variants,
can  simultaneously  exist  within  a  cell  –  a  condition  called  as
heteroplasmy. Through vegetative segregation, variable proportions of
mitochondria harboring different mtDNA molecules may end up to the
daughter cells (Fig. 2.2a). It has been also shown in silico that random
drift  may  drastically  shift  the  levels  of  different  mtDNA molecules
during the life time of a human being when some mtDNA molecules are
clonally  expanded  and  others  are  not  (Chinnery  &  Samuels  1999,
Fig. 2.2b). According to their model, it is an effective factor in avoiding
a pathogenic allele from fixing (i.e. becoming homoplasmic), however,
rare variants may also expand to relatively high levels. If the relative
level  of  a  pathogenic  mtDNA mutation  frequency  reaches  a  critical
biochemical threshold, defects in mitochondrial function can be detected
(Fig.  2.2, Durham et  al.  2007).  Moreover,  if  the functional  defect  is
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compensated by more mtDNA replication, relative levels of wild-type
mtDNA molecules  may  drop,  by  chance,  even  more  (Chinnery  &
Samuels 1999).
1.1.2 Mitochondrial disorders
It can be easily understood that disruptions at any level of such complex
systems  as  mitochondria,  can  have  severe  consequences.  Indeed,
mitochondrial  dysfunction is associated with variety of  heterogenous,
inherited  human  disorders  as  well  as  common  diseases  such  as
neurodegenerative  disorders  or  metabolic  syndromes  (Nunnari  &
Suomalainen 2012). In United Kingdom, it has been estimated that one
in 4300 adults are affected by mitochondrial disorders, making them one
of the most common group of inherited neurological disorders (Gorman
et  al.  2015).  Furthermore,  even  one  in  200  healthy  individuals  are
estimated to be carrier of certain pathogenic mtDNA mutations (Elliott
et al. 2008). 
Pathogenic  mutations  or  deletions  in  nuclear  genes  encoding
mitochondrial  proteins  are  known  to  cause  of  several  mitochondrial
disorders,  such as mutations or deletions in  Polg causing progressive
external  ophthalmoplegias  (PEO,  van  Goethem  et  al.  2001).  These
nuclear-gene derived disorders follow Mendelian rules and are relatively
well  known,  however  a  typical  characteristic  for  a  mitochondrial
disorder is that the exact same mutation may cause variable symptoms
or  onset  ages  between  individuals.  Disorders  caused  by  mtDNA
mutations  or  deletions  are  even  more  complex  than  the  ones  of
chromosomal origin. The transmission of mtDNA in mammals is solely
maternal  and  the  multicopy  nature  and  variable  levels  of  mutation
present in the mtDNA molecules further complicate the interpretation of
the relationship between the mutation and the disorder symptoms of an
individual.  For  example,  myoclonic  epilepsy  and  ragged-red  fiber
disease  (MERRF) is  caused  by a mutation in  mt-tRNA Lys  (K) and
although  the  relative  mutation  frequency  mostly  correlates  with  the
phenotype, the disease onset age varies and as little as 15 % presence of 
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Figure 2.2. Vegetative segregation and relaxed replication. As a mitochondrion harbors thousands of mtDNA molecules, it is likely
that some of them harbor variants. Thus, a cell may carry normal and mutated mtDNA molecules, a condition called as heteroplasmy.
During cell division, mitochondria are divided to daughter cells through vegetative segregation (a). Each daughter cell may then
contain very variable proportions of different mtDNA molecules. Furthermore, mtDNA molecules go through constant turnover, i.e.
relaxed replication (b), and no mechanism exist to ensure each molecule is replicated. Thus, proportion of different mtDNA molecules
may rapidly shift over time. If a pathogenic mtDNA mutation reaches high levels (past a biochemical threshold), disease symptoms
occur due to defects in respiratory chain system. The illustration is based on Stewart & Chinnery (2015). 
wild-type mtDNA molecules was enough for one individual to escape
disease symptoms  (Shoffner et al.  1990). On the other hand, a single
mutation  on  mt-tRNA Leu  (L1)  can  appear  as  different  disorders:
mitochondrial  encephalopathy lactic  acidosis  and  stroke-like  episodes
(MELAS),  maternally  inherited  deafness  and  diabetes  (MIDD),  and
progressive external ophthalmoplegia (PEO,  Nesbitt et al. 2013). This
variability makes clinical genotype-phenotype assessments very difficult
for  novel  pathogenic  mtDNA mutations.  Moreover,  it  challenges  the
understanding of the mechanistic details of the disease progression.
Severity  and  the  onset  of  a  mitochondrial  disorder  may  directly  be
affected  by  the  segregation  of  heteroplasmic  mtDNA molecules  to
daughter cells, or via germ line to the offspring. Although, random drift
is the most dominant factor, selection of certain mtDNA molecules, even
if harboring a phenotypically neutral  variant,  has been shown to take
place  in  a  tissue-  or  mutation-specific  manner  in  somatic  cells  (e.g.
Jenuth et al. 1997; Pyle et al. 2007). How exactly replication of certain
mtDNA  molecules,  mtDNA  compaction  into  nucleoids,  nucleoid
clustering or dynamic fusion-fission network affect the segregation or
turnover  of  different  mtDNA molecules  is  still  not  fully  understood
(reviewed by Jokinen & Battersby 2013). 
1.1.3 Models for mitochondrial DNA mutation research
There are no curative treatments available for mtDNA disorders.  The
current approaches only aim to maintain the health of the patient, and
recently also to avoid inheritance of pathogenic mtDNA mutations by
mitochondrial  replacement  therapies  or  preimplantation  diagnostics
(Poulton  &  Bredenoord  2010,  Chinnery  et  al.  2014).  In  contrast  to
nuclear  genome,  studies  on  mtDNA variants  are  extremely  difficult
since there is no method for mitochondrial reverse genetics  in vivo  to
study  and  confirm  genotype-to-phenotype  causation  (reviewed  by
Patananan et al. 2016). To study different mtDNA disorders, the solution
has been to utilize variety of mouse models,  which are generated by
direct introduction of existing mtDNA mutations by cytoplasmic fusion
strategy or indirectly by modifying the nuclear genes which can affect
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the  mtDNA  composition,  such  as  Polg or  Twinkle (reviewed  by
Tyynismaa & Suomalainen 2009). 
The most relevant mouse model to this thesis is  the mtDNA mutator
mouse  (Trifunovic  et  al.  2004;  Kujoth et  al.  2005).  Trifunovic et  al.
(2004) created a homozygote knock-in mouse expressing proof-reading
deficient POLG, in which the critical aspartate residue of exonuclease
domain in  PolgA was replaced with alanine (PolgAD257A).  These mice
showed normal replication efficiency, but the exonuclease activity was
significantly  reduced  (Trifunovic  et  al.  2004) showing  a  mtDNA-
specific  mutation  load  of  6.6x10-4 mut/bp  (~40x  the  background
mutation rate, Ross et al. 2013) as well as notable amount of truncated,
linear mtDNA molecules  (Trifunovic et al.  2004, Macao et al. 2015).
After ~25 weeks of age, these mice begin to show ageing symptoms like
kyphosis,  alopecia,  decreased  body  fat,  osteoporosis,  anemia,  and
reduced  fertility.  Moreover,  their  median  lifespan  is  only  ~48 weeks
(Trifunovic et al. 2004). 
As  a  saturation  mutagenesis  model,  the  mtDNA mutator  mouse  has
proven to be valuable tool in addressing research question related to
mtDNA biology. Recently, the heterozygote mtDNA mutator mouse was
utilized to establish a new mouse model which harbored a mt-tRNA Ala
(A)  variant  and  presented  with  mitochondrial  disorder  phenotype
(Kauppila et al. 2016). Other studies have utilized the mtDNA mutator
mouse model e.g. to address the effect of mtDNA mutations on ageing
(Vermulst et al. 2007; Edgar & Trifunovic 2009; Williams et al. 2010;
Ameur  et  al.  2011;  Ross  et  al.  2013;  Baines  et  al.  2014),  to  study
mtDNA transmission (Stewart et al. 2008a; Ross et al. 2013; Ross et al.
2014),  or  to  understand  various  processes  involved  in  mtDNA
maintenance  (Hance et al. 2005; Wanrooij S. et al. 2012; Baines et al.
2014; Macao et al. 2015).
1.1.4 Mitochondrial DNA variant detection by traditional methods
Many mtDNA mutation studies simply focus on diagnostic detection of
near-homoplasmic  or  high-frequency,  clonally  expanded  mtDNA
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mutations  or  rearrangements.  This  is  because  the  diseases  symptoms
often occur only after the levels of pathogenic mtDNA reach a relatively
high threshold, often ~70–90 % (Durham et al. 2007). Detection of such
high-level mutations is relatively straightforward with PCR- or blotting-
based  methods  (reviewed  by  Moraes  et  al.  2003)  or  by  Sanger
sequencing, which has a detection threshold of ~15–30 % (Hancock et
al. 2005; Rohlin et al. 2009). However, especially with ageing studies,
there is interest in detecting the total variant load of a tissue, including
de novo mutational events, which are not yet highly clonally expanded,
and  are difficult  to  detect  with the  mentioned methods.  Traditionally
three methods have been used to sensitively measure the total mtDNA
variant load of a tissue: post-PCR cloning and sequencing (PCS), single-
molecule  PCR (smPCR) and  random mutation  capture  assay  (RMC,
compared by Greaves et al. 2009). 
In  PCS, the target  DNA is first  amplified by high-fidelity PCR, then
cloned into a vector and single clones are expanded and sequenced by
Sanger sequencing. As reviewed by Kraytsberg and Khrapko (2005), the
advantages of PCS are fast amplification of the target mtDNA without
mitochondria isolation and utilization of easy-to-use commercial kits for
cloning  and  even  robotics  for  plasmid  purification  (Kraytsberg  &
Khrapko 2005). Furthermore, as mtDNA is very small genome, ~16 kb,
it  is  even possible to analyze the entire  mtDNA genome by lambda-
phage based PCS (Ross et al. 2013, Hagström et al. 2014). One potential
drawback,  however,  is  propagation  of  PCR-errors  which  are
indistinguishable from genuine variants; often used high-fidelity DNA
polymerase  Pfu introduces  1.6x10-6 errors  per  nucleotide  per  cycle
(Lundberg et al. 1991) or even less, down to error rate of 4.4x10-7 with
the  engineered  enzymes  like  Phusion® (New  England  Biolabs,  Inc.).
Furthermore,  DNA polymerases  have  a  tendency  to  jump  between
templates, which is an issue in highly mutated samples, where template
switching  would  create  new  combinations  of  mutated  molecules
(Hagström  et  al.  2014).  PCR-step  may  also  introduce  bias  by
preferential amplification of one but not another allele  (Kraytsberg &
Khrapko 2005). 
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To overcome the issues of PCS, smPCR was suggested as more accurate
method  to  study  mtDNA variant  loads  (Kraytsberg  et  al.  2008).  In
smPCR, the source DNA is serially diluted until only a fraction of PCR
reactions amplify an mtDNA product. The key assumption is that this
way only a single molecule is analyzed, and thus, PCR-errors are easily
distinguished  as  a  heteroplasmic  peak  in  the  sequencing.  Despite
overcoming the  disadvantages  of  PCS,  smPCR introduces some new
issues.  First  of  all,  the  method requires  optimization  of  the  PCR to
succeed  from such  low  amount  of  template  DNA.  This  also  causes
another  major  drawback  –  highly  increased  risk  of  sample
contamination  (Kraytsberg & Khrapko 2005).  Also, large numbers of
samples  are  required for  the serial  template dilutions  (Greaves et  al.
2009). 
Another method to sensitively measure mtDNA variant  loads without
the  risk  of  PCR-induced  errors,  is  RMC.  The  method  is  based  on
restriction digestion of wild-type DNA prior to quantitative PCR, thus,
only molecules harboring a mutated restriction site will be amplified. An
important  step  in  this  method  is  the  quantification  of  the  starting
material in order to be able to determine the final variant load (Greaves
et al. 2009). RMC revealed lower mtDNA variant loads than the other
methods  (Vermulst  et  al.  2007;  Greaves  et  al.  2009),  which  was
suggested  to  indicate  that  RMC  is  more  sensitive  and  effectively
diminishing  the  PCR-errors  as  artefacts.  Furthermore,  RMC  is
insensitive to DNA damage, such as oxidized deoxyguanosine (8-oxo-
dG),  which  would  be  mistakenly  paired  with  adenosine  by  DNA
polymerases  (Shibutani et al. 1991), and thus, artificially detected as a
fixed GC>TA variant. Again, sensitivity to DNA damage is a potential
factor increasing the variant loads observed by PCR-based methods in
comparison  to  RMC  (Vermulst  et  al.  2007).  A major  acknowledged
drawback of RMC is that the result may not be an accurate reflection of
the total variant load of the entire mtDNA genome because the target
restriction site represents only very short part of the genome (Vermulst
et al. 2007; Greaves et al. 2009), thus RMC might not detect clonally
expanded variants which are rare across the mtDNA genome (Greaves et
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al. 2014).
In comparison to the published literature, Vermulst et al. (2007) detected
very  low mtDNA variant  load  in  young wild-type  mice,  on  average
6.0x10-7 ± 0.9x10-7 mut/bp,  whereas  older  mice  showed  1.1x10-
5 ± 0.3x10-5 mut/bp (Vermulst et al. 2007). Meanwhile, Ross et al. (2013)
detected 2.0x10-5 mut/bp in WT mice by PCS and estimated the method
error rate to be <3.5x10-6 mut/bp  (Wanrooij S. et al. 2012, Ross et al.
2013). These results suggest that, despite the discussed disadvantages,
these  methods  are  very  sensitive approaches  to  measure  the  mtDNA
variant load. However, they require extensive optimization or hands-on
time and fail to represent the entire mtDNA genome or the costs become
prohibitive.  Thus, over the recent years  the focus has turned to deep
sequencing technologies.
1.2 Deep sequencing technology overview
For over a  decade already, advancements in various deep sequencing
technologies have decreased the costs significantly and replaced earlier
high-throughput methods, like microarrays, as a routine method used in
DNA variant  detection. These technologies  are often referred to with
variable umbrella  terms and abbreviations with sometimes confusing,
mixed  usage:  deep  sequencing,  high-throughput  sequencing  (HTS),
massively-parallel sequencing (MPS), second-, third-, fourth- or next-
generation  sequencing  (NGS),  DNA-seq  or  simply  by  the  company
name,  who  first  invented  the  sequencing  platform  in  question  (e.g.
SOLiD,  IonTorrent,  PacBio,  MinION or  Illumina  sequencing).  Since
this PhD thesis focuses on deep sequencing of mtDNA, hereafter simply
the  term  'sequencing'  is  used  to  refer  to  deep  sequencing  unless
otherwise mentioned. 
This  chapter  first  introduces  different  sequencing  technologies.  The
reviewed technologies include two long-read sequencing technologies:
single-molecule real-time sequencing (SMRT) by Pacific Biosciences of
California, Inc. (PacBio) and MinION sequencing by Oxford Nanopore
Technologies,  as well as different short-read sequencing technologies:
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IonTorrent  sequencing  and  SOLiD  sequencing  currently  owned  by
ThermoFisher  Scientific  and  HiSeq  sequencing  by  Illumina  Inc.
Comparison of key values such as required input DNA or run time of the
different sequencing platforms is summarized in Table 1.1. Finally, the
main  data  analysis  steps  and  potential  artefacts  introduced  during
sequencing are discussed.
Table 1.1. Comparison of different sequencing platforms. Input DNA, run time,
yields, read lengths and accuracies of different sequencing platforms from the
provider's web pages at the time of writing (08/2017).
Technology Instrument Input(ng) Run time
Yield 
(per run)
Read
length
Accuracy
(%)
Sanger 3703xl 1–300 2 h ~96 kb <1 kbp 99.99
SMRT PacBio Sequel 10–100 0.5–10 h 5–8 Gb >20 kb >99.999
Nanopore MinION 0.01 Real time Up to 17
Gb
Up to
200 kb
~92 (with
1D reads)
SOLiD SOLiD 4 10 12 d 100–300
Gb
35 bp >99.94
IonTorrent Ion 318 v2 10 4.4–7.3 h 0.6–2 Gb 200–
400 bp
99.99
Illumina HiSeq 2500 1–100 5 d ~400 Gb 2 x 100bp
>80 % of
reads with
accuracy
99.9
Illumina HiSeq 3000/ 4000 1–50 <1–3.5 d
750–1300
Gb
2 x 150
bp
>75 % of
reads with
accuracy
99.9
1.2.1 Sequencing library and cluster generation
In short-read technologies, the DNA is first sheared to short fragments,
either  by  mechanical  or  enzymatic  methods.  Mechanical  methods
include commonly used acoustic shearing by Covaris Adaptive Focused
AcousticsTM (AFA)  technology  (COVARIS,  Inc.),  which,  similar  to
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sonication  by  Bioruptor® ultrasonicator  (Diagenode  Inc.),  utilizes  the
acoustic  cavitation to  fragment  the  DNA.  Another,  older,  mechanical
method is nebulization, in which the DNA is forced through a small hole
(Sambrook & Russell 2006). In addition to Covaris shearing, enzymatic
fragmentation is often applied, of which the potentially most common
method is tagmentation. In tagmentation, the DNA is fragmented and
sequencing  adapters  are  simultaneously  ligated  to  the  fragment,  thus
reducing  the  processing steps  (Adey et  al.  2010).  Another  enzymatic
approach is developed by New England Biolabs, and it is based on two
enzymes;  one generates  nicks on the double-stranded DNA (dsDNA)
and the  other  enzyme breaks the  DNA at  the  nicked  site  (NEBNext
dsDNA Fragmentase, New England Biolabs).  Although claimed to be
random,  all fragmentation methods may introduce bias (Poptsova et al.
2014) or  even artefactual  variants  (Costello et  al.  2013, as  discussed
later in this chapter). 
In contrast, with long-read sequencing technologies, direct usage of long
PCR amplicons  or  restriction  digested  DNA is  possible.  However,  if
fragmentation  is  required,  the  long  fragments  can  be  achieved  by
different  methods,  such  as  Covaris  g-Tube,  which  can  fragment  the
DNA up to 20 kb fragments based on centrifugal  forces (COVARIS,
Inc.).  Furthermore,  long-read sequencing technologies do not need to
amplify  the template DNA for sequencing,  but  instead require larger
amount of input DNA fragments to which hairpin adapters are ligated
either to both ends (SMRT) or only to one end (MinION). This differs
from  short-read  sequencing  technologies  which  generally  require  a
template amplification step after the adapter ligation. Moreover, short-
read  sequencing  technologies  reach  massive  parallelization  by
amplification of the DNA to form clonal DNA template clusters on a
solid surface (reviewed by Goodwin et al. 2016). 
Two main techniques are used to form the clonal sequencing clusters –
emulsion PCR and solid-phase bridge amplification. The latter is applied
by Illumina, whereas the other technologies discussed here utilize the
emulsion PCR. In emulsion PCR, as the name already indicates, DNA
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fragments  are  diluted  into  water-oil  droplets  to  such  degree  that  a
droplet contains only a single molecule  (Dressman et al. 2003). Each
droplet  forms  a  microscale  PCR reaction  as  it  also  contains  primer,
dNTPs and DNA polymerase.  The droplets  are combined with beads
covered with primers complementary to the adapter sequence, and when
subjected to PCR cycling conditions, the template DNA hybridize with
the bead-bound primer  leading to  extensive amplification of  a  single
template. The complementary strand is dissociated and the bead is left
with thousands of single-stranded DNA (ssDNA) templates  (Dressman
et al. 2003). The beads can then be immobilized into wells or on a glass
slide for sequencing. 
In  the  solid-phase  bridge  amplification  technique  the  DNA template
cluster synthesis takes  place directly on a slide which has covalently
bound primers.  One  of  the  primers  is  complementary  to  the  adapter
sequence and ssDNA fragments applied to the slide can hybridize with
the primer. After amplification, the original DNA strands are dissociated
whereas  the  newly  formed  complementary  DNA strand,  covalently
bound to the slide, is hybridized to the other adapter bound on the slide
and again amplified – hence the technique name 'bridge amplification'.
This  way  millions  of  distinct  clusters  of  clonal  DNA templates  are
formed (Illumina, Inc.).
1.2.2 Long-read sequencing technologies
Of  the  long-read  sequencing  technologies,  SMRT  was  established
almost a decade ago (Travers et al. 2010), whereas MinION sequencing
has been in developmental use since 2014 (Jain et al. 2016). In SMRT,
or  specifically  SMRTbell,  the  sequencing  takes  place  in  a  miniscule
scale  multi-well  plate  with  transparent  bottoms  called  zero-mode
waveguides (ZMW, Levene et al. 2003). The DNA polymerase is fixed
to the bottom of the well, and a single DNA molecule is sequenced in
each well. The SMRTbell hairpin adapters allow primer binding to the
single-stranded hairpin loop, which is further bound by the polymerase
and incorporation of fluorescently labelled dNTPs is monitored by laser
and camera from each individual  wells (reviewed by  Goodwin et  al.
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2016).  The two hairpin adapters circularize the template allowing the
strand-displacing  DNA  polymerase  to  proceed  through  the  DNA
molecule  multiple  times.  Formation  of  a  consensus  sequence  is
efficiently  excluding  sequencing  errors  and  increasing  the  accuracy
(Travers et al. 2010). At the time of writing, PacBio reports the average
read-length to be >20 kb and maximum >60 kb.
Portable  MinION  (or  larger-scale  GridION  and  in  the  future
PromethION) sequencing is commercial sequencing platform based on
nanopore technology (Oxford Nanopore Technologies). One end of the
DNA fragment is  attached to a leader sequence which can attach the
DNA  to  a  nanopore,  which  is  located  across  a  membrane.  The
membrane separates electrolyte solution, and an ionic current is formed
when the solution is moved through the nanopore. When the template
DNA is moving through the nanopore, changes in the ion current reflect
k-mers of the DNA sequence blocking the pore. Similar to SMRT, the
hairpin  adapter  at  the  other  end  of  the  DNA  fragment  enables
sequencing of  the  both strands  and formation of  consensus sequence
increases the accuracy (Jain et al. 2016). At the time of writing, Oxford
Nanopore Technologies promises to reach even >200 kb read-lengths.
1.2.3 Short-read sequencing technologies
Sequencing-by-ligation technology
Sequencing  by  oligonucleotide  ligation  and  detection  (SOLiD)
technology  is  short-read  sequencing  technology  based  on  short,
fluorescently labelled probes in which one or two nucleotides are known
and the rest are degenerate bases (reviewed by Voelkerding et al. 2009).
The  sequencing  consists  of  multiple  cycles  of  series  of  reactions
including  competitive  annealing  of  the  probe  to  the  template  DNA,
ligation, removal of unbound probes and reading the fluorescent signal.
Once the first round is finished, the formed dsDNA is denatured and
sequencing cycling is continued with an offset of one base and this is
continued  until  35  nucleotides  are  sequenced  multiple  times.  The
resulting sequencing read-out is termed as color space -coding and has
to be deconvoluted (Voelkerding et al. 2009). 
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Sequencing-by-synthesis technologies
Sequencing-by-synthesis  technologies  include  multiple  providers  and
approaches,  here,  two  commonly  used  platforms,  IonTorrent  and
Illumina,  are reviewed.  The former applies single-nucleotide addition
(SNA) approach, which was also utilized by 454 pyrosequencing (not
discussed  here).  Illumina,  as  well  as  Qiagen's  GeneReader,  utilizes
cyclic reversible termination (CRT, reviewed by Goodwin et al. 2016). 
IonTorrent sequencing is also termed as semiconductor sequencing and
it  is  the  first  technology  enabling  sequencing  without  optical  signal
detection  (Rothberg  et  al.  2011).  Instead,  IonTorrent,  as  the  name
indicates, detects the released proton when a dNTP is incorporated. Such
detection  is  enabled  by  sequential  addition  and  washing  of  each
nucleotide and the H+ ion is released only when polymerase incorporates
the  dNTP  to  the  newly  synthesized  strand.  The  change  in  H+
concentration is then measured as a change in pH value by a sensor
including  ion-sensitive  field-effect  transistor  (ISFET)  and
complementary metal-oxide semiconductor (CMOS). The raw voltage
signal is then processed to base calls  (Rothberg et al. 2011), however,
accurate homopolymer sequencing is challenging due to the fact that the
same nucleotides are incorporated during single measurement and the
change in pH value cannot be exactly measured (Goodwin et al. 2016).
The basic idea of cyclic reversible termination approach is similar to
Sanger sequencing in which the dNTP bound to a terminator blocks the
elongation. In contrast to SNA, in CRT all four nucleotides are added
and only one is incorporated by the polymerase. The labelled dNTP is
imaged and the elongation termination is reversed by removal of the
fluorophore and blocking group. Earlier Illumina utilized four-channel
detection  to  image  the  sequence,  however,  the  newer  machines  use
much faster two-channel detection. In two-channel detection, instead of
using four dyes, one for each dNTP, mixture is used and for example G
is detected as non-labelled cluster  (Illumina 2016). Furthermore, since
HiSeq3000, the flow cell type is now a patterned flow cell, on which the
cluster generation takes place in nanowells. This way the clusters are
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evenly spaced decreasing the time required for sequence analysis when
the software does not need to predict the cluster location. Moreover, it
increases the cluster density on the flow cell, thus decreasing the costs
(Illumina 2015).
1.2.4 Key sequencing data analysis steps and their potential 
artefacts
The accuracy of variant detection lies not only in good sample quality
but also on proper data analysis steps,  starting from the fluorescence
image  analysis  until  the  variant  filtering  thresholds.  As  reviewed  by
Nielsen et al. (2011), base-calling algorithms determine the nucleotide
content of a read from the read image (SOLiD, Illumina) including a
measure  of  uncertainty  called  base-call  quality  score  (Nielsen  et  al.
2011),  which is given as Phred score  (Ewing et  al.  1998) defined as
QPhred = −10 log10 P, where P is error probability. Thus, Phred score 30
means  that  the  chance  of  an  incorrect  base-call  is  0.1 %.  Often  the
sequencing platform provider's base-calling algorithm is used, however,
according to Nielsen et  al. (2011),  development of better base-calling
algorithms have improved the error rates up to ~30 %, and for example,
earlier extremely high error  rates of MinION have been significantly
improved by development of MinION compatible tools, including base-
calling algorithms and read aligners (Jain et al. 2016). 
Very often in Illumina sequencing, the samples are multiplexed in order
to reduce the costs as several samples may be sequenced on a single
lane. The index sequence is included into the sequencing adapter and it
is sequenced after the actual read sequencing in a separate process with
a new primer. After base-calling, the multiplexed reads need to be de-
multiplexed i.e. separated based on their index sequence (Kircher et al.
2012). Sequencing errors, errors in the synthesis of the oligos or failure
in library preparation pose a risk that a read is mistakenly assigned to
another  sample  –  a  phenomenon  called  as  index  hopping  or  index
switching  (Illumina 2017; Sinha et al. 2017). The multiplex design is
aimed  to  be  complex  enough  such  that  several  bases  need  to  be
erroneous before the indices are misassigned, thus, effectively lowering
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the  probability  of  a  sequencing  error  to  cause  the  misassignment.
Furthermore, during de-multiplexing only zero or one mismatches are
usually  allowed  in  the  index  sequence.  This,  nevertheless,  does  not
exclude the possibility that oligos are contaminated during synthesis or
library  preparation  (Kircher  et  al.  2012),  which  inevitably  leads  to
indistinguishable indices and misassigned reads. 
Index  switching  has  been  a  known artefact  for  years  (Kircher  et  al.
2012), and it is unavoidable, causing a low base level of errors. This is
not an issue for most sequencing applications  (Illumina 2017), but for
example,  in  accurate  low-frequency  variant  detection,  genotyping  or
single-cell RNA-seq it is a significant problem. The switch to patterned
flow-cell usage significantly increased the occurrence of index hopping
(Illumina 2017), which has recently raised serious concerns  (Hadfield
2016,  accessed  08/2017;  Linck  2017,  accessed  08/2017;  Sinha  et  al.
2017), although, no peer-reviewed publication is available on the topic
at the time of writing (08/2017). As already suggested by Kircher et al.
(2012)  as  well  as  noted  by  Illumina  (2017)  and  also  discussed  by
Hadfield  (2016,  accessed  08/2017),  dual-indexing  is  an  effective
solution to avoid index switching. It, however, is currently only possible
in 6- or 8-plex combinations, thus, reducing the throughput  (Illumina
2017) and  require  paired-end  read  mode,  eventually  increasing  the
sequencing costs. 
Data  pre-processing  generally  includes  trimming  off  of  low-quality
bases and adapter leftovers.  In Illumina reads for example, especially
with the earlier chemistries, the base-calling quality heavily decreased
towards the end of the read. This was and is due to the enzyme activity
and  de-phasing  (Fuller  et  al.  2009).  De-phasing  means  that  while
incorporating new nucleotides to the cluster of probes, due to a missed
incorporation  or  a  failed  termination  reaction  the  synchronization
between different strands within the cluster is lost. This will lead to an
ambiguous  fluorescence  signal  from  that  cluster  and  decrease  the
reliability of the base-call (as reviewed by Reinert et al. 2015). 
Read alignment is the next fundamental analysis step. The aligner has to
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tolerate errors and variants in the read, yet being able to assign it to the
most  correct  location  i.e.  approximate  string  matching  problem  (as
reviewed by Reinert et al. 2015). The basic idea in the read alignment is
to create string indices either from the reference genome, reads or both,
thus, querying of these substrings is much faster than querying the entire
data set (Nielsen et al. 2011; Reinert et al. 2015). A commonly utilized
data  compression  algorithm  is  Burrows-Wheeler  transformation
(Burrows  &  Wheeler  1994),  for  example  implemented  in
Bowtie/Bowtie2  (Langmead  et  al.  2009;  Langmead  &  Salzberg
2012) and  BWA  (Li  &  Durbin  2009),  which,  based  on  number  of
citations,  are  the  most  commonly used  DNA read  aligners  (Fonseca,
accessed 08/2017). Over the years, a plethora of read aligners have been
developed (list of aligners updated in 2015, Fonseca, accessed 08/2017)
and  the  suitability  of  each  aligner  should  be  determined  for  each
application  as  aligners  vary  e.g.  in  their  capability  to,  for  instance,
introduce long gaps (here termed as splice-aware aligners), to conduct
global  or  local  alignment,  or  to  tolerate  different  read  lengths  or
mismatches. Often alignment sensitivity is a trade-off with the run time
(Otto et al. 2014). 
As  in  base-calling,  aligners  also  report  a  quality  score  (mapping
quality),  which  is  for  example  utilized  to  increase  the  accuracy  of
variant calling (Nielsen et al. 2011). Each mismatch or gap in the read
decrease  the  mapping  quality,  as  well  as  failure  to  find  a  ”unique”
match, which is especially difficult  in genomes containing repeats or
low-complexity regions (Reinert et al. 2015). One key issue in utilizing
the mapping qualities is the lack of standardization and documentation
of the tools: different aligners have variable maximum mapping quality
values and variable thresholds for describing ”uniquely mapped” reads
(based on own experiences as well as  Urban 2014, accessed 08/2017;
Bradnam  2015,  accessed  08/2017).  Thus,  an  important  step  in
sequencing data analysis is to find the most suitable aligner, define the
alignment strategy (global/local, mismatch or gap penalties etc.) and to
consider only highly accurately (i.e. ”uniquely”) aligned reads for the
downstream processing.
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Variant calling is the final step and, again, a plethora of algorithms and
reviews on their performances exists (e.g. Altmann et al. 2012; Pabinger
et al. 2013 and Sandmann et al. 2017 just to mention a few). In human
genetics,  the  most  widely  used  variant  callers  seem  to  be  GATK
(DePristo et al. 2011), SAMtools (Li et al. 2009) and VarScan (Koboldt
et  al.  2009).  Recently  VarDict  has  been  suggested  to  be  a  good
alternative  (Lai et al. 2016; Sandmann et al. 2017). Moreover, GATK
Best Practices are widely accepted for variant detection (van der Auwera
et al. 2013). These tools and practices, however, are mostly developed
for genotyping a diploid human genome, thus, their suitability for other
type of applications may be limited. Nonetheless, many steps of the Best
Practices  (van  der  Auwera  et  al.  2013) generally  apply  in  accurate
variant  detection despite  the exact  experiment  in  question:  only high
quality bases should be considered when calling a variant, the variant
should  be  supported  by  many  reads  (total  coverage),  the  read
distribution over forward and reverse strands should be balanced and
also the variant supporting reads should follow the distribution of the
reference  reads  (Fisher's  exact  test  of  strand  bias,  reported  as  Phred
score).  Additionally,  variants  are  often  filtered  with  hard-coded
thresholds for minimum allele frequency (AF) or minimum quality of
the variant call, which can reduce the number of false positive variants
but also lead to false negative results. 
Many tools are based on Bayesian (e.g. GATK, SAMtools) or heuristic
(e.g. Varscan) approaches, whereas LoFreq* (Wilm et al. 2012) is based
on Poisson-binomial  distribution  (Sandmann et  al.  2017).  Some tools
specifically  model  sequencing  (LoFreq*)  or  PCR errors  (VarDict)  to
increase  sensitivity.  And  indeed,  one  key  difference  between  variant
callers  that  is  relevant  for  the  work  presented  in  this  thesis,  is  their
capability  to  detect  low-frequency  variants.  For  example,  GATK  is
recommended for detection of AF >20 % variants (DePristo et al. 2011),
which  is  understandable  given  that  the  tool  is  originally  aimed  for
diploid genome variant analysis. Moreover, not all tools are capable of
handling high-coverage data like VarDict is  (Lai et al. 2016). And, for
example  LoFreq*  is  especially  designed  to  detect  low-frequency
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variants from high-coverage data without assumptions on ploidy as it
has been developed for viral data (Wilm et al. 2012), which would more
resemble the nature of mtDNA. 
Thus, sensitivity and accuracy of the variant detection is dependent on
all of the key data analysis steps presented above. Additional fine tuning
(yet  sometimes  controversial)  analysis  steps  include  for  example  de-
duplication, local re-alignment and quality score re-calibration (van der
Auwera et al. 2013). In summary, the data analysis should be carefully
designed keeping in mind the specific application and suitability of each
tool for the data set and the research question.
1.2.5 Other artefacts
Also other than the above-mentioned data analysis artefacts might exist
in the variant results. These originate from the sample processing and
since those are of biological or chemical origin, they are very difficult to
distinguish from true variants. For example, DNA damage may lead to
misincorporation  of  a  nucleotide  or  during  PCR  enrichment  early
polymerase errors may expand exponentially,  or the enrichment itself
might be biased and not all alleles are amplified equally.
All sample preparation steps should be conducted without unnecessary
damage to the DNA. It is  well-known that heat and acid exposure cause
apurinic/apyrimidinic sites (Cabral Neto et al. 1992), which may either
block  the  DNA polymerase  or  lead  to  substitutions  (as  reviewed  by
Eckert & Kunkel 1991). For example, cytosine deamination leading to
uracil, and thus CG>TA variants, commonly occurs in formalin fixed,
paraffin embedded samples, as well as during PCR thermocycling (Chen
et  al.  2014).  Another  common error  potentially  introduced  by  DNA
polymerases is mispairing T and G, thus leading to artefactual AT>GC
variants. Moreover, polymerase jumping (i.e. strand-switching) is also
said to increase when the DNA is damaged  (Eckert & Kunkel 1991).
This could, for example, lead to increased index hopping during library
preparation PCR. Li & Stoneking (2012) observed 15 % chimeric reads
when 40–90 samples were multiplexed together (Li & Stoneking 2012).
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One commonly observed sequencing artefact are GC>TA variants (Chen
et al. 2017). This variant is commonly used as a signature of oxidative
damage to DNA as an oxidative lesion, 8-oxo-dG, is sometimes paired
with A by DNA polymerase (as reviewed by Kauppila & Stewart 2015).
Oxidative damage may be introduced during DNA extraction if oxidized
phenol is used (Claycamp 1992), thus it is advisable to use other means
to  extract  the  DNA.  Furthermore,  acoustic  shearing  of  DNA during
sequencing  library  preparation  has  been  shown  to  induce  oxidative
damage,  especially  at  certain  GC-rich  motifs  (Costello  et  al.  2013).
Costello et al. (2013) suggested that a contaminant present in the sample
could induce the oxidative damage. Also, the temperature easily rises
during sonication if too harsh shearing conditions are used for low-input
DNA samples. It  was reported that the addition of a chelator into the
sample might reduce the damage (Costello et al. 2013). Similar reports
have  been  published  and  the  use  of  repair  enzymes  in  the  library
preparation  is  suggested  as  a  solution  since  the  exact  cause  of  the
damage  has  not  been  identified  and  thus  cannot  be  excluded
(Arbeithuber et al. 2016; Chen et al. 2017).
1.3 Recent high-sensitivity variant detection methods
As  discussed  by  Fox  et  al.  (2014),  the  development  of  sequencing
platforms continues, yet reliable variant detection <1 % still seem to be
problematic due to various biases introduced during sample processing
or sequencing signal detection. During past years, an increasing number
of more complex sequencing approaches have been proposed in order to
control for various biases and to increase the variant detection accuracy.
1.3.1 PELE-Seq
Paired-End Low-Error Sequencing (PELE-Seq) aims to remove PCR-
and  sequencing  errors  by  sequencing  overlapping  reads  which  are
tagged by two indices  (Preston et al. 2016). Paired-end sequencing is
conducted with short insert size (100 bp), thus the insert is sequenced
twice and a formation of a consensus sequence is possible. The idea is
similar  to  long-read  sequencing  approaches,  and  can  be  applied  to
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remove sequencing errors from the reads as a sequencing error is likely
present only in one of the reads. Incorporation of dual-indexing to the
DNA fragments increases the variant calling accuracy as the variant is
required to be present in the read with both indices (Preston et al. 2016).
PELE-Seq analysis utilizes LoFreq* variant caller (Wilm et  al.  2012)
and reliable variant detection threshold is set to AF of 0.2 % even with
extremely high coverage (~60000x). They suggest inclusion of control
samples with each sequencing run in order to empirically determine the
suitable variant calling thresholds for each experiment. In comparison to
standard sequencing library,  PELE-seq allowed equal sensitivity  with
highly  improved  precision,  and  Preston  et  al.  (2016)  especially
recommended the method for  accurate and cost-efficient  amplicon or
small genome sequencing (Preston et al. 2016). 
1.3.2 Circle sequencing
To improve the sequencing error rates, Lou et al. (2013) developed a
library  preparation  method  that  utilizes  circular  DNA templates  and
rolling circle amplification (Lou et al. 2013). In this circle sequencing,
the  short  DNA  template  (amplicon,  cDNA  or  DNA  fragments)  is
denatured and ssDNA is circularized. The circularized template DNA is
amplified  with  random  primers  by  φ29,  which  possesses  strand-
displacement activity and can replicate continuously around the circular
template, in a process referred to as rolling circle amplification (RCA).
The priming takes place also on newly synthesized DNA strands and the
final DNA product is branched, tree-like structure containing physically
linked,  multiple  copies  of  the  single  template  DNA.  The  original
fragment  length  should  be  approximately  one  third  of  the  desired
sequencing  read  length,  thus  the  original  DNA fragment  is  present
multiple times within a single read. Such linkage allows efficient error
removal when a consensus sequence is formed. The error rate reported
for  the  circle  sequencing  was 2.8x10-4. The main artefactual  variants
were CG>TA, likely arising from spontaneous deamination of cytosine
to  uracil.  By  addition  of  uracil-DNA  glycosylase  (UDG)  and
formamidopyrimidine-DNA  glycosylase  (Fpg)  to  excise  deaminated
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cytosine  and  8-oxo-dG,  respectively,  the  error  rate  was  improved  to
7.6x10-6  (Lou et  al.  2013).  This  approach  could be beneficial  to  any
amplicon  sequencing  experiment  or  even  included  to  the  standard
sequencing library preparation PCR step.  Due to consensus sequence
formation, the maximum theoretical efficiency of the method is 33 %,
however, Lou et al. (2014) observed only ~20 % efficiency (Lou et al.
2013). Thus, the increase in accuracy also increases the sequencing costs
significantly. 
1.3.3 Unique molecular identifiers
Safe-SeqS
Safe-Sequencing System, Safe-SeqS, introduced by Kinde et al. (2011),
utilizes  unique  molecular  identifiers  (UMI)  to  increase  the  variant
detection  accuracy  from  captured  genes  (Kinde  et  al.  2011).  They
simply ligated  standard Illumina adapters  to  the DNA fragments  and
sequenced  the  formed  libraries  observing  an  error  rate  of  2.4x10-4
mut/bp with a stringent variant calling. However, Safe-SeqS analysis is
based on the clever idea of using randomly sheared DNA fragment ends
as  endogenous  unique  molecular  identifiers  to  form  consensus
sequences of the original DNA templates. This way the error rate was
decreased  to  3.5x10-6 mut/bp.  The  approach  was  improved  by  also
adding  exogenous  12–14-nt  single-stranded  identifiers,  which
significantly  increased  the  number  of  UMIs  and  thus  the  number  of
targets that could be analyzed. Safe-SeqS claimed realible detection of
AF 0.001 % (1x10-5) (Kinde et al. 2011). 
Duplex Sequencing
Schmitt  et  al.  (2012),  and  later  updated  by  Kennedy  et  al.  (2014),
extended on the single-stranded UMI applied in Safe-SeqS, to the use of
double-stranded, 12-nt random UMIs at both ends of dsDNA fragment –
a method called Duplex Sequencing (Schmitt et al. 2012; Kennedy et al.
2014). This way, both strands of the DNA template become uniquely
labelled.  After  PCR-amplified  library  preparation  and  high-depth
sequencing,  single-strand  consensus  sequences  as  well  as  duplex
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consensus sequences can be formed. Single-strand consensus sequence
is effective in removing sequencing errors, whereas duplex consensus
sequence  is  used  to  eliminate  even  first-cycle  PCR-errors  which  are
indistinguishable from real variants by all the other sequencing methods
relying  on  single-strand  sequencing.  The  key  in  Duplex  Sequencing
library preparation is that the strands of dsDNA are not separated from
each other before UMI ligation – limiting the usage of certain DNA
extraction or amplification methods, e.g. plasmid prep which is based on
physical separation of the DNA strands from each other (Kennedy et al.
2014). 
Moreover, the input DNA and adapter amounts, PCR amplification and
sequencing  depth  have  to  be  in  a  delicate  balance  to  obtain  optimal
distribution of copies of each UMI pairs  (Kennedy et al. 2014). With
single-strand consensus sequence, Schmitt et al. (2012) observed error
rate of  3.4x10-5 mut/bp  (Schmitt  et  al.  2012),  whereas  application of
duplex  consensus  sequence  analysis  decreased  it  to  an  estimation  of
3.8x10-10 mut/bp.  Duplex  Sequencing  was  capable  to  detect  AF
0.00001 % (1x10-7), and they claim to reach even 5x10-8 AF detection
threshold (Kennedy et al. 2014). However, as with circle sequencing, a
significant  amount  of  data  is  wasted  –  the  efficiency  of  Duplex
Sequencing was estimated to be only 0.8 % (Lou et al. 2013).
CypherSeq
The latest improvement to UMI or circle sequencing is represented by
CypherSeq  (Gregory et  al.  2015).  In  CypherSeq,  the pUC19 plasmid
backbone  with  sequencing  adapters  and  7-nt  double-stranded  UMIs
surrounding the cloning site is utilized. Template DNA is ligated into the
vector  and  amplified  either  by  PCR,  RCA,  or  by  cloning  before
sequencing. As in the other methods, the barcodes allow formation of
consensus  sequences  and  thus  efficient  error  removal.  The  clear
advantage  of  CypherSeq  over  earlier  methods  is  the  simple
amplification  of  the  sample  and  compatibility  with  all  sequencing
platforms.  CypherSeq  was  shown  to  detect  AF  2.4x10 -7  –  without
detecting any erroneous variants (Gregory et al. 2015).
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1.3.4 Summary
Although all  of  the  presented  methods  are  efficiently  decreasing  the
error  rate  and  enhancing  the  detection  precision  (as  summarized  in
Table  1.2),  this  comes  with  a  cost.  Mostly,  the  hands-on  time  is
increased in comparison to standard sequencing, and more importantly,
the required sequencing depth might raise the costs to prohibitive levels.
Indeed, as mentioned by Lou et al. (2013), one should consider whether
the project truly requires detection of ”the rarest of rare variants” (Lou
et  al.  2013).  Furthermore,  the  mentioned  studies  did  not  discuss  the
method sensitivity comprehensively but only reported the lower error-
rates and allele frequency detection thresholds.
Table  1.2.  Comparison  of  detection  thresholds  and  error  rates  of  high-
sensitivity sequencing methods.
Method Sample preparation Detectionthreshold
Error
rate Reference
PCS ~1 kbp PCR n.a. 3.5x10-6 Ross et al. (2013)
PELE-seq Short fragments/amplicons 2x10
-3 n.a. Preston et al. (2016)
Circle
sequencing
Short fragments/
amplicons
n.a. 7.6x10-6 Lou et al. (2013)
Safe-SeqS No additional sample preparation steps
1x10-5 3.5x10-6 Kinde et al. (2011)
Duplex
Sequencing Input optimization
1x10-7 3.8x10-10 Schmitt et al. (2012), 
Kennedy et al. (2014)
CypherSeq PCR/RCA/cloning 2.4x10
-7
n.a. Gregory et al. (2016)
n.a. = not annotated
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1.4 Mitochondrial DNA variant detection by deep 
sequencing
1.4.1 Nuclear sequences of mitochondrial origin – NuMTs
A cell harbors several to thousands of mitochondria which can harbor
altogether  thousands of  mtDNA molecules,  yet  from a total  genomic
DNA (gDNA) extraction <1 % is mtDNA. Although this sounds like a
very  small  amount,  due  to  the  small  size  of  the  genome,  low-depth
sequencing  of  gDNA  (one  Gbases)  can  yield  >600x  coverage  of
mtDNA. Therefore, mtDNA reads can be obtained as a by-product of
whole-genome sequencing, often with >1000x coverage (Li et al. 2012).
In  theory,  such  coverage  would  allow  reliable  detection  of  mtDNA
variants present at as low as ~1 % allele frequency (AF). However, a
major challenge is caused by nuclear sequences of mitochondrial origin
(NuMTs),  as the nuclear genome harbors not only genes required for
mitochondrial  function  but  also  mitochondrial  pseudogenes.  These
NuMTs are  chunks of  mtDNA which are  naturally  transferred to  the
nucleus and incorporated to the nDNA via non-homologous end-joining
at  double-strand  breaks  (Hazkani-Covo et  al.  2010).  NuMTs may be
polymorphic  and  present  or  absent  in  different  individuals,  and
moreover, the mtDNA is constantly transferred to the nucleus creating
new  100 % homologous  NuMTs  and  between-individual  variation  in
their NuMT content (Hazkani-Covo et al. 2010, Calabrese et al. 2012). 
NuMTs have been identified in most species, including  Mus musculus
genome. The mouse genome sequence was estimated to harbor ~37 kbp
of  NuMTs  as  137  BLAST hits  (Hazkani-Covo  et  al.  2010),  or  172
chunks ranging from 33 bp to 4.7 kbp in length with 66–100 % identity
(Calabrese et al. 2012). Malik et al. (2016) estimated that >95 % of the
mouse  mtDNA genome is present in nDNA  (Malik et  al.  2016).  The
number  of  detected  NuMTs  depends  on  search  strategy  as  well  as
nuclear  genome  version  and  completion  level  (Hazkani-Covo  et  al.
2010).
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The  presence  of  NuMTs  and  their  above-mentioned  characteristics
complicate the design of mtDNA primers and, indeed, some reported
pathogenic mtDNA mutations have been actually NuMT polymorphisms
(Yao et al. 2008). Furthermore, it has been acknowledged that NuMTs
may  affect  amplification-  or  blotting-based  mtDNA  content
measurements  (Malik et  al.  2016).  Similarly it  may hamper accurate
mtDNA variant  detection  by  high-throughput  sequencing,  as  NuMTs
may be 100 % identical to mtDNA and increase the wild-type reads and
might cause even false negative variant detection results.  Or,  NuMTs
reads harbor a variant, which will be impossible to distinguish from a
true positive variant  result. Various sequencing approaches have been
applied to reliably detect mtDNA variants and are discussed below in
separate sections.
1.4.2 Indirect and capture-enriched mitochondrial DNA sequencing 
methods
Whole-genome  sequencing  or,  even  more,  exome  sequencing  is
commonly used for nDNA-focused studies. In exome sequencing, the
coding  regions  of  nuclear  genome  are  capture-enriched  before
sequencing. However, even half up to of the sequencing reads originate
from non-target sources, and for example, the mtDNA genome typically
reaches even 100x coverage (reviewed by  Samuels et al. 2013). Thus,
mtDNA can be sequenced indirectly by utilizing these by-products of
these data sets  (Picardi  & Pesole 2012).  A tool,  MitoSeek,  exists for
extracting mtDNA reads from exome or whole-genome sequencing data
and to perform variant detection as well as copy number determination
(Guo et al. 2013). Samuels et al. (2013) stressed that NuMTs are present
in  these  by-product  data  sets,  and  MitoSeek  takes  the  conservative
approach to avoid NuMTs in the data set; reads are first aligned to the
nuclear  reference  genome  and  only  unmapped  reads  are  used  for
mtDNA analysis (Guo et al. 2013; Samuels et al. 2013). Yet, they have
later determined that such alignment strategy leads to poorer results in
variant detection than less conservative alignment, in which either only
the  mtDNA reference  genome  or  the  full  reference  genome  is  used
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(Zhang et al. 2016).
Another method, sequencing of capture-enriched mtDNA (Maricic et al.
2010), is also prone to artefactual variants caused by NuMTs. Li et al.
(2012)  showed  that  NuMTs  are  present  in  capture-enriched  mtDNA
sequencing data and they interfere with accurate low-frequency variant
detection  (Li et al. 2012). With a statistical method, they were able to
reliably detect variants at a level of AF 5 % without any false positive
results. The sensitivity could have been improved by higher sequencing
depth.  Furthermore,  they  compared  the  results  to  whole-genome
sequencing, which showed significant proportion of variants originating
from NuMTs (Li et al. 2012). Thus, indirect or capture-enriched mtDNA
sequencing seems to be suitable only for high-frequency mtDNA variant
detection (Griffin et al. 2014) or, for example, for de novo assembly of
an unknown mitochondrial genome.
1.4.3 Amplification-based mitochondrial DNA enrichment and 
sequencing
Generally, long-range PCR amplification of mtDNA is considered as a
method of choice to cost-efficiently avoid the presence of NuMTs yet to
obtain  high-coverage  over  the  mtDNA genome  (Payne  et  al.  2015).
Different approaches have been suggested to amplify the entire mtDNA:
in multiple short or two or more longer amplicons (Dames et al. 2013;
Payne et al. 2015), or an even better way to avoid NuMTs amplification
would be to amplify the mtDNA in a single long amplicon  (Cui et al.
2013). Li et al (2012) utilized long-range PCR of mtDNA sample as a
reference  when comparing the  variant  results  from whole-genome or
capture-enriched mtDNA sequencing.  However,  even with long-range
PCR, 23 % of the detected variants were likely NuMTs (Li et al. 2012).
These  results  highlight  the  need  of  careful  primer  design  such  that
NuMTs amplification is minimized,  and the primer design should be
tested  by  BLAST,  and  failure  of  NuMTs  amplification  could  be
empirically verified by utilizing ρ0 DNA, which has been depleted from
mtDNA (Payne et al. 2015). 
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Long-range  PCR  amplification  and  sequencing  is  utilized  in  human
studies to detect mtDNA variants or deletions (e.g. (He et al. 2010; Li et
al. 2010; Zaragoza et al. 2010; Payne et al. 2011; Sosa et al. 2012; Payne
et al. 2013; McElhoe et al. 2014; Gardner et al. 2015; Pyle et al. 2015).
Often the variant detection threshold has been high (AF >10 %) mainly
due  to  limited  coverage  and  higher  error-rates  of  the  earlier
technologies, whereas the later publications used lower thresholds (AF
~0.2–1 %). Payne et al. (2015) suggested that sequencing platform error-
rate will be the main limiting factor in variant detection. With a high-
accuracy  platform,  as  low  as  AF  0.1 %  can  be  reached  at  8000x
coverage, and higher coverage would not further improve the sensitivity.
Furthermore, Payne et al. (2015) remind us of the importance of using
high-fidelity DNA polymerase (Table 1.3) for the amplification in order
to avoid unnecessary artefacts (Payne et al. 2015). 
Table 1.3. Fidelities of different DNA polymerases.
Polymerase Error
rate
Fidelity
relative to
Taq
Longest
product
length
Provider(s) Reference(s)
Phusion® 4.4x10-7 >50x <20 kbpa a, b a, b
KOD 5.7x10-6* ~4x ~15 kbp c (Takagi et al.
1997)
PrimeSTAR
GXL
6.2x10-5 60xd >30 kbp d d
φ29 <9.5x10-6 ~2x* >70 kbpa a, b (Esteban et al.
1993; Paez et al.
2004)
a =  ThermoFisher  Scientific,  b  =  New England  Biolabs,  Inc.,  c  =  Merck  Chemicals
GmbH, d = TaKaRa Bio Inc., * estimated from the reported values and Taq fidelity of
2.28x10-5 (reported by ThermoFisher Scientific)
In another similar long-range PCR approach the mtDNA is first enriched
by a plasmid preparation kit – based on the fact that mtDNA genome is
circular  (Quispe-tintaya et al. 2015). This mtDNA enrichment strategy
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was recently utilized to study mtDNA heteroplasmy in Chinese hamster
ovary cells. They were able to detect variants at AF >=1 %, and did not
detect  presence  of  NuMTs  (Kelly  et  al.  2017).  As  plasmid  prep  is
already enriching the mtDNA in relation to nDNA, it is logical to think
that this approach could be less susceptible for the presence of NuMTs,
however, an additional processing step could cause other artefacts. 
Instead  of  long-range  PCR  amplification,  recent  mtDNA  variant
detection approaches have focused on RCA (MitoRCA-seq by Ni et al.
2015, MitoRS by Marquis et al. 2017), which has been earlier used for
viral studies  (Johne et al. 2009). In addition to NuMTs amplification,
biased amplification or the presence of a variant at the primer site, or
sensitive reagent setup is of concern in long-range PCR amplification –
issues  which  can  be  overcome  by  RCA  (Marquis  et  al.  2017).  The
method is also called multiple displacement amplification (MDA) as it
is based on the ability of the DNA polymerase φ29 to displace the non-
template strand and generate multiple copies of a circular template in
hours  at  30 °C.  Furthermore,  amplification  can  be  primed
simultaneously at  multiple sites  with exonuclease-resistant  primers  to
increase  the  reaction  efficiency  (Dean  et  al.  2001).  Small  circular
mtDNA is preferably enriched from linear nDNA with mtDNA-specific
primers  even  from  picograms  of  DNA  (Marquis  et  al.  2017).  The
mtDNA RCA-enrichment has been also commercialized by QIAGEN,
which  provides  REPLI-g  Mitochondrial  DNA kit  (QIAGEN GmbH).
Marquis et al. (2017) combined the amplification to tagmentation-based
library preparation, whereas Ni et al. (2015) utilized restriction digestion
enzymes and size selection on agarose gel before further fragmentation
of the DNA by Covaris.
With ρ0 DNA, NuMTs contamination in RCA was shown to be <0.06 %,
and even that amount of amplification was suggested to originate from
the incomplete depletion of mtDNA (Marquis et al. 2017). However, Ni
et al. (2015) determined the NuMTs contamination with an alignment-
based  approach  reaching  ten  times  higher  estimates  for  NuMTs
originating  reads.  Yet,  even  this  was  much  lower  than  what  was
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estimated earlier for long-range PCR approach. Unlike long-range PCR,
RCA  does  not  introduce  coverage  bias  (Marquis  et  al.  2017).
Furthermore, RCA was determined as an accurate method for variant
detection:  φ29 error  rate  is  at  a  level  of  10-6 (Table 1.3)  and variant
detection  was  reliable  at  AF  1 %  on  ~3000–30000x  coverage  data
(Marquis  et  al.  2017)  or  0.3 % on ~55000x coverage  data  (Ni  et  al.
2015).
Taken  together,  amplification-based  methods  are  fast,  inexpensive,
easily  controlled and  scalable  to  high-throughput  for  mtDNA variant
detection  studies.  However,  the  accuracy  is  greatly  dependent  on
optimal PCR without significant biases and with careful primer design,
yet  still  the  risk  of  enriching  NuMTs  cannot  be  fully  excluded.
Moreover,  as  all  DNA polymerases  make  errors,  it  is  impossible  to
eliminate  these  completely  from any  analysis.  Although high-fidelity
enzymes exist,  early-cycle errors will always be possible and will be
indistinguishable from true variants. If the application does not require
extremely  sensitive  variant  detection  and  if  the  amount  of  available
sample is limited, amplification-based methods, especially RCA, seem
very promising approaches for mtDNA variant studies.
1.4.4 Traditional mitochondrial DNA enrichment and sequencing
Traditionally mitochondria are enriched from other cellular material by
differential  or  density  gradient  centrifugation  methods  (Frezza  et  al.
2007;  Wieckowski  et  al.  2009).  Such  methods  enrich  mitochondria
several folds and mitochondria are generally used for functional assays
or  blotting  experiments.  Only  a  few  studies  have  utilized  gradient
centrifugation to extract mtDNA for sequencing. Williams et al. (2010)
presented a Mito-seq approach utilizing homozygote mtDNA mutator
mouse, Nycodenz gradient and paired-end sequencing. They observed
<10 % and >78 % of sequencing reads aligning to  mtDNA reference
genome in two groups of  samples,  in  which  the latter  samples  were
enriched  with  optimized  protocol,  thus,  containing  significantly  less
nDNA contamination.  Furthermore,  they  concluded  by  ρ0 assay  that
NuMTs did not confound the variant detection analysis as only 0.002 %
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of the reads aligned to mtDNA. However, the variant detection threshold
was  set  to  AF  1 %  and  one  of  the  main  aim  in  their  study  was  a
breakpoint detection (Williams et al. 2010).
Another study with homozygote mtDNA mutator mouse by Ameur et al.
(2011)  utilized  sucrose  gradient  for  mitochondria  enrichment  and
SOLiD sequencing (Ameur et al. 2011). They reported 35–69 % of the
reads to be aligned to mtDNA reference genome and as well concluded
that nDNA contamination varies sample-by-sample and cannot be fully
excluded  with  gradient  enrichment  (Ameur  et  al.  2011).  Similar  to
Williams  et  al.  (2010),  Ameur  et  al.  (2011)  estimated  by  numerical
calculations  that  the  effect  of  NuMTs  should  still  be  negligible  –
approximately less than one NuMT variant containing read out of 5x104
reads (Ameur et  al.  2011).  Since SOLiD is very different technology
from Illumina sequencing, the variant frequency per position was also
determined directly from the reads and no minimum detection threshold
was reported, however, as they describe AF >0.5 % as high-frequency
variants (Ameur et al. 2011), the detection threshold was likely much
below that.
1.4.5 Other mitochondrial DNA enrichment strategies for 
sequencing
Other  mtDNA enrichment  strategies  recently  published  are  based  on
enzymatic degradation of nDNA. Jayaprakash et al. (2015) developed an
approach called Mseek  (Jayaprakash et al. 2015), in which total DNA
(gDNA)  is  extracted  and  treated  with  exonuclease  V (ExoV).  ExoV
specifically digests linear ssDNA or dsDNA, thus, circular mtDNA stays
intact and is enriched. The digestion is, however, very long, 48 hours at
37 °C, after which the nDNA contamination level is controlled by PCR,
and in case of successful PCR, the digestion is continued for additional
16  hours  (Jayaprakash  et  al.  2015).  While  being  a  very  simple  and
inexpensive approach with minimal hands-on time, the approach is very
slow. A major drawback of their method was very inefficient sequencing
library preparation as only 40 % of the reads were mtDNA origin and
the rest were mostly adapter dimers. In the end, they also recommend to
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combine the sample preparation with long-range PCR (Jayaprakash et
al. 2015).
Another  similar  approach,  published  by  Gould  et  al.  (2015),  utilizes
Plasmid  Safe  ATP-dependent  DNase  to  digest  nDNA  (Gould  et  al.
2015). They utilized the enzymatic treatment after extraction of DNA
from an enriched mtDNA preparation (kit-based mtDNA enrichments).
Yet, they were able to obtain only ~36–62 % mtDNA sequencing reads.
This  was  an  improvement  in  comparison  to  only  enriched  mtDNA
prepration, however, the samples were still highly nDNA contaminated.
An  intriguing  suggestion  from  Gould  et  al.  (2015)  was  to  create
mitoplasts before mtDNA extraction. The idea behind it is that nDNA
attached  to  the  mitochondria  would  be  efficiently  removed  while
removing the outer membrane, and thus, such approach could yield in
highly pure mtDNA preparation – ideally close to 100 % (Gould et al.
2015).
1.5 Data analysis approaches for mitochondrial DNA 
variant detection
Early on Li et al. (2010) utilized long-range PCR and low-coverage data
(~70x) as well as simulated data sets to suggest an analysis workflow for
mtDNA variant detection. They concluded that a highly important step
in reliable variant detection is double-strand validation i.e. the variant
has  to  be  present  on  both strands  at  least  in  two independent  reads.
Further requirements were that  duplicate reads should be excluded as
they may have huge impact on detected AFs in low-coverage data and
minimum base-call quality should be at least 20. However, due to low-
coverage,  their  variant  detection  threshold  remained  very  high,  AF
>=10 % (Li et al. 2010).
Later they developed an approach to detect low-level mutations. Their
approach was based on the fact that errors occur strand- and position-
dependently and that there are error hotspots and these were included
into statistical models to separate them from true mutations. With their
new approach, variant detection was possible down to AF >2 % from
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500x  data.  They  were  able  to  efficiently  exclude  sequencing  errors,
however,  they  noted  that  contamination  or  chimeric  reads  cannot  be
distinguished and experimental protocols should be refined in order to
reduce such artefacts (Li & Stoneking 2012).
Guo et al. (2012) utilized GATK variant caller to detect AF 1 % mtDNA
variants from long-range PCR amplified data at ~4000x coverage (Guo
et al. 2012). They applied relatively stringent criteria that each strand
had to be covered >200x and strand-bias Phred score should not deviate
from zero.  Later  on  they  developed  their  approach  as  the  MitoSeek
pipeline  to  analyze  by-product  reads  from  exome  or  whole-genome
sequencing  data  sets.  They  introduced  their  own  variant  calling
approach, as GATK is developed for a diploid genome and is inaccurate
for mtDNA variant calling. In their approach, they compare empirical
allele  counts  from  tumor  and  normal  samples  and  the  algorithm
automatically adjusts the detection threshold suitable to the depth of the
data  set  (Guo  et  al.  2013).  Similarly,  Calabrese  et  al.  (2014)  have
developed MToolBox.  They utilize SAMtools  for  variant  calling and
implement variant calling quality score as well as minimum number of
supporting reads. Different from other tools, MToolBox also assign a
haplogroup and annotates the variants  (Calabrese et al. 2014). Further
advancement to analysis pipelines was mit-o-matic, which in contrast to
earlier command-line tools, is cloud-based (Vellarikkal et al. 2015). The
most sensitive analysis pipeline is mtDNA-server, which models several
quality aspects in their variant calling approach  (Weissensteiner et  al.
2016).
A major drawback with the pipelines is their relatively poor flexibility as
certain minimum thresholds may be hard-coded, or the user has poor
control over many parameters, and some analysis options are not even
included or cannot be excluded. mit-o-matic provides the possibility to
choose between three different aligners and accounts for circularity of
the mtDNA genome by adding some bases from the beginning to the
end of the reference genome (Vellarikkal et al. 2015). Similarly, Ding et
al.  (2015)  have  developed  their  own  likelihood-method  to  detect
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mtDNA variants and they consider the mtDNA genome circularity by
dual approach: First aligning the reads and calling variants on normal
reference genome and then to a reference genome in which the genome
junction is shifted to the middle. The resulting variants are combined
such that  only the middle part  of the genome is considered from the
normal reference genome analysis, and only the junction region from the
shifted reference genome analysis (Ding et al. 2015). Although mtDNA
is different from nDNA and requires specific considerations in analysis
steps, one additional drawback of these various pipelines is their poor
comparability to other methods.
The above-mentioned pipelines are available for human mtDNA only
and  no  pipeline  for  mouse  mtDNA exists.  Thus,  there  is  a  need  to
establish  an  accurate  mouse  mtDNA variant  detection  analysis.  This
could be achievable by following the above discussed guidelines and
strategies  for  quality  measures  in  sample  preparation  and  sequence
analysis and by utilizing the already existing tools.
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2 PROJECT AIMS
This PhD thesis focuses on deep sequencing of the whole mitochondrial
genome in order to reliably detect extremely rare mtDNA variants. The
mitochondrial  DNA mutator  mouse  is  used  as  a  model  for  mtDNA
saturation mutagenesis throughout the thesis projects.
The aims of the thesis are divided into three subprojects as follows:
1. Optimization of mitochondrial DNA extraction method.
2. Selection  of  the  sequencing  method  for  low-frequency
mitochondrial DNA variant detection.
3. Application  of  the  optimized  approaches  to  address
mitochondrial biology research questions.
First,  the  projects  aim  to  develop  an  improved  mtDNA sequencing
approach for reliable detection of extremely rare mtDNA variants. With
the improved method it is possible to build a detailed picture and expand
earlier studies on how mtDNA may be mutated and transmitted. Such
information  is  of  key  importance  in  understanding  mitochondrial
biology,  especially  mtDNA maintenance.  Moreover,  it  may  help  to
develop  preventive  measures  for  transmission  of  mitochondrial
disorders.
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3 Materials and methods
3.1 Experimental animals
All  animal  experiments  were  performed  in  strict  accordance  with
guidelines of the Federation of the European Laboratory Animal Science
Association (FELASA). Protocols were approved by the Landesamt für
Natur, Umwelt und Verbraucherschutz, Nordrhein-Westfalen, Germany. 
All  mouse  lines  were  originally  generated  by  using  inbred
C57BL/6NCrl (Charles River Laboratories, Germany, strain code 027)
background. Mice were fed ad libitum on a standard mouse food (ssniff
M-H Low Phytoestrogen, Ssniff Spezialdiaeten GmbH) or enhanced diet
(ssniff M-Z Low-Phytoestrogen) during breeding or with newly weaned
mice  and  maintained  at  21 °C  in  a  12-hour  light/dark  cycle  by
Comparative Biology of Max Planck Institute for Biology of Ageing.
3.1.1 Animals for optimization of the methods
To optimize the mtDNA extraction, multiple tissues (mostly liver and
brain, but also heart and kidneys) from fifty mice were utilized: half of
the mice were from the mtDNA mutator mouse lineage (as described
below in Chapter 3.1.2), but significant amount of the tissues were also
obtained as a surplus from experiments conducted by others (e.g. liver,
brain or kidneys from a heart-specific knock-out mouse lineage). Use of
surplus tissues reduced the number of mice required for the project, and
additionally diminished the waste produced in other experiments. 
For spike-in control samples, a single wild-type mouse carrying NZB
mtDNA (NZB) was used. The mtDNA of these mice deviates from the
reference strain at 89 positions as listed in Appendix 1.
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3.1.2 Animals for creating the variant profile of the entire 
mitochondrial genome
In total, six mice carrying mutated mtDNA were generated by crossing
males  heterozygous for the exonuclease-deficient  mtDNA polymerase
gamma (PolgAWT/D257A) to females heterozygous for knock-out alleles of
PolgA (PolgAWT/KO)  and  selecting  genotypes  PolgAD257A/KO (MKO)  as
experimental animals lacking maternally transmitted mtDNA mutations.
Three true wild-type (PolgAWT/WT, WT) mice were bred as separate lines,
and  one  WT mouse  was  a  littermate  from  an  aforementioned  cross
(genotype  PolgAWT/WT,  not  carrying  maternally  inherited  mtDNA
mutations). Immediately after dissection of target tissues, mitochondria
were isolated according to the protocol below.
3.1.3 Animals for studying purifying selection and mitochondrial 
RNA processing
The same mouse breeding scheme was used for purifying selection and
mitochondrial RNA processing projects. Both projects utilized the MKO
mices as founders (F1) to generate mtDNA mutations. These founders
were mated with PolgAWT/WT males in order to create wild-type female
lineages  carrying  maternally  inherited  mtDNA mutations.  First,  N1
generation  females  were  selected  for  PolgAWT/KO genotype  and  were
mated  to  PolgAWT/WT males.  The following generations  (N2 and N3)
were either of PolgAWT/KO or PolgAWT/WTgenotype. Heterozygote knock-
out mice (PolgAWT/KO) have half of the PolgA transcript present and up
to 15 % less mtDNA copies in comparison to wild-type mice, but they
have no difference in phenotype (Hance et al. 2005).
For the purifying selection project, four F1 mice were used as founders.
Two mice per generation, per lineage were dissected. For mitochondrial
RNA processing project, a single F1 founder was used to produce N1
generation mice. Of these, three littermates were used. One of them was
the mother of three N2 generation littermate mice. For RNA extraction,
~50 mg piece of tissue was snap-frozen in liquid N2 and stored at -80 °C
until RNA extraction.
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3.2 Mitochondria isolation and DNA extraction 
protocols
3.2.1 Gradient centrifugation methods
Unless  otherwise  mentioned,  in  all  gradient  centrifugation  methods,
mitochondria were isolated by first homogenizing the isolated tissue in
15 ml of isolation buffer (320 mM sucrose, 20 mM Tris, 1 mM EGTA, 3
mM CaCl2, pH 7.2 at room temperature, 0.2 % w/v BSA) at 1000 rpm
for  12  strokes  with  a  glass-teflon  homogenizer  (Potter  S,  Sartorius).
Then,  20  ml  of  isolation  buffer  was  added  and  the  cell  debris  was
removed by centrifugation (1200 g, 10 min, 4 °C). The supernatant was
collected into a fresh tube and the pellet was resuspended into 35 ml
isolation  buffer  by  vigorous  shaking  and  re-pelleted  (800 g,  10 min,
4 °C).  Mitochondria  were  pelleted  from  the  supernatants  by
centrifugation (8500 g, 10 min, 4 °C) and the pellet was washed once by
re-suspension into 35 ml buffer and re-pelleted. 
Sucrose gradient
The final pellet was resuspended into 1 ml of 0.6 M sucrose. Sucrose
gradient was formed by placing 5-ml layer of 1.5 M (or 1.75 M) sucrose
and 5-ml layer of 1 M sucrose carefully on top of each other into an
ultracentrifuge tube (Beckman Coulter, Inc.). Mitochondria suspension
was placed on top of  the  layers  and  the tube was  filled  with 0.6 M
sucrose. Carefully balanced tubes were centrifuged either with SW-28
rotor  (22000 g,  30 min,  4 °C)  or  with  SW  41  Ti  rotor  (15000 rpm,
24 min,  4 °C,  Beckman  Coulter,  Inc.).  Mitochondria  were  collected
between  the  layers  with  a  syringe  and  pelleted  by  centrifugation
(16000 g, 10 min, 4 °C).
The pellets were subjected to DNA extraction with Gentra® Puregene®
Tissue kit (QIAGEN GmbH) with an adjusted protocol. The pellets were
resuspended by vortexing in 800 µl of Cell lysis solution preheated to
65 °C, and 8 µl of Proteinase K (10 mg/ml) was added. Mitochondria
were lyzed at 55 °C, 600 rpm for 3 hours or until the solution was clear.
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RNA was digested by adding 8 µl of RNase A Solution and incubated at
37 °C for 15–60 min. Samples were incubated on ice for 1–2 min before
addition of 270 µl Protein Precipitation Solution and vigorous vortexing.
The  incubation  on  ice  was  continued  for  5–30  min.  Proteins  were
pelleted  by  centrifugation  (16000 g,  3 min,  room  temperature)  and
supernatant was collected into a fresh tube. DNA was precipitated by
adding 850 µl isopropanol and incubating at room temperature for 16–
20 hours. DNA was collected by centrifugation (16000 g, 30 min, room
temperature), washed with 1 ml of 70 % EtOH and repelleted. DNA was
dissolved into nuclease-free H2O.
CsCl-gradient
The CsCl-gradient protocol followed the sucrose gradient protocol until
DNA  extraction  step.  Instead  of  DNA  extraction  by  the  kit,  the
mitochondria  pellet  was  resuspended  into  1.6  ml  TE-buffer  by
vortexing. Mitochondria were lyzed by addition of 0.4 ml SDS 10 %
and 133 µl Proteinase K (10 mg/ml) and incubated for 10 min at room
temperature. Then the sample was incubated with 330 µl of 7 M CsCl
solution  at 4 °C  for  16–20  hours.  Mitochondrial  membranes  were
pelleted by centrifugation (17000 rpm, 10 min,  4 °C),  the supernatant
was collected into a  fresh tube and the volume was measured.  Solid
CsCl was added to the solution at  a  concentration of 0.93 g/ml.  The
sample density was adjusted to 1.57 ± 0.01 g by adding either solid CsCl
or  TE-buffer.  Then,  10  µl/ml  of  SYBR® Safe  DNA  Gel  stain
(ThermoFisher Scientific) was added. The sample was transferred into
an  ultracentrifuge  tube  and balanced  with  a  balancing  solution (0.57
g/ml  CsCl  in  TE-buffer).  DNA was  separated  by  centrifugation  in  a
MLS-50 rotor (27000 rpm, 69 hours, 20 °C, Beckman Coulter, Inc.) and
afterwards the DNA band was visualized with UV-light and collected
with a syringe. SYBR® Safe DNA Gel stain was removed by adding
equal volume of 1:1 mix of 1-butanol and 7 M CsCl solution into the
sample. The phases were separated by centrifugation (1500 rpm, 3 min,
room temperature) and the aqueous phase was collected. The separation
was  repeated  1–4  times,  until  the  pink  color  disappeared  from both
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phases. The collected sample was diluted with 5 ml ddH2O and DNA
was precipitated 16–20 hours at -20 °C by adding 10 ml absolute EtOH.
DNA was pelleted by centrifugation (12000 g, 15 min, 4 °C), washed
with 5 ml 70 % EtOH and repelleted by centrifugation (12000 g, 5 min,
4 °C). Traces of EtOH were evaporated and DNA pellet was dissolved
into nuclease-free H2O.
Percoll gradient
In Percoll gradient protocol, tissues were homogenized at 100 rpm for
10 strokes, cell debris was pelleted by centrifugation (1000 g, 10 min, 4
°C) and mitochondria collected from the supernatant by centrifugation
(12000 g, 10 min, 4 °C). The mitochondria pellet was resuspended into
200 µl of isolation buffer.  Percoll gradients were prepared by adding
18 w-% of Percoll (Sigma-Aldrich Co.) into 5 ml of cold isolation buffer
in an ultracentrifugation tube and loading the resuspended mitochondria
on  top  of  it.  The  mitochondria  were  separated  from  the  other  cell
membranes or organelles by centrifugation with MLS-50 rotor (40000g,
20 min, 4 °C). The supernatant was carefully removed and mitochondria
were resuspended into the remaining Percoll  solution by swirling the
tube. Finally, Percoll was removed by adding 10 volumes of isolation
buffer and pelleting the mitochondria by centrifugation (6300 g, 10 min,
4 °C). DNA was extracted as described in the sucrose gradient protocol. 
3.2.2 Mitochondria isolation kit
Mitochondria  extraction  kit  –  Tissue  and  Mitochondria  isolation  kit
mouse tissue (Miltenyi Biotec GmbH) were used together according to
the  manufacturer's  instructions  in  order  to  isolate  highly  pure
mitochondria  utilizing  the  Anti-TOM22  labelled  magnetic  beads.
However,  these  experiments  resulted  in  highly  nDNA contaminated
samples from liver, brain and heart. Thus, the method was improved by
adding DNase I treatment step (as discussed below in  Chapter 3.2.3)
after the bead purification, but the DNA was completely lost in these
experiments. Finally, only Mitochondria extraction kit – Tissue was used
to  homogenize  the  tissue  (N1  generation  mice,  livers),  and  the
43
mitochondria were collected by centrifugation (8500 g, 10 min, 4 °C).
Next,  the  protocol  was  similar  as  described  below  for  mtDNA-seq
(Chapter 3.2.3) from DNase I treatment step on, except the final DNA
was dissolved into nuclease-free H2O.
3.2.3 mtDNA-seq
Mitochondria were isolated using protocol described by Kennedy et al.
(2013) with minor modifications. Briefly, 500–800 mg of mouse liver
tissue and a full brain (~430 mg) were collected and homogenized in
mitochondria isolation buffer (MIB, 320 mM sucrose, 20 mM Tris, 1
mM EGTA, 1 % BSA, pH 7.2 at room temperature, 1 % w/v BSA) with
a glass-teflon homogenizer. Cell debris was removed by centrifugation
(800 g, 10 min, 4 °C), supernatant was transferred to a fresh tube and the
centrifugation was repeated one more time. Finally, mitochondria were
pelleted  (8500 g,  10 min,  4 °C).  Pellets  were  resuspended  into  Mito-
DNase buffer (Kennedy et al. 2013) containing 0.03 mg/ml DNase I and
0.02 mg/ml  RNase  A.  The  homogeneous  solution  was  divided  into
subfractions representing 100–150 mg of the original tissue sample, and
incubated at 37 °C for 1–1.5 hours. Mito-DNase buffer was removed by
pelleting the mitochondria (13000 g, 30 min, 4 °C). Pellets were washed
twice  by  resuspending  into  MIB  (containing  0.2 %  w/v  BSA)  and
centrifugation (13000 g, 15 min, 4 °C). Clean pellets were snap-frozen
in liquid N2 and stored at -80 °C until the mtDNA extraction on the same
day.
For  mtDNA extraction,  mitochondria  pellets  were  lyzed  overnight  at
56 °C in lysis buffer (20 mM Tris, 150 mM NaCl, 20 mM EDTA, 1 %
SDS,  pH  8.75  at  room  temperature,  0.02 mg/ml  Proteinase K,
0.02 mg/ml  RNase  A),  and  DNA  was  purified  by  chloroform:
isoamylalcohol  extraction  in  presence  of  1.2 M  potassium  acetate.
Before ethanol precipitation for 3 hours at -80 °C, the DNA preparations
were treated with 100–200 µg RNase A at 37 °C for 45–60 min. DNA
was pelleted at 16000 g for 15 min, the precipitate was washed twice
with 500 µl of 70 % ethanol and pelleted at 16000 g for 15 min at room
temperature. The DNA pellet was dissolved into 18–35 µl of 5 mM Tris,
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pH  8.5  (Macherey-Nagel).  Level  of  nDNA  contamination  was
confirmed by PCR with GoTaq® DNA Polymerase (Promega GmbH)
and  PolgA-specific  primers  (5'-CTTCGGAAGAGCAGTCGGGTG-3'
and 5'-GGGCTGCAAAGACTCCGAAGG-3'), at conditions: 
Subfractions highly pure from nDNA (i.e. barely visible PCR product on
the  gel)  were  combined  and  concentration  was  quantified  with  the
fluorometric  method  (QubitTM dsDNA HS  Assay  kit,  ThermoFisher
Scientific).  The total  yield of highly pure liver  or  brain mtDNA was
>2 µg and ~100–200 ng, respectively.
3.3 Genomic DNA extraction
Genomic DNA (gDNA) was  extracted from a  ~50-mg piece of  liver
tissue (snap-frozen in liquid N2 immediately after dissection and stored
at -80 °C) that was minced with a mortel. The DNA extraction was as
described  above  for  mtDNA-seq  (Chapter  3.2.3),  but  ethanol
precipitation was shortened to  1 min and the DNA was dissolved into
200 µl of 5 mM Tris, pH 8.5 (Macherey-Nagel).
3.4 Total RNA extraction
The total RNA was extracted from a 50-mg piece of a snap-frozen tissue
with  TRIzolTM Reagent  (ThermoFisher  Scientific)  according  to
manufacturer's instructions with minor modifications. Briefly, the frozen
tissue was first minced with a mortel. The homogenization was finalized
by adding 1 ml TRIzolTM Reagent and using Lysing Matrix D tubes (MP
Biomedicals,  LLC)  with  settings  24x2,  6 m/s,  4x20 s.  Tubes  were
incubated  on  ice  for  5 min  before  addition  of  200 µl  chloroform
followed by 2–3 min incubation on ice.  Samples were centrifuged at
12000 g for 15 min at 4 °C. Aqueous phase was collected to a fresh tube
and incubated  with 500 µl  isopropanol  for  20 min on ice.  RNA was
pelleted by centrifugation at  16000 g for  30 min at  4 °C and washed
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with 1 ml of 75 % EtOH. RNA was re-pelleted at 16000 g for 5 min at
4 °C,  and  after  removal  of  the  supernatant,  the  leftover  EtOH  was
spinned  down  at  16000 g  for  1 min  at  4 °C.  Traces  of  EtOH  were
evaporated by heating the sample at 55 °C for 2 min. The final  RNA
sample  was  dissolved  into  50 µl  nuclease-free  H2O  by  heating  the
sample at 55 °C for 2 min. 
Any  contaminating  DNA was  removed  using  6 µg  of  the  RNA for
TURBO DNA-freeTM treatment (ThermoFisher Scientific) according to
manufacturer's  instructions.  The  integrity  and  concentration  of  the
samples were measured from 1 µl of the sample by a miniaturized gel
electrophoresis system, ExperionTM RNA StdSens Analysis kit (Bio-Rad
Laboratories, Inc.). 
3.5 Mitochondrial DNA cloned into a plasmid 
backbone, pAM1
A pAM1-plasmid containing a full mouse mtDNA – deviating from the
mouse  mtDNA  reference  genome  (C57BL/6J,  NC_005089.1)  at
positions 4794.C>T, 9348.G>A, 9461.T>C, 10918.A>G and 12048.T>C
– restriction digested with HaeII (restriction site RGCGCY, at position
2603),  cloned  into  a  2.5-kb  pACYC177  plasmid  backbone  also
restricted  with  HaeII  was  kindly obtained  from Prof.  Dr.  Nils-Göran
Larsson. A single clone was expanded and DNA extracted using Plasmid
Midi kit (QIAGEN GmbH) according to manufacturer's instructions. 
3.6 Amplicon PCR
3.6.1 Amplicon PCR without tagged primers
Amplicons  were  designed  to  represent  the  entire  mtDNA genome in
2.8–7 kb amplicons as indicated in Table 3.1. The amplification PCR
was done with Phusion® High-Fidelity DNA Polymerase (New England
Biolabs, Inc.) according to the manufacturer's instructions, in 20–60 µl
reaction volume using 10 µM final concentration of primers, 1.25 mM
of dNTPs and 1 µl template DNA with following conditions: 
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where the annealing temperature was adjusted for each amplicon 1–4 as
indicated in the superscript. 
Table 3.1. List of amplicon primers without tags.
Primer Sequence (5' → 3') Startposition
Amplicon
length (bp)
Amplicon 1 forward TTGATGAGGATCTTACTCCC 9376 7057
Amplicon 1 reverse TCTATGGAGGTTTGCATGTG 113
Amplicon 2 forward GAAACTTTATCAGACATCTGG 15773 2841
Amplicon 2 reverse ACTTTGACTTGTAAGTCTAGG 2315
Amplicon 3 forward TTGACCTTTCAGTGAAGAGG 2115 4444
Amplicon 3 reverse TTGCTCATGTGTCATCTAGG 6559
Amplicon 4 forward CCATTCCACTTCTGATTACC 4240 5923
Amplicon 4 reverse GTAGGTTGAGATTTTGGACG 10163
The DNA samples used were low-yield mtDNA-seq samples from three
N1 generation brains and two N2 generation brains. Additionally, one
N2 generation liver was used as a template. All DNA templates were
diluted to approximately 1 ng/µl concentration. The liver sample carried
heavy RNA contamination causing inefficient PCR and, different from
the brain samples, the amplification was repeated for 20 cycles. In order
to obtain high yield of amplicons, reactions were replicated 6–15 times.
For  sequencing,  each  technical  replicate  sample  of  an  amplicon  was
pooled  and  purified  with  NucleoSpin® Gel  and  PCR  Clean-up kit
(Macherey-Nagel) according to manufacturer's instructions and the final
sample  was  concentrated  to  ~10  µl  volume  with  EppendorfTM
VacufugeTM Concentrator  (Eppendorf  Vertrieb  Deutschland  GmbH).
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Representative  mtDNA  samples  were  formed  by  pooling  all  four
amplicons in equimolar ratios into minimum of 20 ng/µl concentration
in 10 µl final volume.
3.6.2 Amplicon PCR with tagged primers
The improved amplicon design included non-mtDNA 18-bp tags to the
5' end of the primers. Moreover, the overlaps between amplicons were
harmonized and number of amplicons was reduced to three (Table 3.2).
PCR reactions were as with non-tagged primers, except 25 ng/µl input
DNA was preferred instead of 1 ng/µl (this doubled or tripled the final
amplicon  yield).  Triplicate  of  20-µl  reactions  were  used  with  the
following conditions:
where the annealing temperatures and extension times were adjusted for
each amplicon 1–4 as indicated in the superscript. Also the number of
cycles  was increase  to  25 in  comparison to  the PCR without  tagged
primers. 
Table 3.2. List of amplicon primers with tags.
Primer Sequence (5' → 3') Start position
Amplicon 1
forward
TGTAAAACGACGGCCAGTTTGATGAGGATCTTACTCCC 9376
Amplicon 1
reverse
CAGGAAACAGCTATGACCTCTATGGAGGTTTGCATGTG 113
Amplicon 2
forward
TGTAAAACGACGGCCAGTGAAACTTTATCAGACATCTGG 15773
Amplicon 2
reverse
CAGGAAACAGCTATGACCGATAGTAGAGTTGAGTAGCG 4373
Amplicon 3
forward
TGTAAAACGACGGCCAGTCAAGCCCTCTTATTTCTAGG 3756
Amplicon 3
reverse
CAGGAAACAGCTATGACCGTAGGTTGAGATTTTGGACG 10163
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Reactions were purified with NucleoSpin® Gel and PCR Clean-up kit
according  to  manufacturer's  instructions,  by  adjusting  the  sample
volume to 100 µl with H2O and including also the optional wash step.
The DNA was eluted twice into 15 µl by centrifugation first 30 g for 1
min and then 11000 g for 1 min, as suggested in the kit manual for long
PCR fragments.
3.7 Rolling circle amplification
Approximately  40  ng  (1  µl)  of  mtDNA enriched  from  a  single  N1
embryo  by  the  mtDNA-seq  method  (Chapter  3.2.3)  and  gDNA
extracted from WT liver were used as templates  for REPLI-g rolling
circle  amplification  with  2  µl  of  human  mt-primer  mix  (QIAGEN
GmbH) according to manufacturer's instructions. The amplified samples
were purified by ethanol precipitation as described for genomic DNA
above, except that the final DNA pellet was dissolved into 100 µl.
3.8 Illumina HiSeq library preparations and 
sequencing
3.8.1 Illumina HiSeq DNA-seq 
In total, >100 ng of each highly enriched mtDNA sample was sent for
sequencing  at  Max-Planck  Genome-center  Cologne  (MP-GC,
Germany).  The  sequencing  libraries  were  prepared  at  MP-GC  and
library preparation steps were always adjusted according to the centre's
current best practices or the sample concentration. Here, for clarity, the
exact details are given only for those samples presented in  Chapters
4.3.1  and  Chapter 4.3.2. Other libraries were prepared and sequenced
very similarly, with minor modifications to the protocols. This was not
considered  to  be  a factor  affecting the final  results  and  thus omitted
here.
The DNA samples were sheared by Covaris Adaptive Focused Acoustics
technology  (COVARIS,  Inc.)  and  library  preparation  was  done  with
NEBNext  Ultra  DNA Library preparation kit  (old)  or with NEBNext
Ultra II DNA Library preparation kit (new, New England Biolabs, Inc.).
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Samples of the first two mouse lineages in Chapter 4.3.2 were sheared
as  70 ng  DNA in  120 µl  to  average  fragment  size  of  250 bp  with
settings:  intensity 5,  duty cycle 10 %, 200 cycles  per burst  and 180 s
treatment time with old kit and eight PCR cycles. N1 and N2 generation
samples were sequenced as 1x100bp, whereas N3 generation samples
were  1x150bp  (single-end  mode).  The  samples  from  additional  two
mouse  lineages,  however,  were  sheared  as  100 ng  DNA in  120 µl
containing  1 mM  EDTA to  average  fragment  size  of  400 bp  with
settings:  intensity  5,  duty  cycle  5 %,  200 cycles  per  burst  and  55 s
treatment time with new kit and seven PCR cycles. All of these samples
were sequenced as 2x150 bp (paired-end mode).
The conditions for samples presented in Chapter 4.3.1 were as follows:
WT1–4  and  MKO1–4  samples  were  sheared  as  100 ng  in  55 µl  to
average fragment size of 400 bp with settings: intensity 5,  duty cycle
5 %, 200 cycles per burst and 55 s treatment time with the old kit and
eight PCR cycles. MKO5 was prepared otherwise similarly but with the
new kit and seven PCR cycles, and MKO6 was prepared as the first set
of N3 generation samples mentioned above. Furthermore, replicates of
WT3–4 and MKO1 and MKO5 were also sequenced with the paired-end
approach, libraries prepared as mentioned above for the additional two
mouse lineages.
All  samples  were  sequenced  with  Illumina  HiSeq3000,  with
HiSeq3000/4000  SR  Cluster  Kit  and  the  corresponding  SBS  Kit
(Illumina) until one Gbase (single-end) or two Gbases (paired-end) of
sequences  were  achieved.  Only  amplicon  samples  without  tagged
primers were sequenced with HiSeq2500.
3.8.2 Illumina HiSeq RNA-seq
Approximately 3 µg of extracted total RNA was sent for sequencing at
MP-GC.  First,  1 µg  of  the  RNA was  used  for  rRNA depletion  with
RiboZero  rRNA  Removal  Kit  (Human/Mouse/Rat)  (Epicentre)
following  manufacturer's  instructions.  The  sequencing  libraries  were
prepared  with  NEBNExt  Ultra  Directional  RNA Kit  (New  England
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Biolabs  Inc.)  following  manufacturer's  instructions.  Libraries  were
sequenced with HiSeq2500 until 5 Gbases of sequence was achieved.
3.9 Sequencing data analysis
3.9.1 Analysis of mtDNA-seq data
Sequencing reads were trimmed with Flexbar version 2.5  (Dodt et al.
2012) for  quality and adapter  leftovers  (parameters  -q 28 -m 50
-ao 10 -at 1 -ae ANY).  Standard  mouse  mtDNA reference
genome (C57BL/6J, NC_005089.1) was used, however, it deviates from
our mouse strain at positions 4891 and 9461 (T>C), and for some of our
mice, also at position 9027 (G>A). Reads were aligned to the reference
genome with BWA version 0.7.12-r1039 (Li & Durbin 2009), invoking
mem  (Li  2013) (parameters  -T 19 -B 3 -L 5,4).  To  fix  the
problem of alignment to a circular reference genome, a dual alignment
approach was used such that  reads were aligned to  both,  the normal
reference genome and to a split genome in which the first half of the
normal  reference  genome  was  transferred  to  the  end  of  the  normal
reference genome. Only uniquely aligned reads were filtered for further
analysis with samtools (parameter  -q 1).  Per position coverage was
calculated  using  bedtools  version  2.22.1  (Quinlan  &  Hall
2010) genomecov (parameter -d).
Variants were called with LoFreq* version 2.1.2 (Wilm et al. 2012): first
indel  qualities  were  set  with  indelqual  (parameter  --dindel),  variants
were  called  with  command  lofreq  call-parallel  (parameters
--parallel-threads 20 -N -B -q 30 -Q 30 --call-
indels --no-default-filter) and  filtered  with  lofreq  filter
(parameters  --snvqual-thres 70 --sb-incl-indels -B
60 --no-defaults).  Variants  were further  filtered and annotated
using SnpEff version 4.2 (Cingolani et al. 2012a; Cingolani et al. 2012b)
with  mitochondrial  codon  usage  table.  Filtering  conditions  required
minimum fifteen alternative base supporting reads (expression  DP*AF
>= 15)  and  minimum of  three  alternative  base supporting reads on
each  strand  estimated  based  on  the  DP4  values  (expression
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DP4[2] >= 3 & DP4[3] >= 3). However, in comparison to the
strand bias filtering, the effect of this minimum number of read filtering
step was miniscule,  and mainly applied to ensure that every detected
variant fulfilled at least this threshold.
Dual alignment approach results for coverage and variant calling were
combined  as  follows:  the  results  comprising  genome positions  200–
16099 were taken from the alignment to the normal reference genome,
whereas  the  results  for  the  genome  junction  region  (positions
corresponding  to  the  original  genome  positions  1–199  and  16100–
16299) were obtained from the alignment to the split genome.
3.9.2 Analysis of pAM1 data
Data analysis steps for pAM1-plasmid samples were similar to mtDNA-
seq samples, except pAM1 sequence was used as a reference genome
(Appendix 2). The analysis followed that for mtDNA-seq (described in
Chapter  3.9.1),  except  without  separate  junction  approach.  Variant
calling results were kept  only for  variants on mtDNA (excluding the
restriction site positions 2306–2308) of the plasmid and positions were
corrected to correspond the original mtDNA positions. Further filtering,
annotation and analysis followed the analysis for mtDNA-seq, except
the removal of strain variants. One variant immediately downstream of
the restriction site, at position 2609, was excluded since it appeared in
all of the pAM1-containing samples and most likely originated from the
restriction-ligation  reaction  or  read  alignment  step.  Thus,  it  was
considered as an arterfactual variant not present in mtDNA-seq samples.
3.9.3 Analysis of amplicon sequencing data
Analysis of amplicon sequencing data produced without tagged primers
followed the analysis of mtDNA-seq. Analysis of amplicon sequencing
data produced with tagged primers had an additional trimming step to
remove the tag-containing reads with Flexbar after the above-mentioned
quality  and  adapter  trimming  (Chapter  3.9.1).  Flexbar  barcode
trimming  (parameter  -b)  required  a  fasta  format  file  indicating  the
primer sequences in forward and reverse order. Primers were required to
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overlap at least 15 nt, with maximum two mismatches at any end of the
read and output including unassigned reads i.e.  other than first  PCR-
cycle reads were kept for the downstream analysis (parameters -bo 15
-bt 2 -bu -be ANY).
3.9.4 Analysis of RNA-seq data
RNA-seq  reads  analysis  was  similar  as  explained  for  mtDNA-seq
(Chapter  3.9.1),  but  reads  were  aligned  only  to  mtDNA reference
genome with an aligner designed for RNA data, STAR  version 2.4.1d
(Dobin et  al.  2013) (default  parameters,  except  for  genome indexing
--genomeSAindexNbases 6).  Moreover,  reads were not aligned
considering the junction region as this was not relevant for RNA data.
3.10 Post-processing of the variant calling results
3.10.1 Variant loads
In this thesis, the terms ”unique” and ”total” variant loads are used to
separate  two  different  variant  loads  from  each  other  and  to  better
characterize the sample differences. Although slightly misleading term,
the  ”unique  variant  load”  does  not  represent  exactly  unique  variants
observed within a sample, but it is rather used to describe the number of
different  variant  types observed  within a  sample (e.g.  6958.C>T and
9829.T>A are counted as two ”unique” variants). Due to the nature of
the high-throughput technology, in order of a variant to be detected, it
has to be present in multiple reads, thus, an observed variant cannot be
unique (in  the  exact  meaning  of  the  term)  but  the  variant  is  always
amplified  or  clonally  expanded.  The  total  variant  load,  on  the  other
hand,  represents  the  number  of  all  variant  reads  observed  within  a
sample (e.g. 6958.C>T and 9829.T>A observed on 40 and 160 reads,
respectively, are counted as 200 variant reads in total).
Unique variant load was calculated as:
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unique variant load= number of observed variant types
number of alignedbases
.
Total variant load was calculated as:
where the number of variant reads was obtained by multiplying depth
(DP value) by allele frequency (AF value) reported by LoFreq*. Both
loads  were  calculated  either  over  the  whole  mtDNA genome or  per
defined regions, separately.
3.10.2 Spike-in sample comparisons
The variant results from the NZB spike-in samples were compared by
several values representing accuracy of the variant detection.
Precision
Precision or positive predictive value (PPV) is  the proportion of true
positive results of all observed positive results:
False discovery rate (FDR) can be simply obtained as 1 – PPV.
Sensitivity
Sensitivity, recall or true positive rate (TPR) is the proportion of true
positive results of all expected true results:
F1 score
F1 score or F1 measure (F1 score) determines the accuracy of the test as
a weighted average of precision:
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F 1 score=2∗PPV∗TPRPPV+TPR .
TPR= true positivestrue positives+ false negatives .
PPV= true positivestrue positives+ false positives .
total variant load= number of variant reads
number of aligned bases
,
False positive and negative rates
False positive rate (FPR) is the proportion of true positive results of all
expected true negative results:
False negative rate (FNR) is the proportion of false negative results of
all expected true results:
3.10.3 DNA and RNA variant comparisons
Resulting variant lists obtained by amplicon sequencing and RNA-seq
were filtered for minimum AF 0.5 % as this was considered as reliable
limit  in amplicon sequencing. The final  variant  lists  were merged by
common variants (position and the alternative base) in order to reduce
the  data  and  focus  only  on  variants  of  interest.  To  detect  variants
showing highly different variant AF values observed in DNA and RNA
sample for the same, shared variant, log2-fold-change was calculated to
represent the allelic imbalance of each common variant:
 
3.11 Rodent sequence alignment
Sequence  alignment  was conducted  by James  B.  Stewart.  Briefly,  in
total  112  rodent  strain  mtDNA the  control  region  sequences  were
aligned  with  MAFFT  (Katoh  &  Standley  2013).  A neighbor-joining
phylogenetic  tree  was  generated  with  MAFFT to  divide  the  aligned
sequences into three distinct  phylogenetic clades at  varying distances
from the reference genome sequence (NC_005089). Variable sites were
assembled for the ”mouse” clade only (70 sequences), ”mice/rats” clade
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FNR= false negativestrue positives+ falsenegatives=1−TPR .
FPR= false positivesfalse positives+true negatives .
allelic imbalance= log2(
RNA variant AF
DNAvariant AF
).
(106 sequences) or all 112 aligned sequences (”rodents”).
3.12 Statistics, plots and code availability
All  plots  were  produced  with  R  (https://www.r-project.org),  version
3.1.2.  Packages  ggplot2  (Wickham  2009) and  circlize (Gu  et  al.
2014) were utilized for plotting and color schemes were from package
RColorBrewer  (Neuwirth  2014).  Error  bars  representing  95 %
confidence  interval  were  calculated  with  stat_summary,  function
mean_cl_normal, and exact n values are reported in each figure legends.
The  curves  were  fitted  by  geom_smooth with  method  loess  (local
polynomial regression fitting).
The exact commands to conduct the optimized data analysis steps per
sample (as described in Chapter 3.2.3) are given in Appendix 3.
56
4 RESULTS AND DISCUSSION
4.1 Optimization of the mitochondrial DNA extraction 
method
A key  for  a  successful  mtDNA variant  detection  study  is  a  highly
enriched mtDNA sample free from nDNA contamination. Differential
centrifugation (Frezza et al. 2007) or density gradient methods (CsCl,
sucrose  and  Percoll  gradients)  have  been  routinely  used  to  enrich
mitochondria  (Boore  et  al.  2005,  Wieckowski  et  al.  2009).  Such
methods enrich the mitochondria from cellular debris and the extracted
mtDNA is pure enough for most mitochondrial studies, but the mtDNA
still  does  contain  significant  amount  of  nDNA.  Many  approaches
attempt  to  simplify  the  laborious  or  time-consuming  tissue
homogenization  and  centrifugation  steps.  Various  companies  sell
mitochondria enrichment kits or even mtDNA extraction kits, and also
regular plasmid preparation kits have been applied to enrich mtDNA
from nDNA (Quispe-Tintaya et al. 2013).
Of  the  commercial  kits,  Abcam's  Mitochondrial  DNA Isolation  kit
(ab65321),  for  example,  is  based  on  successful  differential
centrifugation enrichment of mitochondria after enzymatic treatment of
the  cells.  However,  the  enzyme  mix  composition  is  proprietary
information. BioVision also sells  a  kit  including a step of  enzymatic
treatment to the DNA. It can be speculated that these enzymatic steps
are  based  on  enzymes  like  ExoV  (Jayaprakash  et  al.  2015)  or
PlasmidSafe (Gould et al. 2015), which are supposed to degrade linear
nDNA but  not  the  circular  mtDNA.  Bioo Scientific  even  provides  a
complete kit starting from mtDNA extraction with ExoV treatment and
finishing  with  Illumina  library  preparation  (Bioo  Scientific
Corporation). Such methods, however, are not suitable for MKO mice
which  also  carry  linear,  truncated  mtDNA molecules  that  would  be
degraded along with the linear nDNA. Furthermore, with ExoV protocol
the DNA is treated at  least for 48 hours at 37 °C (Jayaprakash et al.
2015), a  long treatment protocol may expose the DNA to damage and
57
other  unintended  artefacts.  Miltenyi  Biotec  GmbH  provides  another
approach  with  a  gentleMACS  Dissociator  device  and  mitochondria
enrichment with anti-TOM22 coated magnetic beads,  which has been
shown  to  enrich  functional  mitochondria  (Franko  et  al.  2013).
Mitochondria enrichment with kits is  more expensive than traditional
methods, yet the kits may significantly reduce the hands-on time.
Despite  the  utilized  enrichment  method,  nDNA contamination  is  not
addressed or is a neglected issue. It can hamper accurate mtDNA variant
detection due to the presence of NuMTs. Moreover, a huge proportion of
sequencing  capacity  is  wasted  for  non-target  nDNA reads.  Thus,  to
increase the reliability and sensitivity of mtDNA variant detection, the
method  to  extract  mtDNA  was  optimized.  Traditional  enrichment
methods  were  tested  for  mitochondria  isolation  from  several  tissues
(brain,  heart,  liver,  spleen,  kidney)  in  combination  with  various
commercial  or  traditional  DNA  extraction  methods  (e.g.  QIAGEN
Gentra Puregene Tissue kit or phenol:chloroform extraction). However,
mtDNA was  poorly  enriched  from nDNA contamination,  which  was
detected as clearly positive PCR amplification of nDNA-encoded PolgA
(for example  Fig. 4.1a). Alternatively, the total mtDNA yield of these
samples was very low (below 50 ng) and did not meet the minimum
requirement for standard Illumina sequencing library preparation. One
reason  for  high  nDNA contamination  may  be  that  the  protocols  for
tissue homogenization are rigorous (e.g. in Frezza et al. [2007] and in
Wieckowski  et  al.  [2009]  4–8  strokes  with  1500–1600  rpm),  which
easily leads to increased release of nDNA from the broken nuclei.
The  problem  of  nDNA  contamination  and/or  low  mtDNA  yield,
especially in human mtDNA studies, is often overcome by long-range
PCR (Payne et al. 2015), or recently by rolling circle amplification (Ni
et  al.  2015,  Marquis  et  al.  2017).  Amplification-based  methods,
however,  are  thought  to  be  prone  to  polymerase  errors  leading  to
artefactual variants. Thus, suitability of these methods for low-frequency
mtDNA variant  detection  was  investigated  using  low-yield  or  highly
nDNA-contaminated mtDNA samples as templates.
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Figure 4.1. Quality control examples of liver and brain mtDNA samples.  a)
Qualitative PCR to test for presence of nuclear DNA in sample. An example of
20-μl PolgA-PCR from pure liver and brain mtDNA samples (lanes 1 and 2,
respectively) as well  as clearly contaminated brain mtDNA sample (lane 3).
Wild-type genomic DNA (lane 4) and H2O (lane 5) were used as controls for the
PCR and only 5 µl was loaded on the gel to avoid overloading. M = GeneRuler
100 bp DNA Ladder. b) An example showing the integrity of 100-ng liver (lane
1) and brain (lanes 2 and 3) mtDNA samples (same samples as used for the
PCR  in  a).  The  lowest  band  is  linear  and  the  strongest  is  nicked  mtDNA
molecules.  M  =  Lambda  DNA/HindIII  Marker.  c) Examples  of  RNA
contaminated  liver  mtDNA  samples:  mtDNA  extraction  without  RNase  A
treatment and insufficient RNase A treatment of the final mtDNA preparation on
lane 1 and 4, respectively. Lane 2 and 3 represent high-quality liver mtDNA
samples, lane 5 is an empty well. M = GeneRuler 1 kb DNA Ladder. All gels
contained 1 % agarose and 5 μg/ml ethidium bromide.
Kennedy et al. (2013) emulated the earlier protocols in which enriched
mitochondria  were  treated  with  DNase  I  (Kasamatsu  et  al.  1971) to
efficiently remove nDNA contamination. Yet Kennedy et al. (2013) used
simple  differential  centrifugation  for  the  mitochondria  enrichment
instead of sucrose gradient (Kennedy et al. 2013). The idea of DNase I
treatment  is  based  on  the  fact  that  mtDNA is  protected  inside  the
isolated, intact mitochondria, whereas the contaminating nDNA remain
outside  of  the  outer  membrane  of  mitochondria,  and  thus  may  be
digested by the enzyme. A slightly modified protocol of that presented
by Kennedy et al. (2013) was tested and also applied in combination
with a mitochondria isolation kit alone or together with a magnetic bead
isolation kit (Miltenyi Biotec GmbH). One key step in this protocol was
to reduce the tissue homogenization to 3–5 strokes with only 200 rpm,
potentially  decreasing  the  total  mitochondria  yield,  but  keeping  the
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nuclei intact and reducing the overall nDNA contamination. According
to the  PolgA-PCR, mtDNA samples extracted by these methods were
extremely pure and free from nDNA contamination (e.g. Fig. 4.1a). The
high total mtDNA yield was suitable for sequencing. The integrity of the
extracted mtDNA was always verified by agarose gel  electrophoresis
(Fig. 4.1b), and a rigorous RNase A treatment of the mtDNA was found
to be necessary (Fig. 4.1c).
Samples  obtained  by  different  methods  from  various  tissues  were
compared  by  the  percentage  of  sequenced  reads  aligned  to  mtDNA
reference genome (hereafter referred to as mtDNA alignment,  Fig. 4.2,
summarized  in  Table  4.1).  First,  to  enable  mtDNA variant  detection
from sample types showing poor mtDNA enrichment, the suitability of
amplification-based methods was investigated. Similar to study by Ni et
al.  (2015),  RCA was optimized using mouse mtDNA specific  primer
sets  according  to  REPLI-g® Mitochondrial  DNA  kit's  instructions
(QIAGEN). Despite the extensive experimentation with the primer mix
composition,  primer  concentration,  amplification  duration  and
temperature as well as the source of the template DNA, amplification
efficiency was poor (data not shown). Finally, the human mt-primer mix
provided  within  the  kit  surprisingly  showed  superior  amplification
efficiency for the mouse mtDNA and was used to enrich mtDNA from
an  isolated  embryo  mtDNA  and  liver  gDNA  samples  (similar
observation was also made by Marquis et al. [2017]). Amplification of
embryo mtDNA was  relatively  successful  (71 % mtDNA alignment).
Despite an apparently equally efficient reaction, amplification of liver
mtDNA from gDNA template  was  not  specific,  which  was  noted by
positive PolgA-PCR (data not shown) and only <1 % mtDNA alignment
(Fig. 4.2).  The difference in amplification efficiencies could originate
from  the  DNA extraction  methods.  The  embryo  sample  was  poorly
enriched  for  mtDNA  by  mtDNA-seq  protocol,  during  which  the
contaminating nDNA was likely highly fragmented by the DNase I. This
could enable efficient mtDNA amplification by REPLI-g relative to the 
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Figure 4.2. Comparison of different mtDNA extraction methods by the percent of sequencing reads aligning to mtDNA reference
genome. In these thesis projects and our other studies, mtDNA samples from different mouse tissues have been obtained by different
methods  and  sequenced  with  Illumina  HiSeq  or  SOLiD  sequencing  (Ameur  et  al.  2011).  To  understand  the  level  of  mtDNA
enrichment,  the  percent  of  sequencing  reads  uniquely  aligned  to  mtDNA reference  genome (mtDNA alignment)  was  compared
between the mtDNA extraction methods. Poorly enriched samples were used as templates for rolling circle and PCR amplification.
Enriched embryo mtDNA (N1 n = 1) and liver gDNA (WT n = 1) samples were used in rolling circle amplification, yielding 71 and
1 % mtDNA alignment, respectively. Amplicon PCR samples (liver MKO n = 1, WT n = 1, N2 n = 1, brain N1 n = 5) showed the
highest mtDNA alignment – 99 % – of all of the evaluated methods. As expected, sequencing of genomic DNA (gDNA) showed <1 %
mtDNA alignment (WT n = 3). Mitochondria isolation from liver by Miltenyi Biotec kit,  followed by DNase I treatment, reached
median of 30% mtDNA alignment (N1, n = 4).  A traditionally used mitochondria enrichment method,  sucrose gradient,  showed
median mtDNA alignment  57 % for  liver  (data obtained from Ameur et  al.  2011,  n = 9)  and 44 % for  heart  samples  (samples
extracted and sequenced by Stanka Matic during her PhD projects, n = 6). The method optimized in this thesis (simple differential
centrifugation combined with DNase I treatment) showed consistently high mtDNA enrichment for liver mtDNA samples and also
brain mtDNA samples performed relatively well with median mtDNA alignments 95 and 78 %, respectively (liver MKO n = 6, WT
n = 4, N1 n = 8, N2 n = 11, N3 n = 15, brain MKO n = 6, WT n = 4, N2 n = 5, N3 n = 7). However, heart mtDNA samples (samples
extracted and sequenced by Johanna Kauppila during her PhD projects, n = 20) performed equally to sucrose gradient samples;
median  mtDNA  alignment  was  52 %,  but  the  high-yield  heart  mtDNA  samples  (outliers)  were  obtained  from  mice  with
cardiomyopathy phenotype potentially affecting the mtDNA yield. This was despite equal amount (mg) of tissue was used for the
mtDNA extraction. The optimized mtDNA-seq method was not successful in enriching spleen or embryo mtDNA, as the median
mtDNA alignment was 4 % (MKO spleen n = 5, WT spleen n = 4, N2 embryo n = 1). Error bars represent 95 % confidence intervals.
Table 4.1. Summary of different mitochondrial DNA extraction methods and their performance. Different mitochondria isolation
methods were tested on multiple mice (Samples tested). The method was evaluated based on estimated time consumed after mouse
dissection (Hands-on time/total time), total yield of mtDNA obtained and amount of nuclear DNA (nDNA) contamination detected by
PolgA-PCR. Good quality samples were sequenced (Seq samples) and the performance was judged by the fraction of reads aligning
to mtDNA reference genome (mtDNA alignment). 
Method Samples tested
(n)
Hands-on
time/total time (h)
mtDNA total 
yield (ng)
nDNA  (PolgA-
PCR)
RNase A
treatment
Seq samples
(n)
mtDNA alignment
(%)
CsCl-gradient 8 4/90 50–850ND –/++ – – –
Sucrose gradient 18 3/22 25–750ND + – – –
Percoll gradient 9 3/24 250Q–8000ND – – – –
Rolling circle amplification (gDNA/E mtDNA) 54 2/27 n.a. ++/(+) + 2 <1 / 71
Amplicon PCR (gDNA/mtDNA) 8 2.5/22 n.a. n.a. + 8 99
Mitochondria isolation kit (beads) and DNase I 11 2/24 39 –100Q ++ + – –
Mitochondria isolation kit with DNase I (L/B/H) 40 1.5/22 150–900Q – + 4 30
Differential centrifugation with DNase I (S/E) 20 3/24 600–1200Q ++ + 10 4
Differential centrifugation with DNase I (L/B/H) 139 3/24 70–3500Q –/(+)/+ + 53 78–98
gDNA = genomic DNA as a template, S = spleen, E = embryo, L = liver, B = brain, H = heart, ND = NanoDrop (spectrophotometric), Q = Qubit (fluorometric), n.a. = not
analyzed nuclear DNA (nDNA) contamination by PolgA-PCR: – = not detectable, (+) = barely detectable, + = clear contamination, ++ = highly contaminated RNase A
treatment: – = no additional treatment, + = treatment of extracted DNA, Seq samples/mtDNA alignment: – = samples not sequenced
nDNA fragments  in  contrast  to  the  liver  gDNA sample  where  intact
nDNA might serve as a template for the amplification. Due to time and
financial  constraints,  no  more  rolling  circle  amplified  samples  were
sequenced,  as  the method did not seem promising for  low-frequency
mtDNA variant detection (discussed further in Chapter 4.2.2).
Another amplification-based method, similar to commonly used long-
range PCR method, was evaluated.  mtDNA was amplified in 2–7 kb
PCR amplicons either  using enriched mtDNA sample or  gDNA as  a
template and the purified amplicons were pooled in equimolar ratio to
create  a  representative  sample  of  the  entire  mtDNA.  As  expected,
amplicon samples showed 99 % mtDNA alignment, confirming specific
and  efficient  amplification  of  mtDNA.  Furthermore,  amplicon
sequencing,  especially directly from gDNA, significantly reduced the
required hands-on time in comparison to mtDNA isolation methods.
Despite  this  successful  enrichment  by  amplification-based  protocols,
methods based on mitochondria enrichment would be more favorable
for  the  reasons  outlined  before  (Chapters 1.4.3 and  4.2.2). As  a
reference,  sequencing  of  liver  gDNA  resulted  in  <1 %  mtDNA
alignment (Fig. 4.2). Mitochondria isolation kit combined with DNase I
treatment enriched mtDNA from nDNA only ~30x, although, the PolgA-
PCR was negative for these samples. According to the prior-sequencing
quality control  at the MP-GC, these samples were fragmented, which
could suggest incomplete digestion of nDNA, possibly explaining the
false-negative PCR result and high fraction of nDNA reads. Others have
successfully extracted mtDNA by sucrose gradient (see Fig. 4.2 legend
for details), and sequencing data from those studies was included to the
comparison.  Gradient-based  method  seemed  slightly  better  than  the
mitochondria  isolation  kit,  however,  one  drawback  seemed  to  be
sample-to-sample and person-to-person variation in the sample quality.
And yet, the median mtDNA alignment was only 57 and 44 % for liver
and heart samples, respectively.
In  comparison  to  other  methods,  the  differential  centrifugation
combined with DNase I treatment showed superior mtDNA enrichment
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– especially for  liver  and brain mtDNA samples – resulting in up to
98 % mtDNA alignment  (Fig.  4.2).  Kidney mtDNA samples  showed
equal  quality  to  liver  mtDNA samples  and  would be expected to  be
highly pure mtDNA, but were not sequenced for these thesis projects.
Heart mtDNA samples were consistently less pure than liver or brain
mtDNA samples. This was likely due to small amount of difficult-to-
homogenize  tissue  available,  inevitably  leading  to  the  breakage  of
mitochondria  as  well  as  presence  of  more  broken  nuclei  during  the
homogenization, and thus to the higher level of nDNA contamination in
the final sample. However, the method was not successful for mtDNA
enrichment from spleen or embryo. Despite extensive optimization of
the tissue homogenization and nDNA digestion steps, only 4 % mtDNA
alignment was obtained (Fig. 4.2). In order to understand whether the
non-mtDNA reads truly originated from contaminating nDNA and not
from  for  example  artefacts  in  sequencing  library  preparation  (e.g.
significant adapter dimer formation), reads were also aligned to the full
mouse reference genome with exactly the same alignment parameters as
was used for the alignment to mtDNA reference genome. Indeed, >99%
of the reads were aligned to the full mouse reference genome confirming
that the low proportion of mtDNA reads was caused by failed mtDNA
enrichment process, and thus significant nDNA contamination.
Due to consistent and significant purity of liver mtDNA samples, as well
as  simplest  hands-on  steps  without  a  potentially  error-inducing
amplification step,  differential  centrifugation combined with DNase I
treatment  was  chosen  as  the  most  promising  method  to  study
low-frequency mtDNA variants (hereafter denoted as mtDNA-seq). The
key steps to diminish nDNA contamination were mild homogenization
and DNase I treatment of the mitochondria. Also, extensive RNase A
treatment of  the mitochondria,  as well  as the final  mtDNA prep was
crucial  because  significant  RNA contamination  occurred,  and  caused
overestimation  in  the  spectrophotometric  concentration  measurement
and  inhibited  PolgA-PCR,  giving  false-negative  results  regarding  the
nDNA contamination. As an alternative, amplicon sequencing may be a
potential method for difficult-to-enrich samples or as a fast method for
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studies which do not require extremely sensitive variant detection (for
further discussion see Chapter 4.2.2). For the studies presented in this
thesis, liver (as a mitotic) and brain (as a post-mitotic) were selected as
representative tissues.
4.2 Selection  of  the  sequencing  method  for
low-frequency  mitochondrial  DNA  variant
detection
Different  sequencing  technologies  have  been  used  to  detect  mtDNA
mutations  and  more  accurate  sequencing  approaches  are  constantly
being developed. As Duplex-Sequencing was the most accurate method
at the time of starting these thesis projects (Fox et al. 2014), the first
sequencing experiments were conducted in collaboration with Finnish
Institute for Molecular Medicine (FIMM) Technology Center (Finland)
in  order  to  set  up  a  similar,  UMI-based  method.  However,  the
experimentation quickly showed – a topic of which was also touched by
Kennedy et al. (2014) – that the method may often require sample-to-
sample  optimization,  which  would  always  include  sequencing.  Thus,
this approach was assumed to wind up as a very expensive and time-
consuming approach,  unless  one has  a  direct  access  to  a  sequencing
platform. As in-house Illumina sequencing was not a possibility for our
group,  the  suitability  of  less  sensitive  sequencing  approaches  was
investigated in detail.
First, this chapter focuses on important sequencing data analysis steps
which were optimized keeping in mind the characteristics of mtDNA
genome.  The  data  analysis  workflow  was  developed  along  with  the
mtDNA enrichment method optimization. Next, this chapter presents the
evaluation  of  variant  calling  results  obtained  from  different  mtDNA
enrichment experiments in order to choose the most optimal approach in
terms  of  sensitivity,  accuracy,  hands-on  time  and  costs.  Finally,  the
validation of the optimized protocol utilizing spike-in control samples is
presented.
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4.2.1 Optimization of the data analysis steps suitable for circular 
mitochondrial genome
Still today, there is no ”standard” data analysis procedures for analyzing
high-throughput sequencing data from mtDNA samples. A survey of the
literature  reveals  that  analysis  details  are  often  not  documented  in
enough  detail  to  be  reproducible,  or  they  neglect  the  physical
characteristics  of  mtDNA leading to  poorer  results.  Key steps  in  the
reliable low-frequency mtDNA variant detection are:
1. Quality  and  adapter  trimming  should  be  always  carefully
applied for sequencing reads,
2. mtDNA is  circular  and nDNA contain even 100 % identical
NuMTs, 
3. mtDNA is  a  small  genome and duplicate reads are likely to
naturally occur, and
4. variant calling thresholds often applied are not able to detect
low-frequency variants.
Read trimming
Sequencing read trimming is probably the most important step in the
sequencing  data  analysis.  Low-quality  bases  or  sequencing  adapter
leftovers can appear as false sequences in genome assemblies or cause
poor  alignment  results.  For  example,  the  Cyprinus  carpio  reference
genome  (Xu  et  al.  2014) appers  to  contain  Illumina  TruSeq  adapter
sequences due to vague trimming steps before the genome assembly –
an accidental discovery when analyzing non-mtDNA reads from a failed
library preparation consisting mainly of Illumina TruSeq adapter dimers.
This  observation  was  further  supported  by  others  (Etherington  2014,
accessed 08/2017). Despite the clear advantage of read trimming, it is
not always an included step, or the reporting of this step is neglected.
For example, complete human mtDNA data analysis pipelines, such as
MToolBox (Calabrese et al. 2014) or mtDNA-Server (Weissensteiner et
al. 2016), do not include the read trimming into their data pre-processing
steps. They probably expect the data to be pre-processed by the user,
thus, reducing the reproducibility of the results.
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Tools  and  parameters  used  for  read  trimming  should  be  carefully
determined  (Del Fabbro et  al.  2013).  Flexbar (Dodt  et  al.  2012) was
chosen for the projects presented in this thesis. In addition to adapter
and quality trimming of the reads, it is one of the rare tools capable of
removing barcodes (Jiang et al. 2014), which was a required process for
the  amplicon  sequencing  approach  used  in  these  thesis  projects.
Trimming  parameters,  however,  required  optimization  since  the
recommended default parameters lead to fuzzy results in mtDNA read
trimming (Fig. 4.3).
A key reason for the fuzzy results was the required minimum overlap of
three nucleotides with the adapter sequence (similar default paramters
also in another common tool,  Cutadapt [Martin 2011]), and moreover,
flexbar allows for even three mismatches per ten nucleotides to trim an
adapter. As illustrated in Figure 4.3 (red line), this leads to the trimming
of true mtDNA sequences from the reads, in comparison to the much
smoother coverage obtained with more stringent trimming parameters
(grey  line).  Thus,  the  final  parameters  for  mtDNA-seq  data  analysis
were  minimum  adapter  overlap  of  ten  nucleotides,  allowing  only  a
single mismatch, and additionally, in order to increase the reliability of
alignment and variant calling, reads were trimmed for minimum length
of fifty nucleotides with a minimum base call quality Phred score 28.
Many tools, and thus also their default parameters, have been developed
with a focus on nuclear genome.  These results emphasize that, despite
the  suggestions  in  manuals  of  many  bioinformatic  tools,  the  default
parameters should not be carelessly applied – at least not to mtDNA data
analysis.
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Figure 4.3. Effect of read trimming parameters on coverage.  Although bioinformatic tools often recommend the use of default parameters, the
suitability of those for the data set in question should be carefully addressed. For example, the default trimming parameters of flexbar require only a
3-nt overlap and allow 3 mismatches per 10-nt overlap with the adapter sequence in order to remove it from the read. This would lead to artefactual
drops in coverage (red line) in comparison to more stringent requirement of minimum 10-nt overlap allowing 1 mismatch (grey line) used in the
projects presented in this thesis. Only a short part of the genome coverage is illustrated as the trend was similar for the entire mtDNA genome. The
maximum per base coverage difference was ~5000 bases (i.e. 8 % less) and in total two times more bases were trimmed off with the default parameters
in comparison to stringent parameters. In both trimming approaches, adapter sequences were detected from both ends of the reads (-ae ANY) and
minimum base call Phred score (-q) was 28. The stringent parameter set additionally required minimum length of 50 nt for the read whereas default
is 18 nt. The example data is from a WT liver mtDNA sample.
Alignment
Genome  circularity. Most  read  aligners  are  designed  for  linear
genomes  and  the  alignment  performance is  poor  at  the edges  of  the
linear genome leading to a drastic coverage drop (Fig. 4.4). For most
applications,  the  interest  does  not  focus  on  the  chromosome  ends;
however,  for  a  circular  genome  such  as  mtDNA,  this  means  poor
coverage  and  difficult  variant  calling  at  the  genome junction  region
potentially leading to false conclusions. Some studies (e.g. Kennedy et
al.  2014, Ni et  al.  2015, Zhang et  al.  2016) have not considered the
mtDNA  circularity  in  their  alignment  steps.  Whereas,  in  many
publications, the circularity is solved by different approaches, such as
adding certain amount of bases from the beginning of the genome to the
end of the genome (e.g.  Ameur et al. 2011; Li et al. 2015; Vellarikkal et
al. 2015) or by a ”dual approach” such that the reads are aligned to the
normal reference genome and to a split reference genome, in which the
first half of the genome sequence is transferred to the end of the genome
(e.g.  Ding et  al.  2015).  However,  the  former  approach could lead to
biased alignment since the added genome region is present twice in the
reference genome and reads may align to multiple places.
The easiest solution for circular genome alignment is to align the reads
with a splice-aware aligner, e.g.  bwa mem (Li 2013), and to optimize
the parameters such that read splicing is not heavily penalized, i.e. allow
reads to align almost equally likely to the genome junction region as to
the other parts of the genome.  Figure 4.4 illustrates the difference of
optimized bwa mem splice-aware alignment (black, parameters -T 19
-L 5,4)  in  comparison  to  bwa aln non-splicing  alignment  (red,
default parameters) commonly used for DNA reads. Results produced
with  another  non-splicing  aligner,  bowtie2 (local  alignment  mode
with  default  parameters,  Langmead  &  Salzberg  2012),  were  highly
similar to bwa aln. Even though the coverage was well-rescued with
bwa mem, the alignment was further optimized as variant calling failed
to detect variants in the first and last five bases of the genome, probably
due to the proximity of the read end decreasing the reliability of the
variant call.
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Figure 4.4. Effect of alignment tool and strategy on coverage. Relative coverage (per base coverage/total number of bases aligned
to mtDNA reference genome) obtained by different alignment strategies is illustrated a) over entire, b) at the beginning and c) at the
end of the mtDNA genome. Non-splicing aligners (e.g. bwa aln, default parameters, red line), failed to align reads at the edges of
the linear reference genome, whereas splice-aware alignment strategy with bwa mem rescued most of the reads (parameters -T 19
-L 5,4, black line). Coverage of the first and last five bases of the genome was further rescued by dual alignment strategy: reads
were aligned to both the normal and split reference genomes. Coverage results from the alignments were combined such that results
comprising ±200 positions around the junction were kept from the split alignment, and results for the rest of the genome positions
were from normal reference genome alignment. The data here is from a WT liver mtDNA sample.
The  final  approach  was  to  not  only  to  use  bwa mem optimized
alignment (Fig. 4.4, black), but to align the reads separately to a split
reference genome (first 8150 bp of the genome transferred to the end of
the genome, as in Ding et al. 2015). The final resulting coverage and
variant  calling files  were  created  by combining results  from the  two
separate analyses such that genome positions 200–16099 were from the
normal reference genome analysis, and the rest of the genome positions,
i.e. the junction region of the normal reference genome, were obtained
from the split reference genome analysis. Thus, the resulting coverage at
the  genome junction  region  (Fig.  4.4, grey)  was  rescued  and,  more
importantly, variant detection succeeded on the first and last bases for
MKO mtDNA samples. This approach is considered less biased than the
published ones, as there are no longer artefactual gaps in the coverage
and in both alignments the reads are aligned to the full mtDNA genome
allowing the use of only uniquely aligned reads in downstream analyses.
In addition to Ding et al. (2015), similar alignment strategy was recently
applied also by Kelly et al. (2017). The only difference to the published
approaches was that  they used even  ±4 kbp junction region, whereas
here only ±200 bp was considered to be enough as the read length was
150 bp at maximum.
Nuclear mitochondrial sequences.  Another alignment issue is caused
by NuMTs. The full mouse reference genome contains 100 % identical
regions in both the chromosomes and the mtDNA genome. Thus, the
often applied alignment strategies in which the reads are aligned to full
mouse  reference genome would cause  true  mtDNA reads to  align to
multiple positions or more conservatively, the reads are first aligned to
nuclear reference genome and only unmapped reads are aligned to the
mtDNA reference genome (Guo et al. 2013, Zhang et al. 2016). As it is
advisable  to  keep  only  the  uniquely  aligned  reads  for  more  reliable
variant calling, in comparison to alignment to mouse mtDNA reference
genome alone (Fig. 4.5, grey line), a significant proportion of the reads
would be filtered out from the data set if the reads were aligned to full
mouse reference genome (Fig. 4.5, red line). Therefore, for mtDNA 
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Figure 4.5. Effect of reference genome and alignment strategy on coverage. Presence of up to 100 % homologous NuMTs
in the chromosomes affect the coverage, if full mouse genome is used as a reference for alignment and only uniquely aligned reads
(red line) are kept for the downstream analysis. If only the mouse mtDNA genome is used as the reference genome for alignment (grey
line), uniquely aligned reads can be kept for downstream analysis without a huge loss of data.  The data here is from a WT liver
mtDNA sample.
variant studies,  it  is recommended to align reads only to the mtDNA
reference genome.
De-duplication 
Sequencing  data  analysis  steps  often  include  de-duplication,  which
means removal of duplicate reads.  Rationale behind de-duplication is
that from a complex DNA sample, e.g. gDNA, it is unlikely to obtain
exactly  the  same  DNA fragment  multiple  times,  and  thus,  duplicate
reads are considered likely to originate from the PCR amplification of
the library preparation, or as optical duplicates during sequencing (with
non-patterned  flow-cell  type).  Duplicate  reads  could  also  skew  the
variant calling results. De-duplication is suggested in the GATK Best
practices (van der Auwera et al. 2013), which are often used as golden
guidelines  for  sequencing data analysis.  However,  de-duplication is a
controversial step (Dyer et al. 2015) even for standard deep sequencing
data analysis due to difficulties to identify truly artefactual duplicates
from natural duplicates (Bainbridge et al. 2010; Niu et al. 2010; Balzer
et  al.  2013).  True  duplicate  identification  would  only  be  enabled  by
DNA  fragment  tagging  with  UMIs,  e.g.  by  Duplex  Sequencing
(Kennedy et al. 2014), yet, even that may be difficult due to potential
artefacts caused by index switching.
Commonly  used  de-duplication  tools  are  samtools  rmdup  (Li  et  al.
2009) and Picard MarkDuplicates (Broad Institution, accessed 08/2017).
Both of these tools define a duplicate read based on the 5' end positions
of the aligned reads only, with an assumption that duplicated reads have
identical  starting  positions.  The 3'  end  of  the  read  is  not  considered
because that  is  often trimmed or  the  base call  quality,  and thus also
alignment  quality,  is  often  decreasing  towards  the  end  of  the  read.
Therefore,  instead of  blindly implementing the established guidelines
also to the mtDNA sequencing data analysis, careful consideration of
mtDNA genome characteristics is needed:  When millions of reads are
produced from highly pure 16.3-kb mtDNA sample, it is likely that the
exactly same sequence occurs more than once in the data set. Roughly
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estimated, from 1 Gbase of 150-bp sequencing reads i.e. ~6.7 M reads,
there  should  be  ~400  reads  starting  from  each  genome  position
(~6.7x106/16300  ≈ 400).  Hence,  de-duplication  would  remove  likely
occurring natural duplicates and is not a recommended step for mtDNA
or other small-genome data analyses.
Variant calling
Many mtDNA variant studies, especially earlier ones, use relatively high
variant calling thresholds for allele frequency (AF, 0.5–10 %) due to low
read  coverage  (often  ~100–1000x  for  human  data),  or  PCR
amplification of the DNA, but also because lower detection thresholds
have not been considered reliable (e.g. Li et al. 2010; Ameur et al. 2011;
Calabrese et al. 2014; Just et al. 2014; Ding et al. 2015; Pyle et al. 2015;
Vellarikkal  et  al.  2015) without  special  approaches  (e.g.  PELE-seq
reaching reliable detection of AF 0.2 % [Preston et al. 2016]). Highly
sensitive  detection  is  rather  obtained  by  much  more  complicated
methods,  such as  utilizing  UMIs  (Kennedy et  al.  2014)  or  by circle
sequencing (Lou et  al.  2014).  Since these complicated methods were
considered too time-consuming and expensive for the projects presented
in this thesis, other means to accomplish sensitive variant detection from
standard sequencing were required.
For viral studies, variant calling methods capable of detecting variants
even below the sequencing error rate have been developed (Wilm et al.
2012;  McElroy  et  al.  2013;  Verbist  et  al.  2015).  The  variant  caller
chosen for these thesis projects,  LoFreq* (Wilm et  al.  2012),  is  fast,
sensitive  and  specific  (McElroy  et  al.  2013;  Huang  et  al.  2015).
Furthermore, no assumptions on ploidy is included in LoFreq* making it
an ideal variant caller also for heteroplasmic mtDNA. Wilm et al. (2012)
showed with experimental data that LoFreq* reliably detects variants at
AF 0.5 %, moreover, with simulated data, they detected variants even at
AF 0.05 %, and the false-positive rate was impressively low – <5x10-7.
During  these  thesis  projects,  experimentation  with  LoFreq*  variant
calling parameters – mainly removal of the hard-coded variant filtering
76
thresholds  –  with  WT mtDNA-seq  samples  showed  only  handful  of
variants,  most of which were likely true heteroplasmies.  The average
total mutation load was only 7.6x10-6   mut/bp (SD 1.8x10-7  mut/bp, WT
liver and brain mtDNA-seq samples, n = 8). In contrast, even >17000
variants were detected per MKO mtDNA-seq sample (median variant
allele  frequency was  <0.1 %) and  total  mutation  loads  were  1.4x10-3
mut/bp  (SD 1.1x10-4 mut/bp, n = 6) and 6.7x10-4 mut/bp  (SD 1.2x10-4
mut/bp, n = 6)  for  liver  and  brain  mtDNA-seq  samples,  respectively.
These  results  were  very  comparable  to  previous  results  obtained  by
post-PCR cloning and sequencing of tail biopsies by Ross et al. (2013):
2.2x10-5 mut/bp  and  6.6x10-4 mut/bp  for  WT  and  MKO  mice,
respectively.  The results  for  WT and MKO mtDNA-seq samples  are
discussed in detail in Chapter 4.3.
In  summary,  these  promising results  suggested  that  the  data  analysis
protocol,  especially  LoFreq*  and  very  relaxed  variant  calling
parameters,  allow highly sensitive and accurate variant  detection – at
least for highly pure mtDNA-seq samples. The optimized data analysis
protocol  was  applied  to  evaluate  the  different  mtDNA enrichment
methods  (see  Chapter 4.2.2),  and  finally  validated  utilizing  spike-in
samples (see Chapter 4.2.3).
4.2.2 Selection  of  the  mitochondrial  DNA  enrichment  and
sequencing method
First  in  this  section,  the  results  from  different  mtDNA enrichment
methods  –  rolling  circle  amplification,  amplicon  PCR,  mitochondrial
DNA isolation kit with DNase I treatment and differential centrifugation
with  DNase  I  treatment  (mtDNA-seq)  –  are  evaluated  based  on  the
variant results obtained by the optimized data analysis protocol. Then,
this section will focus on the improvement of mtDNA-seq method in
order to diminish the observed major artefacts and further increase the
accuracy of the method.
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Comparison of the different mitochondrial DNA enrichment 
methods
The mtDNA enrichment methods were optimized in parallel yet here,
the  variant  results  are  compared  by  using  mtDNA-seq  samples  as
”standards”,  because  mtDNA-seq was  assumed to be  the  least  error-
prone method based on high mtDNA enrichment without amplification
and  the  observed  very  low  variant  load  in  WT  samples.  The  key
evaluation criterion was the observed variant profile (i.e. proportion and
load of different variant types observed) for each sample (Fig. 4.6). The
variant profile could reveal odd samples such as those likely containing
artefactual variants e.g. unexpected load of GC>TA variants (Costello et
al. 2012; Chen et al. 2017). Some variation between the different mouse
lineages could also arise from clonal expansion of some variants but not
the others within a litter or an individual mouse.
Rolling  circle  amplification.  Lou  et  al.  (2014)  have  successfully
utilized  RCA  approach  for  circlized  short  mtDNA  fragments  to
sensitively  detect  mtDNA variants.  However,  Ni  et  al.  (2015)  and
Marquis et  al.  (2017) have suggested direct  use of  RCA for mtDNA
variant detection – escpecially valuable approach for precious, low-yield
samples, since the amplification is possible from <1 ng of DNA. Due to
the  nature  of  RCA  –  i.e.  the  same  circular  template  molecule  is
amplified multiple times – polymerase errors should not highly expand
and  less  false-positive  variants  should  be  detected  in  comparison  to
regular  PCR  amplification  where  the  polymerase  errors  may  be
exponentially  amplified.  Thus,  RCA approach  would  result  in  more
reliable  mutation  detection,  although,  previous  studies  have  used
relatively high – 0.3 and 1 % – variant detection thresholds (Ni et al.
2015; Marquis et al. 2017).
Since extraction of highly pure mtDNA from spleen or embryo was not
successful, suitability of rolling circle amplification was investigated for
these  DNA samples.  WT  liver  gDNA and  poorly  enriched  embryo
mtDNA were amplified by rolling circle  with human mtDNA primer
mix. Only the embryo mtDNA sample was highly enriched for  mtDNA 
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Figure 4.6. Comparison of variant profiles obtained by different mitochondrial DNA enrichment methods.  The variant results
obtained by sequencing samples prepared by different mtDNA enrichment methods were compared. The results from mtDNA-seq were
considered as ”standards”, because the method was assumed to be the least error-prone method based on high mtDNA enrichment
without amplification and the very low observed variant load in WT samples. When fractions of different mutation types (left panel)
are compared, samples containing a high amount of the most likely artefactual GC>TA variants are easily visualized, e.g. embryo
sample amplified with rolling circle (N2 E14, light green) or WT (grey) amplicon sample as well as single N2 (pink) mtDNA-seq
samples. Moreover, unique variant load (right panel) supports the variant profile by showing more clearly, for example, that MKO
amplicon sample carried ~10 times higher load of GC>TA variants than MKO mtDNA-seq samples. The unique GC>TA variant load
of N2 amplicon samples was significantly different from N2 mtDNA-seq samples (only brains, p = 0.011, Welch two sample t-test),
however, such difference could originate either from the mtDNA enrichment method or due to expansion of certain variants within a
mouse lineage (all N2 amplicon samples were from a single litter, whereas N2 mtDNA-seq samples originated from several maternal
lineages). Interestingly, N1 mtDNA samples, obtained by any method, always showed similar variant profile, despite the fact that the
samples enriched with mitochondria isolation kit were severely nDNA contaminated as illustrated in  Figure 4.2.  The number of
samples from various tissues: rolling circle N2 E14 n = 1 (embryo), amplicon PCR WT n = 1 (liver gDNA); MKO n = 1 (liver); N1
n = 3 (brain); N2 n = 3 (brain 2, liver 1), mitochondria isolation kit N1 n = 4 (liver), mtDNA-seq WT n = 3 (liver); MKO n = 6
(liver); N1 n = 8 (liver); N2 n = 16 (brain 5, liver 11). Error bars represent 95 % confidence intervals.
reads (Fig. 4.2) and analyzed further. The embryo was obtained from N1
mother, thus carrying maternally transmitted mutations, yet, detection of
>2500 GC>TA variants  (representing  ~80 % of  all  detected  variants,
median AF 0.01 %) was surprisingly high (Fig. 4.6, left panel). MKO
(see  Chapter 4.3  for  details)  or  PolgAD275A/D275A (Ameur  et  al.  2011)
mice  do  not  show bias  towards  transversions,  and  moreover,  in  our
hands,  N1  mtDNA-seq  samples  showed  only  median  of  29  GC>TA
variants with median AF 0.2 % (i.e. median 1.2 % of all variants, n = 8,
Fig. 4.6). Thus, the embryo mtDNA sample (n = 1) seemed to harbor a
significant artefactual GC>TA variant load. Whereas if, similar to Ni et
al. (2015), minimum AF was set to 0.3 %, only 30 GC>TA variants were
detected, which would be more expected result considering the maternal
mtDNA variant load.
Rolling  circle  amplified  DNA is  a  tree-like,  branched  structure  and
during the long amplification step (even 8–16 hours) the DNA may stay
single-stranded for a prolonged time potentially exposing the DNA for
damage. As noted by Costello et al. (2013), presence of a contaminant in
the DNA sample during the sonication step of the library preparation
may induce oxidative damage. Such contaminant could be a leftover due
to  an  incomplete  purification  of  the  sample  after  the  amplification
reaction.  Another  issue  regarding  the  RCA  method  is  that  the
amplification is supposedly highly efficient on a circular template but
less  on  a  linear  template,  thus,  the  method  would  fail  to  accurately
represent the linear, truncated mtDNA molecules present in MKO mice
(e.g.  Hämäläinen  et  al.  [2015]  and  Ni  et  al.  [2015] did  not  observe
mtDNA alignment coverage variations that are diagnostic for the linear
mtDNA fragments in homozygote mtDNA mutator mouse tissue or cell
culture samples).
Taken  together,  the  level  of  mtDNA  enrichment  by  rolling  circle
amplification  was  not  impressive,  extremely  high  load  of  artefactual
GC>TA variants were detected, and accurate representation of various
mtDNA molecule types is questionable. These results, although based
on  a  single  sample  due  to  time  and  financial  constraints,  raised
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suspicions  towards  suitability  of  rolling  circle  amplification  for  low-
frequency mtDNA variant  detection,  so sequencing experiments  with
RCA method were not continued. It is, however, impossible to conclude
based on a single sample whether such burst of artefactual variants was
only a random event or more common limitation of the RCA method.
Amplicon PCR. Amplicon PCR would enable sequencing of low-yield
mtDNA samples  or  even  simplify  the  DNA extraction  step  to  easy
genomic DNA extraction with easy-to-use kits, directly from dissected
or frozen tissue sample. An important concern, however, is the risk of
unintended amplification of 100 % homologous NuMTs regions, which
is extremely difficult to exclude despite careful primer designs. PCR-
based methods are also thought to be prone for early-cycle polymerase
errors, which would be indistinguishable from real variants. Payne et al.
(2015)  stated  that,  even  with  extreme-depth  sequencing,  the  variant
detection is only possible down to AF 0.1–0.2 % due to the error rates of
the sequencing platforms.
Amplicon sequencing was first tested with normal PCR primers using
low-yield  mtDNA samples  obtained  during  the  mtDNA enrichment
optimization as templates: N1 brain (n = 3) and N2 liver (n = 1) and
brains (n = 3). Not so surprisingly, these samples showed high coverage
bias at the primer sites. Thus, the amplicon approach was improved by
adding  a  non-mitochondrial  tag  sequence  to  the  primers  (M13F  or
M13R, see Chapter 3.6.2), allowing efficient removal of the first PCR-
cycle reads and normalizing the coverage at the primer sites (Fig. 4.7).
The amplicon overlaps and lengths were also increased such that only
three  amplicons  were  enough  to  cover  the  entire  mtDNA genome.
Templates for the improved approach were WT liver gDNA (n = 1) and
MKO liver mtDNA-seq (n = 1) samples.
The  mutational  profile  from  N1  and  N2  amplicons  resembled  those
obtained  by  mtDNA-seq,  however,  GC>TA  variants  were  slightly
overrepresented in N2 samples. Only N2 mice from a single litter were
used for amplicon PCR, thus, it is not possible to conclude whether the
observed  increase  in  GC>TA  variant  amount  was  due  to  the
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amplification method or expansion of certain variants inherited from the
mother.  Similar  to  RCA,  both  the  WT and  MKO amplicon  samples
showed  >2000  GC>TA  variants  representing  94  and  11 %  of  all
observed variants, respectively. This was clearly an artefact, since for
WT,  no  GC>TA variants  were  expected.  Moreover,  the  same  MKO
template DNA was also sequenced by mtDNA-seq in which only 1 % of
the detected variants were GC>TA, similar to what was observed for
other MKO mtDNA-seq samples (Fig. 4.6).
Even if GC>TA variants were ignored, the WT amplicon sample was
left  with  129  variants  (median  AF  =  0.09 %),  most  of  which  were
CG>TA transitions – a common error introduced during PCR (Chen et
al. 2014). If  GC>TA variants indeed arise due to DNA damage, it  is
impossible to rule out that other observed variants would not be induced
by  the  same  damaging  factor.  Although,  the  WT  total  variant  load
without  GC>TA variants  was  only  1.3x10-5 mut/bp  –  similar  level  to
what  has  been  observed  with  WT mtDNA-seq  samples  or  by  other
methods (Ross et al. 2013) – the variants occurred at several positions
and were of low frequency. This suggested these variants to be false-
positive results rather than true heteroplasmies, which would be seen as
few, higher frequency variants. If the minimum AF was set to 0.3 %,
only 6 variants  were detected,  which resembled the observation with
WT mtDNA-seq samples. However, for the MKO amplicon sample such
threshold would leave only 710 variants, whereas mtDNA-seq detected
~17000 variants for the same MKO sample. Such stringent AF threshold
apparently  improved  the  variant  calling  precision  at  the  cost  of
sensitivity.
Since significant amount of artefactual GC>TA variants were observed
only in two amplicon samples  (WT and MKO),  but  not in six  other
samples  (N1  and  N2),  it  cannot  be  concluded  to  be  caused  by  the
amplicon PCR itself. However, as suggested for RCA, it is possible that
sometimes an unknown contaminant (Costello et al. 2013), for example
due to incomplete PCR purification, may induce DNA damage during
sonication. Based on observations made during these thesis projects, it is
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 Figure 4.7. Effect of the tagged amplicon read removal on coverage.  In amplicon sequencing, the primer regions are inevitably
overrepresented (red peaks)  and are difficult  to trim off  without also removing otherwise normal genome sequences.  When the
primers included a non-target tag sequence (here M13 forward or reverse primer sequence was added to the 5' end of the amplicon
primers), the first-cycle reads could be trimmed off of the data set (grey line) to normalize the coverage to contain only the natural
amplicon overlap peaks. Additional tag trimming was conducted with flexbar option to remove barcode sequences (parameters -bo
15 -bt 2 -bu -be ANY), which specifically separated the tag-containing reads from the rest of the reads. The example data is
from WT liver gDNA amplicon sample.
tempting to suggest  that  amplification-based methods would be more
prone to the occurrence of such artefacts. Presence of other artefactual
variants  induced  by  the  method  itself  can  neither  be  confirmed  nor
excluded based on a single WT amplicon sample. Until more control
experiments with amplicon PCR are made, the only putative conclusion
here is that the amplicon PCR is a suitable mtDNA enrichment method
for various samples, but the variant detection threshold has to be set at
minimum AF of ~0.3–0.5 %. Thus, extremely low-frequency mtDNA
variant  detection  with  amplification-based  methods  does  not  seem
possible  with  standard  Illumina  HiSeq  sequencing.  It  can  be  further
hypothesized, that the limitation of the detection threshold in amplicon
sequencing  is  due  to  artefacts  induced  during  the  sample  processing
steps.
Mitochondrial  isolation  kit.  As  illustrated  in  Figure  4.6,  the  N1
samples enriched by mitochondrial isolation kit and treated with DNase
I, did not differ from N1 samples enriched by other methods. Despite the
substantially higher nDNA contamination, these samples did not show
more potential NuMT variants than other N1 samples: This was tested
by  a  BLAST search  (Altschul  et  al.  1990) of  mtDNA against  Mus
musculus. A large, >3-kb NuMT region was identified in chromosome 2
showing 72 variants in comparison to mtDNA genome. Of these NuMT
variants, 5–12 were detected in the N1 samples,  all samples showing
similar results despite the extraction method. Thus, these samples were
used along with the other N1 samples (Chapter 4.3.2) although they
were likely fragmented (as discussed in Chapter 4.1).
The reason for the DNA fragmentation remained unclear. One possible
factor  could be  that  samples  prepared  with this  method were always
dissolved into nuclease-free water, and it is known, that the pH of water
may  sometimes  be  too  acidic  for  stable,  long-term  DNA  storage.
However,  during  the  course  of  the  mtDNA  enrichment  method
optimization, other samples were also stored in water and poor sample
quality  occurred  only  with  the  mitochondrial  isolation  kit.  It  can  be
speculated that another factor, e.g. a contaminant leftover from the kit
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reagents, also contributed to the fragmentation. Since the sample quality
could not be improved, experimentation with this method was stopped.
However, the variant profile comparison suggested that the method has
potential  for  low-frequency  mtDNA  variant  detection.  Especially
difficult-to-enrich samples, such as heart mtDNA, may benefit from the
kit enrichment. The method still requires optimization, and testing with
WT control samples is highly recommended.
mtDNA-seq. As briefly mentioned before, mtDNA-seq was considered
the most reliable method, despite the fact that standard Illumina HiSeq
sequencing  is  said  to  have  up to  a  1  % error  rate.  The accuracy  of
mtDNA-seq was further supported by the single-end sequencing results
(discussed in detail in Chapter 4.3), which showed very precise variant
detection from WT samples, and also highly sensitive variant detection
from MKO samples  (Fig.  4.6).  Together  these  data  suggest  that  the
mtDNA-seq  method  indeed  is  very  accurate,  and  the  sensitivity  is
satisfactory  for  the  research  questions  addressed  within  these  thesis
projects. The precision and sensitivity of the mtDNA-seq was validated
by  spike-in  samples  as  discussed  in  Chapter  4.2.3.  As  a  short
conclusion,  mtDNA-seq  was  chosen  as  the  optimal  method for  low-
frequency  mtDNA  variant  detection  studies,  however,  further
improvements to the method were required due to a sudden introduction
of artefactual variants as discussed next.
Improved method to diminish the occurrence of artefactual variants
After tens of successfully sequenced mtDNA-seq samples, an increased
load of GC>TA variants was noted, similar to RCA and amplicon PCR
samples.  The  number  of  artefactual  variants  varied  from  handful  to
hundreds  or  thousands  (e.g.  Fig.  4.6,  N2  outlier  sample).
Simultaneously,  between-library  cross-contamination  reached  an
intolerable  level:  instead  of  maximum  a  handful  of  likely  cross-
contaminating variants  in  the  earlier  successful  samples,  >100 cross-
contaminating variants were detected in some samples. A variant  was
considered a cross-contamination if it was present at low-frequency in a
sample in which it was not expected (e.g. WT), and it was present at
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high-frequency in another  sample  included  into the same sequencing
run.
In order to understand the source of of GC>TA variants, a series of WT
mtDNA-seq  samples  were  re-sequenced  by  varying  the  input  DNA
amount (50 ng or 100 ng) with old or upgraded library preparation kit
(NEBNext® UltraTM and  NEBNext® UltraTM II  Library  Prep  Kit  for
Illumina, New England Biolabs, Inc.), since these were the only changes
in the library preparation that had taken place between the successful
and  artefactual  samples  at  the  sequencing  facility  responsible  of  the
library preparation and sequencing (MP-GC). Furthermore, since single-
end  libraries  were  always  prepared  with  dual  multiplexing  primers
although  they  were  sequenced  in  a  single-end  run  mode.  Now,  an
additional  test  was to sequence the samples  in  paired-end run mode,
which enabled the read de-multiplexing based on both indices. Dual de-
multiplexing  enables  the  removal  of  cross-contaminating  reads
originating from mix up of indices during sequencing – more likely to
happen  with  a  single  index,  but  much  less  likely  with  two  indices
(already  suggested  by  Kircher  et  al.  [2012]).  Additionally,  1  mM of
EDTA was  added  to  the  samples  for  sonication  step,  suggested  by
Costello  et  al.  (2013)  as  a  potentially  effective  measure  to  reduce
oxidative  damage to  the  DNA.  In  order  to  detect  potential  between-
library  cross-contamination,  one  sample  harboring  known
high-frequency mutations was included into the otherwise WT sample
set.
To  resemble  the  single-end  sequencing  approach  of  the  successful
samples, only read 1 (R1) de-multiplexed with single index was used for
the  analysis.  All  of  the  tested  library  preparation  conditions  showed
similar  results,  and  intriguingly,  no  artefactual  GC>TA variants  were
detected in this control experiment. In order to understand the difference
between the successful and artefactual samples (e.g. if the number of
GC>TA  variant  reads  was  just  below  the  filter  threshold  in  the
successful  samples and slightly above the threshold in the artefactual
samples),  non-filtered  variant  results  were  compared  in  addition  to
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normally  filtered  variant  results  (Fig. 4.8).  The  comparison  revealed
inherent  difference  between  the  GC>TA  variant  profiles  in  the
successful and artefactual samples. This difference does explain why the
variants were detected in the artefactual samples but filtered from the
successful  samples.  Why  the  identically  extracted  mtDNA samples
showed such different variant profiles is not understood. Moreover, one
of  the  successful  control  samples  was  simply  a  technical  library
preparation  replicate  from  the  exact  same  mtDNA  sample  aliquot
showing  artefactual  results  earlier  (Fig.  4.8,  2508.B  and  2399.I),
illustrating that the occurrence of the artefact is not explained by the
DNA extraction  process  or  biological  sample-to-sample  variation  but
rather the causing factor lies in the library preparation or sequencing
processes.
Technically,  the  only  potential  explanatory  differences  between  the
successful and artefactual samples were paired-end run mode and library
preparation  on  another  day,  which  included  EDTA addition.  Since
paired-end  sequencing  uses  the  same  chemistry  as  single-end
sequencing, it should not be the explanatory factor. Addition of EDTA
could be a logical reason why all these control experiment samples were
clean from the artefactual GC>TA variants, however, it does not explain
why the earlier successful samples showed equally good variant profiles
without  the  presence  of  EDTA.  It  seems  that  the  artefact  could  be
explained  by  the  batch  of  reagents  used  or  the  laboratory  personnel
preparing the library, or some other random variable not considered here
could equally likely be the artefact contributing factor.
Similar  to  artefactual  GC>TA  variants,  between-library  cross-
contamination  was  reduced  back  to  tolerable  levels  in  the  control
experiment: only 1–4 out of 10 known high-frequency variants from the
mutated  sample  were  detected  as  low-frequency  variants  in  WT
mtDNA-seq samples, if the data was analyzed using single index de-
multiplexed  R1  (Table  4.2).  Furthermore,  one  of  the  samples  was
exactly  the  same  DNA aliquot  that  had  shown  >100  likely  cross-
contaminating variants (of which one known cross-contamination was 
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Figure 4.8. Comparison of GC>TA variant profiles between successful and artefactual samples. GC>TA variant profiles of different
WT or WT-like (i.e. biologically the sample should contain no GC>TA variants) liver mtDNA-seq samples were compared in order to
understand the nature of  the artefact.  a) The number of  observed unique GC>TA variants,  b) the unique GC>TA variant  load
(mut/bp), c) the total number of GC>TA variant supporting reads, and d) the GC>TA variant strand bias Phred score results were
obtained from non-filtered (red) and filtered (grey) variant calling results and compared between the successful (Sample ID 2043.x
and 2508.x) and artefactual (Sample ID 2305.x, 2399.x, and 2481.x) samples. The control experiment (Sample IDs 2508.x) aimed to
test for the effect of library preparation variables on the number of artefactual GC>TA variants included, whereas all the other
samples were regular mtDNA-seq samples prepared within these thesis projects or by Johanna Kauppila (Sample IDs 2305.x and
2481.x). The samples are presented in the order of sequencing over a ~10-month period of time. Furthermore, Sample IDs 2399.I and
2508.B were the exactly same DNA aliquot used for the two different library preparations and sequencing runs. All samples were
analyzed as if they were single-end sequencing samples i.e. for Sample IDs 2508.x only R1 de-multiplexed by a single index was
analyzed. Together these data show that the artefactual samples had high numbers of unique GC>TA variants already in non-filtered
variant results (a and b), whereas the total number of GC>TA variant supporting reads (c) and GC>TA variant strand bias Phred
score (d) were lower in the artefactual samples than in the successful samples. These different characteristics of the GC>TA variants
explain why the variant filtering step is effective for successful samples but not for artefactual samples. Sequencing depths as well as
median variant allele frequencies were at similar levels for all samples and thus do not explain the observed differences.
Table  4.2  Effect  of  single  or  dual  de-multiplexing  strategy  on  artefactual
variant detection. In the control experiment, three WT samples (2508.A, D and
E) were sequenced together with a sample containing ten known high-frequency
variants  (known,  potential  cross-contamination  source)  in  paired-end  mode
allowing read de-multiplexing based on one (single) or two (dual) indices and
comparison of the variant results obtained by read 1 (R1) or read 2 (R2) alone
(single-end analysis) or in combination (R1 + R2, paired-end analysis).
Read R1 R1 R2 R2 R1 + R2 R1 + R2
De-multiplexing strategy Single Dual Single Dual Single Dual
2508.A
GC>TA variants 0 0 11 10 10 8
Known cross-contamination 1 0 0 0 2 0
Other  low-frequency
variants
0 0 4 3 3 3
2508.D
GC>TA variants 0 0 16 12 18 14
Known cross-contamination 4 0 3 0 0 0
Other  low-frequency
variants  
0 0 9 9 12 8
2508.E
GC>TA variants 0 0 3 2 4 3
Known cross-contamination 1 0 1 0 0 0
Other  low-frequency
variants  
1 1 2 1 0 0
present even at AF 2.6 %) in the first sequencing run. Yet now, with the
new library preparation and sequencing run, this sample showed only
one  clear  cross-contamination  and  three  other  unexpected  variants.
Based  on  a  single  sample,  these  results  suggest  that  the  unexpected
variants were not originally present in the DNA sample, but they were
rather cross-contaminations either from library preparation or from the
sequencing step. Moreover, the cross-contamination was not detectable,
if  the dual de-multiplexed R1 was used for  the analysis (Table 4.2).
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Despite  the  low  number  of  cross-contaminating  variants,  the  data
suggest that  the dual de-multiplexing strategy is effectively removing
between sample cross-contamination. The idea of dual de-multiplexing
to increase accuracy has also been supported by others (Kircher et al.
2012, Preston et al. 2016).
To ensure that the change to use the improved mtDNA-seq in the middle
of  the  projects  was  appropriate,  two  WT  and  MKO  liver  mtDNA
samples  successfully  sequenced  with  single-end  sequencing  approach
were  re-sequenced  with  the  improved dual  approach  and  the  variant
results were compared (Fig. 4.9). The number of detected variants (Fig.
4.9a,d) as well as unique (Fig. 4.9b,e) and total (Fig. 4.9c,f) mutation
loads were highly similar between the approaches. Even more precise
comparison would include technical replicates from both approaches in
order to understand whether the slight variability is simply due to re-
sampling  the  pool  of  mtDNA molecules  and  not  necessarily  by  the
different approach itself.  Either way, the results clearly show that the
change of the sequencing approach does not drastically affect the final
variant results.
In conclusion, the mtDNA-seq method was modified such that 1 mM
EDTA was added to the sonication step, sequencing run was in paired-
end mode, reads were dual de-multiplexed and only R1 used for the data
analysis.  The  dual  de-multiplexing  approach  is  expected  to  slightly
improve  the  accuracy  of  the  mtDNA-seq  method  in  comparison  to
single-end  run  mode,  since  even  the  tolerably  low  level  of  cross-
contaminating variants are removed. On the downside, sequencing costs
are doubled since now two Gbases of sequences are required for equally
high  mtDNA  coverage  as  obtained  by  the  single-end  approach.
However, one advantage of the paired-end sequencing is the potential
multiuse of the data: in addition to low-frequency variant analysis with
R1,  both  R1  and  R2  together  can  be  utilized  in  e.g.  breakpoint  or
deletion detection.
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Figure 4.9. Effect of single or dual de-multiplexing strategy on variant detection.  Two WT (grey) and MKO (green) mtDNA-seq
samples were sequenced and analyzed by the original mtDNA-seq method (single) as well as by the improved mtDNA-seq method
including paired-end sequencing with dual de-multiplexing strategy (dual). The variant results obtained by the two methods were
compared by  a,d) unique variant count,  b,e) unique mutation load (mut/bp), and  c,f) total mutation load (mut/bp).  By the dual
method, on average 4.2 % less variants were detected in MKO samples than by the single method. The average coverages of the total
obtained data sets were systematically higher for single than dual data sets (~60000x and ~50000x), thus, to guarantee the most
accurate  comparison  between  the  two  approaches,  unique  alignment  files  (.bam)  from  the  single  data  sets  were  randomly
downsampled to similar coverage levels (~52000x) as the corresponding dual data sets (with command samtools view, parameter -s
0.897, 0.85, 0.8 and 0.86 for WT3, WT4, MKO1 and MKO5, respectively) before the analysis without junction fix for the single data
sets.
4.2.3 Validation of the method for low-frequency mtDNA variant 
detection
The improved mtDNA-seq approach was validated by sequencing spike-
in  samples:  the  background  sample  was  a  plasmid  containing  full
mtDNA genome (pAM1, harboring five known variants) and the spike-
in additions were titration of a known concentration of mtDNA from
NZB mouse strain harboring 88 variants in comparison to the reference
sequence (list of variants is given in Appendix 1). It was preferable to
use  pAM1 as  a  background,  because  any  unexpected  low-frequency
variant  could be considered as an error,  whereas if  WT mtDNA was
used  as  a  background,  the  possibility  of  naturally  occurring
heteroplasmies  could  not  be  ruled  out  complicating  the  error  rate
determination. However, it is important to keep in mind that the use of
plasmid  background  is  confoundingly  different  from  mtDNA-seq
samples  because  majority  of  the  sample  DNA was  then  prepared  by
miniprep and not by mtDNA-seq protocol.
In total, two spike-in samples representing NZB mtDNA variants at AF
0.05 % and single spike-in samples representing AF 0.1, 0.2 and 0.5 %
were sequenced and the reads were subsampled to represent different
coverage  levels  (10000–60000x).  The  accuracy  of  the  method  was
measured by counting true positive (total 88 NZB variant positions) and
negative  variants  (total  16206,  the  rest  of  the  mtDNA  genome
positions),  and  false  positive  and negative  variants  as  unique  variant
counts.  Precision (positivie predictive value,  PPV) and sensitivity (or
recall,  true positive rate,  TPR) were calculated (Chapter 3.10.2)  and
plotted against the variable coverage levels (Fig 4.10a). The comparison
showed that variant detection is already efficient at 40000x coverage.
However, in the spike-in sample representing AF 0.05 % only ~25 % of
the  NZB  mtDNA variants  were  detected  even  at  60000x  coverage.
Furthermore,  slightly  more  false  positive  variants  were  detected  at
higher coverage levels as the precision started to decrease. A relatively
low total  number  of  false  positive  variants  were  detected  at  60000x
coverage level. Over all of the spike-in samples, median of five false
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positive  variants  were  observed  per  sample,  and  all  but  one  were
GC>TA variants (Table 4.3).
Since  higher  coverage  increased  the  sensitivity  without  markedly
decreasing  precision,  samples  with  60000x  coverage  were  used  as
representative control samples for the experiments (Fig. 4.10b, Table
4.3). Also, this was the coverage level obtained for mtDNA-seq liver
samples. In addition to precision and sensitivity, the total variant read
counts were utilized to calculate total true and false positive loads (Fig.
4.10b). The true positive variant loads were as expected for all spike-in
samples except for the lowest AF 0.05 %. The false positive variant load
was  low  (median  1.37x10-7 mut/bp),  and  varied  sample-by-sample,
mostly  indicating  a  variable  number  of  artefactual  GC>TA variants.
Presence of the artefact could be due to use of pAM1 as background
DNA, yet, to definitely address this, WT mtDNA-seq samples could be
sequenced along with the spike-in samples in the future experiments.
To roughly compare the spike-in samples to mtDNA-seq samples, two
WT  mtDNA-seq  samples  re-sequenced  earlier  with  the  paired-end
approach (Fig. 4.9) were utilized by considering the variants detected by
both, single-end and paired-end approaches as true positive results and
variants  detected  by  a  single  method  only  as  false  positive  results.
Single and dual approach showed average PPV values 0.68 and 0.86,
respectively,  whereas  false  positive  variant  loads  were  9.20x10-8 and
6.18x10-8 mut/bp (Table 4.3). The artefactual GC>TA variants were not
present in the dual mtDNA-seq sequencing run, thus expectedly, these
WT  samples  showed  slightly  lower  false  positive  variant  load  and
similar precision as NZB spike-in samples.
These results show that the data analysis optimized within these thesis
projects  leads  to  highly  accurate  and  relatively  sensitive  variant
detection.  Furthermore,  if  the  presence  of  low  levels  of  artefactual
GC>TA were  indeed  caused  by the  pAM1 plasmid  preparation,  it  is
possible  that  mtDNA-seq  samples  actually  show  even  lower  false
positive loads, similar as estimated with the single-end and paired-end
re-sequenced WT samples (Table 4.3). At AF 0.05 % (simulated 
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Figure 4.10. Variant detection accuracy determined by spike-in samples.  NZB mouse mtDNA was used as spike-in DNA in pAM1
plasmid background to determine the variant detection accuracy. Median NZB variant allele frequency (AF) varied from 0.05  % to
0.5 % in the tested samples, results for AF 0.05 % are average of two replicate samples whereas results for other samples are from
sequencing of single samples.  a)  Comparison of  precision (PPV) and sensitivity  (recall,  true positive rate,  TPR) over series of
coverage subsets (10000x to 60000x) from spike-in samples representing AF levels 0.05–0.5 %. Most variants were detected already
at 40000x, however, AF 0.05 % samples detected only ~25 % of the NZB variants even at ~60000x. Slightly more false positive
variants were observed at higher coverage levels.  b) Coverage level ~60000x was chosen as the representative spike-in sample for
precision and sensitivity of mtDNA-seq. Total true positive variant loads were at expected levels, only AF 0.05  % samples were
underestimated. For all AF samples, the total false positive variant loads were extremely low. PPV = true positive variants / all
detected variants, TPR = true positive variants / all expected variants.
Table 4.3. Variant detection accuracy. NZB mouse mtDNA was used as spike-in
sample  in  pAM1  plasmid  background  to  determine  the  variant  detection
accuracy.  Median  NZB variant  allele  frequency  (AF) varied  from 0.05 % to
0.5 %  in  the  tested  samples.  Unique  true  and  false  positive  (TP  and  FP,
respectively)  variant  counts  were  used  to  calculate  positive  predictive  value
(PPV).  False  positive  variants  showed mainly  the oxidative  damage artefact
signature (FP GC>TA). True positive rate takes into account the number of false
negative variants (non-detected variants out of total 88 NZB variants, TPR) and
F1 score is the harmonic mean of PPV and TPR (F1 score). Total TP or FP
loads  were  calculated  as  the  total  number  of  variant  reads  per  the  total
coverage.
Sample AF
(%)
TP FP FP
GC>TA
PPV TPR F1
score
Total TP
load
(mut/bp)
Total FP
load
(mut/bp)
NZB 5x10-4 1 0.05 16 7 6 0.70 0.17 0.29 4.70x10-7 2.17x10-7
NZB 5x10-4 2 0.05 23 2 2 0.92 0.26 0.41 6.85x10-7 5.90x10-8
NZB 1x10-3 0.10 88 11 11 0.89 1 0.94 5.47x10-6 2.96x10-7
NZB 2x10-3 0.20 88 3 3 0.97 1 0.98 1.06x10-5 7.99x10-8
NZB 5x10-3 0.49 88 5 5 0.95 1 0.97 2.64x10-5 1.37x10-7
WT3 mtDNA-
seq liver, single
n.a. 5 3 0 0.63 n.a. n.a. 1.66x10-6 1.40x10-7
WT3 mtDNA-
seq liver, dual
n.a. 5 2 0 0.71 n.a. n.a. 1.73x10-6 1.24x10-7
WT4 mtDNA-
seq liver, single
n.a. 3 1 0 0.75 n.a. n.a. 1.73x10-5 4.43x10-8
WT4 mtDNA-
seq liver, dual
n.a. 3 0 0 1 n.a. n.a. 1.80x10-5 0
n.a. = not annotated
LoFreq* detection threshold), only 25 % of the expected variants were
detected,  which  may well  be due to  difficulties  in  accurate pipetting
(median AF values were 0.047 and 0.0472 %) and thus easily leaving
some  of  the  variants  just  below  the  LoFreq*  detection  threhold.  To
investigate  this  possibility,  also  completely  non-filtered  results  were
compared. Only two more true positive variants were observed but also
13 additional  false positive variants.  This  suggested that  the spike-in
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variant frequencies truly were below the detection threshold of LoFreq*.
Moreover, these results show that the applied filtering steps indeed are
effective  in  removing  false  positive  variants  but  not  at  the  cost  of
sensitivity as hard-coded AF threshold would be. However, if absolute
precision  would  be  required  rather  than  higher  sensitivity,  then  the
minimum AF threshold should be set at >0.07–0.1 %, as the observed
maximum false positive variant AF was 0.07 %.
4.2.4 Discussion
To  summarize,  mtDNA-seq  approach  is  a  cheap,  fast  and  sensitive
method  to  study  low-frequency  mtDNA  mutations  over  the  entire
mtDNA genome as an alternative to more labor-intensive or expensive
methods  (e.g.  PCS,  UMI  methods  or  circle  sequencing).  A  major
drawback is  that  the  extremely  rare  variant  detection may be  highly
sensitive  to  artefacts  and  biases.  A clear  example  of  that  was  the
observed  artefactual  GC>TA variants  (Fig.  4.8)  and  between-sample
cross-contamination (Table 4.2). Since both of these artefacts appeared
and  disappeared  simultaneously,  it  is  tempting  to  suggest  that  they
would have a common origin. Unfortunately, how such issues suddenly
arose, still remains to be clarified.
Intriguingly, it seems that artefactual GC>TA variants showing samples,
despite  the  mtDNA enrichment  method,  occurred  at  a  certain  time
frame, suggesting it  to be a batch-dependent problem. Ever since the
control  experiment, the artefact has mainly disappeared. However, all
samples have been also sequenced by the improved approach. Thus, to
finally conclude whether paired-end run mode or EDTA addition would
have an effect, or whether the artefact was present only for a period of
time,  mtDNA-seq  samples  should  be  sequenced  again  by  both  run
modes simultaneously. The appearance and disappearance of the artefact
emphasized that extremely rare variant detection may be susceptible to
the slightest changes in the sample preparation or sequencing protocols.
Therefore,  it  is crucial to follow good laboratory practices and, more
importantly,  good  controls  with  known  variant  profiles  should  be
included into the  sample  set  for  each  sequencing run.  Cautious data
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analysis  has  to  be  always  applied  keeping  in  mind  that  unexpected
artefacts may arise at any point even with well-established protocols.
Amplicon sequencing of WT sample further highlighted that instead of
simply  determining  the  total  variant  load,  it  is  also  essential  to
investigate the variant profile in detail. Even if the WT sample showed a
low total variant load, the number of unique variants was many and they
occurred  at  very  low  AF  levels  suggesting  them  to  be  artefactual
variants.  A  similarly  low  total  variant  load  could  be  obtained  by
observing  only  a  few  higher  frequency  variants,  which  more  likely
represent  true  heteroplasmic  variations  than  sequencing  artefacts.
Nevertheless, simply verifying the expected variant load is not enough
to conclude successful results.
Sequencing data  analysis  approaches as  well  as  chosen  data analysis
tool may have a huge impact on the final  variant  calling results.  For
example, variant callers perform very differently and results may even
poorly ovelap for the same data set (Pabinger et al. 2013). Chosen data
analysis strategy may also have huge impact on the results – e.g. which
reference genome to use, usage of single-end or paired-end reads, de-
duplication  or  variant  calling  thresholds.  Zhang  et  al.  (2016),  for
example, evaluated from exome sequencing and RNA-seq data, how the
alignment  strategy affects the mtDNA variant  detection (Zhang et  al.
2016). Here, instead of extensive benchmarking of each data analysis
step with different tools, a single tool for each step was carefully chosen
and parameters optimized to obtain satisfactory variant calling results.
Without  a  comparison  it  is  impossible  to  conclude  that  the  chosen
strategy  is  the  most  optimal  combination  and  also  more  recently
developed tools could even perform better.  Nevertheless,  the spike-in
samples  showed very  good precision of  the  applied  protocol  and  no
further optimization or updates were considered necessary.
Sequencing errors are often used as an umbrella term for false positive
variants,  yet  clarification  of  the  error  source  could  lead  to  better
corrections.  Sequencing  with  dual  indices  effectively  removed
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artefactual errors arising during the sequencing process. Furthermore, a
good variant caller, like LoFreq*, was well able to distinguish between
an actual sequencing error or a biological variant – thereby efficiently
removing  artefacts.  What  was  left,  were  the  artefactual  variants
chemically  present  in  the  sample  (e.g.  mispairing  of  an  oxidative
damage adduct during PCR), and thus, such variants are very difficult to
exclude by any standard data analysis steps and requires more complex
prediction (like in Costello et al. [2013]). Instead of developing more
and  more  ”correction  algortihms”,  it  would  be  very  important  to
understand at which processing step and why the bias occurs and take
all possible measures to minimize that.
Schmitt  et  al.  (2012)  investigated  the  extent  of  GC>TA variants  by
Duplex Sequencing, whereas Diegoli et al. (2012) and Lou et al. (2013)
successfully  included  repair  enzymes  to  the  sample  preparation  to
reduce  artefactual  variant  results.  Furthermore,  Costello  et  al.  (2013)
investigated the potential source of the damage, and recently Chen et al.
(2017)  showed  how the  damage  is  confounding  the  somatic  variant
identification in cancer studies – even up to AF 5 %, thus passing even
most of the stringent variant calling thresholds. Although Chen et al.
(2017) do have a conflict of interest, with the building evidence and also
observations made during this thesis,  it  is  tempting to suggest  that  a
repair step, or other measures to prevent the propagation of the oxidative
damage  artefacts,  should  be  included  into  the  standard  sequencing
library preparation – at least for low-frequency variant detection studies,
and  until  the  cause  can  be  identified  and  eliminated.  Here,  the  final
mtDNA-seq protocol included EDTA additon as suggested by Costello
et  al.  (2013),  however,  only  additional,  well-controlled  experiment
would show whether EDTA actually affects the occurrence of GC>TA
artefact or not.
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4.3 Mitochondrial  biology  research  questions
addressed by mtDNA-seq
The mtDNA-seq and amplicon sequencing approaches were applied to
address various questions in the field of mitochondrial biology. First, the
variant  profile  of  the  entire  mtDNA genome  was  created  to  reveal
regions  critical  for  mtDNA  replication.  Second,  the  developmental
timing and mechanism of mtDNA purifying selection was clarified. And
third,  the effect  of mtDNA variants on mitochondrial  RNA (mtRNA)
processing was studied. The final or preliminary results of each project
are presented in this chapter with a brief introduction to each topic.
4.3.1 Creation of variant profile of the entire mitochondrial genome 
and identification of regions essential for replication and 
replication-associated transcription
The widely accepted model for mtDNA replication is so called strand-
displacement  model  (as  reviewed  by  Gustafsson  et  al.  [2016],  Fig.
4.11a).  Briefly,  the  origin  of  replication  of  heavy-strand  (H-strand),
OriH,  is  located  at  the control  region of  mtDNA genome and is  the
initiation  site  for  the  entire  mtDNA replication.  First,  mitochondrial
RNA polymerase (POLRMT) forms a short  RNA fragment,  which is
used as a primer by POLG for DNA synthesis of the nascent H-strand.
Additionally,  the  mitochondrial  replisome  requires  replicative
mitochondrial  helicase  (TWINKLE)  to  unwind  the  double-stranded
DNA (dsDNA), and mitochondrial single-stranded DNA binding protein
(mtSSB), which bind to and stabilize the displaced parental H-strand.
Once the  unidirectional  replication  passes  OriL,  this  region  becomes
single-stranded and is able to form a stem-loop structure. POLRMT uses
the  structure  to  produce  another  short  RNA primer,  which  allows
another POLG to initiate synthesis of the nascent L-strand (Fig. 4.11a).
Now,  the  replication  proceeds  simultaneously  in  both  directions.  To
form two daughter mtDNA molecules, the RNA primers need to be 
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Figure 4.11. Models for mitochondrial DNA replication and transcription. a)  The replication of mtDNA requires a short RNA
fragment (pink) formed by mitochondrial RNA polymerase POLRMT upstream of origin of replication of the heavy-strand (OriH, H-
strand, RNA-DNA transition site around conserved sequence blocks [CSBs, purple blocks]) to prime the mtDNA synthesis by POLG
and other mtDNA replisome components; the replicative mitochondrial helicase TWINKLE and mitochondrial single-stranded DNA
binding protein mtSSB. When the replication has proceeded approximately two thirds of the genome, the origin of replication of the
light-strand (OriL, L-strand) becomes single-stranded and forms a stem-loop structure. POLRMT synthesizes another RNA primer
and the mtDNA synthesis by POLG continues in both directions until the strands are complete.  b) The transcription of mtDNA
initiates at promoter regions, one for H-strand (HSP) and one for L-strand (LSP). The transcription complex consists of at least
POLRMT and mitochondrial transcription factors A (TFAM) and B2 (TFB2M). Transcription from LSP is terminated at mt-tRNA L1,
whereas HSP transcription terminates at the extended termination associated sequences (ETASs, green blocks). In addition to full
replication  or  transcription  processes,  also  pre-maturely  terminated  products,  7S  RNA and 7S  DNA are  formed  in  significant
amounts, however, their functions are not yet fully understood. The processes are reviewed by Gustafsson et al.  (2016), and the
illustrations are based on the same paper.
removed, and this RNA-DNA transition site of the H-strand is mapped
at the conserved sequence blocks (CSB I–III,  Fig. 4.11a). Furthermore,
newly synthesized DNA strands  are ligated by co-operation of  DNA
ligase III and POLG exonuclease activity. In MKO mice, this process is
inefficient due to exonuclease-deficient POLG leading to formation of
linear, truncated mtDNA molecules (Uhler & Falkenberg 2015).
Transcription  of  mtDNA is  also  initiated  at  the  control  region  (Fig.
4.11b), which harbors two transcription promoters: one for the H-strand
(HSP)  and  one  for  the  L-strand  (LSP).  Transcription  is  initiated  by
mitochondrial  transcription factor A (TFAM) binding upstream of the
transcription initiation site within the promoter region and changing the
DNA structure.  This  allows  interaction  with  POLRMT  and  further
conformational changes enable binding of  mitochondrial  transcription
factor  B2  (TFB2M).  The  transcription  complex  then  proceeds  to
produce near-genome-length transcripts. Transcription of the L-strand is
terminated at  mt-tRNA L1 by mitochondrial  transcription termination
factor  1  (MTERF1,  Terzioglu  et  al.  [2013]),  whereas  the  H-strand
transcription  is  terminated  at  the  extended  termination  associated
sequences  (ETAS)  by  yet-unknown  mechanisms  (Gustafsson  et  al.
2016).
The replication and transcription of mtDNA are complex events, which
require careful regulation at the busy control region in order to avoid
collisions of replication or transcription machineries. In addition to the
described  basic  processes,  short  7S  RNA and  7S  DNA products  are
formed by pre-mature termination of transcription or replication (Fig.
4.11b). The function of these products are not known but speculated to
facilitate  the  transcription  and  replication  processes:  7S  RNA,  for
example, is suggested to secure the delicate ligation process of the DNA
synthesis  by  moving  the  ligation  event  further  away  from  the
trancriptively active regions. On the other hand, 7S DNA is forming a
triple-stranded structure – D-loop – at the control region, and this D-
loop,  among  the  many  other  hypotheses  (reviewed  by  Nicholls  &
Minczuk 2014),  may function as a regulator to avoid replication fork
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collisions.
A  long-standing  issue  for  studies  deciphering  the  mechanisms  of
mtDNA replication and transcription is that mammalian mitochondrion
cannot be transfected (Patananan et  al.  2016).  Thus, mtDNA mutator
mouse model has been used as a saturation mutagenesis model to clarify
these  key  biological  events.  For  example,  Wanrooij  S.  et  al.  (2012)
showed selection against variants at OriL, whereas multiple studies have
observed  also  low  variant  load  at  the  mtDNA control  region  (e.g.
Trifunovic  et  al.  2004;  Rovio  2006;  Ameur  et  al.  2011).  Such
observations highlight the essential nature of those regions for mtDNA
maintenance. In these studies, however, it was not possible or simply not
in the focus of the study to create a variant profile of the entire mtDNA
genome. Detailed information of the mtDNA mutational characteristics,
especially at the control region, would aid the research focusing on the
mechanisms  of  mtDNA replication  and  transcription.  Here,  with  the
highly sensitive mtDNA-seq, the aim was to generate a detailed variant
profile of the entire mtDNA genome and to identify regions essential for
replication and replication-associated transcription. The produced data
set is considered to be a highly valuable resource for other researchers;
the  data  can  be  used,  for  example,  as  a  starting  point  to  form new
hypotheses  or  to  narrow down the  target  sites  in  a  search  of  novel
proteins and protein-binding sites.
Highly sensitive variant detection from high-coverage sequencing 
data
With the single (and dual) mtDNA-seq approaches,  uniform coverage
over  the  entire  mtDNA genome  was  obtained.  Moreover,  the  linear
deletions (brain and liver) as well as control region multimers (brain, as
in Williams et al. 2010) of MKO mice were detectable in the coverage
profiles  (Fig. 4.12).  These  coverage  patterns  further  confirmed  the
validity  of  the  mtDNA-seq,  as  information  of  the  linear  mtDNA
molecules would be easily lost by PCR-based methods. Due to higher
levels of nDNA contamination in brain mtDNA-seq samples, the median
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Figure 4.12. Median relative coverage of liver and brain WT and MKO mtDNA-seq samples. Median relative coverage (coverage
per position/total number of bases aligned to mtDNA reference genome) over four and six WT and MKO mtDNA-seq samples,
respectively. The linear, truncated mtDNA molecule present in MKO mice is clearly seen in liver coverage profile (green, less notably
in  brain  [orange])  as  the  relative  MKO coverage  is  higher  between  positions  ~5100–16000  (i.e.  between  the  two  origins  of
replications, indicated by black arrows) than in WT samples (grey). Furthermore, the MKO brain samples show high coverage peak
at ~15000–16000, which is caused by the control region multimers (CRM, Williams et al. 2010).
coverage  per  position  of  six  brain  mtDNA-seq  samples  was  36000x
(min 28000x, max 58000x), whereas results for liver were less variable,
median 61000x (min 60000x, max 63000x).
As mentioned in Chapter 4.2, mtDNA-seq enabled reliable detection of
extremely  low-frequency mtDNA variants,  yet,  despite  the  extremely
low detection threshold, only few variants were observed in WT samples
(Fig. 4.13a–c), in contrast the majority of the ~17000 variants detected
per MKO sample were at AF <0.1 % (Fig. 4.13d). On average only 0.8
% (SD = 0.1 %) of the variants were observed at high frequency (AF
>0.5 %). Other mtDNA variant studies have often been limited to even
higher variant detection thresholds, thus, by mtDNA-seq, it was possible
to obtain even ten times better sensitivity and observe significantly more
variant  results  per  sample.  This  is  not  only  leading  to  more  precise
variant  profile  but  also  ultimately  reducing  the  number  of  required
animals per experiment.
The total variant loads were lower in MKO brain samples than in liver
samples (Fig. 4.13f). This could reflect the fact that brain (post-mitotic
tissue) likely has less on-going mtDNA replication than liver (mitotic
tissue).  However,  brain  samples  also  had  higher  level  of  nDNA
contamination leading to systematically lower coverages than what was
obtained for liver samples and the sequencing depth might easily affect
the extremely low-frequency variant detection sensitivity.
To further address the issue of variable coverages, the MKO liver and
brain  alignment  files  were  subselected  (samtools view -s)  to
represent different average coverages per position (range from 10000x
to 60000x), and variant calling steps were repeated for these subsets.
The comparisons showed that  sequencing coverage above 30000x is,
especially in liver samples, already reaching plateau in the number of
variants detected (Fig. 4.14a). Thus, only more of the same mutational
events  that  have  independently  taken  place,  or  clonal  expansion  of
existing variants are detected with higher sequencing depth as the total
variant read count kept increasing with the increasing sequencing depth
(Fig. 4.14b). Furthermore, a single brain sample reached 58000x 
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coverage, yet, the variant count was still  well below the liver variant
counts. Together these data would suggest that the difference between
the two tissues,  indeed,  is  biological,  but  definite  conclusions would
require sequencing of more high-coverage brain samples.
To further support the hypothesis that mtDNA-seq with ~30000–60000x
coverage  was  sensitively  detecting  variants  at  near-saturation  level,
Venn  diagrams of  variant  positions  observed  in  five  of  the  total  six
MKO liver and brain samples were compared (Fig. 4.15a). Also, variant
position results obtained from the liver and brain of a single mouse were
compared, pairwise. Venn diagrams showed, that the mutational profiles
of the mice were highly homogeneous, showing mostly shared variant
positions not only between the different tissues of a single mouse but
also  between  the  mice.  Moreover,  the  variant  allele  frequencies  of
common  variants  observed  in  liver  and  brain  from  a  single  mouse
showed high correlation (data not shown). Intriguingly, only a median of
127 and 102 unique variant positions were observed in each independent
liver  and  brain  samples,  respectively.  However,  the  brain  sample
showing  58000x  coverage  (MKO5)  harbored  1723  unique  variant
positions in comparison to other brain samples.
To better visualize the contribution of each mouse in terms of number of
detected  variant  positions,  the  variant  position  results  were  also
represented  as  a  cumulative  plot  (Fig.  4.15a).  A single  mouse  liver
sample  carried  variants  at  ~80 %  of  all  mtDNA genome  positions.
Further  liver  samples  only slightly increased  the  number  of  detected
variant positions. With six mouse livers, >90 % of the mtDNA genome
positions  were  observed  to  be  variable.  Brain  samples  showed  less
saturation than liver samples – <70 % of all mtDNA genome positions
carried variants, yet, highly pure MKO5 brain sample had a relatively
large impact on the number of observed variant positions, whereas other
five brain samples showed more similar behavior.
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Figure  4.13.  Variant  loads  and  frequencies  observed  in  WT  and  MKO
mtDNA-seq samples. Unique variant counts (a) were very low for WT liver and
brain samples (grey), thus also unique (b) and total (c) variant loads were at
extremely  low  levels.  Whereas  for  MKO  liver  (green)  and  brain  (orange)
mtDNA-seq  samples,  highly  sensitive  variant  detection  showed  majority  of
variants at allele frequency (AF) <0.1 % (d) (total number of observed mtDNA
variants for all liver and brain samples were 102500 and 59622, respectively).
Similar trend was observed throughout the genome regions (n in plotting order
for liver: 76507, 9122, 14989, 152, 71, 1659, and for brain: 44615, 5119, 8405,
81, 26, 1376). Inside the violin, the white bar corresbonds to the median allele
frequency and the black box to the 25 th (bottom) and 75th (top) percentile values.
Unique (e) and total (f) variant loads for MKO showed equal distribution of the
variants throughout the genome regions – except at OriL and the control region.
The total variant loads in MKO brain samples were consistently lower than in
liver  samples,  which could reflect  the fact  tha brain is  a  post-mitotic  tissue
whereas liver is a mitotic tissue. Error bars represent 95 % confidence intervals.
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Taken together,  these data suggest  that  the two organs – representing
mitotic and post-mitotic tissues – show highly similar variant profiles.
Although, brain samples would slightly benefit from higher coverage,
brain  mtDNA  does  harbor  fewer  variants  than  liver  mtDNA.  In
conclusion, the results and discussion is focused mainly on liver samples
for the sake of clarity. Moreover, it can be concluded that sequencing
more mouse samples would not add a considerable value to the results,
thus, the variant detection from MKO mice by mtDNA-seq seem to be
close to saturation level.
Figure 4.14.  Effect of  sequencing depth on variant  detection sensitivity.  In
order  to  compare  the  effect  of  coverage  to  variant  detection  sensitivity,
sequenced  MKO  liver  and  brain  mtDNA-seq  samples  were  subselected  to
different  average  coverage  levels  (10000x—60000x,  labelled  as  10k  to  60k)
where possible. As seen in a) the unique variant count started to reach plateau
already at 30000x, especially in liver samples. Whereas the total variant read
count  b) showed a linear relationship with the coverage. Together these data
suggest, that increasing sequencing depth to over one Gbase (used here, single-
end mtDNA-seq), will not significantly increase the number of detected variants.
Rather  the  same mutational  event,  or  clonal  expansions  are  detected.  Liver
samples had median coverage of  61000x,  whereas brain samples  were more
variable (median coverage 36000x, minimum 28000x and maximum 58000x).
Thus, six samples were used for liver (green) subsets, whereas six, three and one
sample subsets were available for brain (orange) coverages of 10k–30k,  40k
and 50k–60k,  respectively.  The curves were fitted with method loess and the
shaded area represents 95 % confidence interval.
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Non-uniform distribution of variants over the mitochondrial genome
regions
In  total,  from the  six MKO brain  and  liver  mtDNA samples,  21713
unique variants  were detected  at  14898 different  genome positions –
91.4 % of the entire mtDNA genome positions were observed to harbor
a variant at least once. As shown earlier (Fig. 4.13e,f), the variants were
distributed equally throughout the mtDNA genome – except at OriL and
control  regions  (Fig. 4.16).  The  extremely  low-frequency  variant
detection enabled the observation of very saturated variant  frequency
profile over the majority of the mtDNA genome (Fig. 4.16, first track).
If  more  stringent  variant  detection  thresholds  (AF  >=0.5 %)  were
applied,  like  in  earlier  studies,  only  229  variants  would  have  been
detected (Fig.  4.16,  second track).  Interestingly,  some positions were
recurrently hypervariable (positions which carried not only a transition
but also the two transversions at the same position at least in three liver
samples, Fig. 4.16, third track), whereas, in addition to OriL and control
region, some sites were mutational coldspots (average variant frequency
was  zero  over  three or  more consecutive  positions,  Fig.  4.16,  fourth
track).
Previously, Wanrooij S. et al. (2012) showed by PCS of ~1-kb mtDNA
region from homozygote mtDNA mutator  mice that  OriL region is  a
mutational  coldspot.  With  in  vitro experiments,  they  confirmed  that
variation at  OriL region lead  to  poor  mtDNA replication.  Thus,  they
hypothesized  that  mtDNA  molecules  harboring  variants  at  regions
critical for mtDNA maintenance will not be efficiently replicated. By
comparing the data obtained by Wanrooij S. et al. (2012) to this analysis
– a comparison of  two completely different  technologies  – strikingly
similar  variant  frequency  profiles  were  observed  (Fig.  4.17a),
confirming that mtDNA-seq is a reliable method. Moreover, these new
results  –  with  extremely  sensitive  variant  detection  –  supported  the
earlier hypothesis that variants hampering mtDNA maintenance are not
expanded to such high-frequency levels that they would be detectable
with mtDNA-seq.
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Figure 4.15. Comparison of the variant positions between mice and tissues.
The observed variant profiles between different mice and tissues were compared
by Venn diagrams and cumulative plots for a) the entire mtDNA genome and b)
separately for the control  region.  Both tissues showed significant overlap in
terms of variant positions over the entire mtDNA genome and over the control
region. Each liver and brain sample harbored only ~100 or ~10 unique variant
positions over the entire mtDNA genome and the control region, respectively.
The total number of mutated positions in liver and brain samples were 14740
and 12697 of the entire mtDNA genome (total 16299 positions), whereas only
353 and 361 mutated positions were observed on the control region (total 877
positions). MKO5 brain sample showed more variant positions due to much less
nDNA contamination present in the sample, and thus almost double coverage, in
comparison  to  other  brain  samples.  Pairwise  comparisons  of  the  variant
positions between the liver and brain from a single mouse showed that majority
of the variant positions were common to both tissues. Cumulative plots further
illustrated the value added by each sample – most of the variant positions were
already observed in a single sample and the curves reached plateau already
after  2–3  samples.  Over  the  entire  mtDNA genome,  >90 %  of  the  genome
positions were  mutated,  whereas  only  ~40 % of  the  control  region  positions
harbored a variant. Venn diagrams between mice were constructed using only
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five MKO liver and brain mtDNA-seq samples, because Venn diagram for six
samples is not feasible (MKO2 was excluded as it showed highly similar results
as most of the other samples). Pairwise comparisons between liver and brain of
a single mouse are shown only for two representatives: MKO1 was similar with
most  of  the other samples,  whereas  MKO5 was  the  most  different  one.  The
cumulative curves were fitted with method loess, and horizontal lines represent
90 % and 50 % levels of the total positions.
Since  the  OriL region has  been  already well  characterized,  here,  the
focus  was  on  the  control  region.  Although  control  region  has  been
already  earlier  noted  to  be  a  significant  mutational  coldspot  (e.g.
Trifunovic et  al.  2004,  Rovio 2006, Ameur et  al.  2011),  none of the
studies characterized the variant profile of the control region in detail. In
total,  six  MKO liver  and  brain  samples  showed 528 variants  at  436
positions  –  49.7 % of  the  control  region  positions  were  observed  to
harbor a variant at least once. Similarly as was observed for the entire
mtDNA genome  (Fig.  4.15a),  the  mice  showed  quite  homogeneous
variant  position profiles (Fig. 4.15b).  However,  as is  observed in the
cumulative plots, a single liver sample contributed to ~89 % of the total
variant position results over the entire mtDNA genome, whereas only
~64 %  of  the  variant  position  results  over  the  control  region  were
observed in a single liver sample. The contribution of the last sample
represented only 0.7 percentage points (pp) more variant sites over the
entire mtDNA genome, and 2 pp over the control region. Sequencing
even more samples was not considered necessary or very cost-efficient.
The control region is known to be highly conserved between rodents,
mainly at  CSB I–III,  at  central  domain (commonly known as  D-loop
region)  and  at  ETAS I–II  (Sbisà  et  al.  1997).  To  compare  the
evolutionary  conservation  to  the  variant  frequency  profile,  mtDNA
control region sequences of mouse species (mice), mouse and rat species
(mice/rats) and various rodents (rodents) were aligned (Fig. 4.17b). The
comparison  of  the  variant  and  invariant  sites  from  the  alignment
revealed  highly  evolutionarily  conserved  regions  with  mutational
coldspots (Fig. 4.17c).  This observation supported the hypothesis that
those regions are highly important for mtDNA replication efficiency.
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Figure  4.16.  Variant  profile  of  the  entire mitochondrial  genome. Variant
profile  over  the  entire  mtDNA  genome  of  the  MKO  liver  samples.  Track
descriptions from outside to inside: The outer-most, green track shows average
mutation frequency per genome position of six MKO mice (y-axis is 1/-log10 of
average mutation frequency,  5-bp bins,  values ranging from 0 to  0.44).  The
second,  magenta  track  shows  genome  positions  carrying  high-frequency
mutations (allele frequency >0.5 %, total 229 positions). The third, yellow track
shows recurrent hypervariable genome positions (three different mutations i.e.
one transition and two transversions, observed at least in three mice, total 576
positions). The fourth, blue track shows at least 3-bp long coldspot stretches i.e.
average mutation frequency was 0 at least for three adjacent genome positions
(total 139 stretches). The fifth, line track shows average coverage per genome
position for four wild-type mice (WT, grey line) and for six MKO mice (green
line, y-axis is 1/-log10 of read depth, 5-bp bins, values ranging from 0.23 to
0.24). The sixth track shows genes encoded on the H- (outward boxes) and L-
strands (inward boxes); mRNAs are purple, tRNAs yellow, rRNAs brown and
non-coding regions (NCR i.e. control region and OriL) are grey. The plot was
constructed with R package circlize (Gu et al. 2014).
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To  further  characterize  the  variant  profile  at  the  control  region,
distribution of the variant types were compared. The variant profile was
created separately for control region and for the entire mtDNA genome,
and the proportion of each variant type, e.g. A>G, was calculated from
unique and total loads of that base change in question (i.e. the unique or
total variant count of A>G variants were divided by the coverage on As,
Table  4.4).  Thus,  the  observed  proportions  were  normalized  to  the
mtDNA base  composition  of  the  reference  strand  (L-strand).  If  no
selection and truly random POLG replication errors were assumed, each
base would be expected to harbor ~25 % of the observed variants. The
assumption was true over the entire mtDNA genome,  whereas in the
control  region the distribution of unique and total  variant  loads were
significantly  different  (p = 7.3x10-4 and  6.6x10-4,  respectively,  Chi-
squared test). Both A and T bases harbored >30 % of the variants and
larger proportions of the variants were either T>C or A>G.
Approximately half of the G>A variants were observed in the control
region in comparison to the entire mtDNA (Table 4.4). Similarly, the
distribution of highly conserved bases (from an alignment of all rodent
mtDNA sequences)  was  different  from  the  base  distribution  of  the
control  region  (p = 0.046,  Chi-squared  test);  Gs  and  Cs  were
overrepresented,  whereas  As  were  underrepresented  among  the
conserved sites.  Together these results suggest that the control  region
GC-content is important for mtDNA maintenance. 
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Figure 4.17. Variant profile at non-coding regions of the mitochondrial genome. a) To further confirm the realiability of mtDNA-
seq, the observed average variant frequencies from six MKO liver (green) and brain (orange) samples were compared to the results
obtained by Wanrooij S. et al. (2012) by PCS of homozygote mtDNA mutator mouse tissues (grey, 5-bp sliding window). Despite the
completely different technologies applied, strikingly similar variant frequency profiles were obtained. The pink arrow points to OriL
region, which was further characterized in in vitro studies by Wanrooij S. et al. (2012), revealing that variants at that region affect
mtDNA replication efficiency.  b)  In addition to OriL, the control region was also a significant mutational coldspot. The variant
frequency  profiles  showed long  stretches  where  variants  were  never  observed  in  any  of  the  six  MKO liver  or  brain  samples.
Intriguingly,  these  mutational  coldspots  aligned  with  the  evolutionarily  conserved  regions  (purple  tracks):  bars  represent  non-
conserved and gaps conserved sites of control region sequences from 26 representative rodents, which were subset to 21 mouse and
rats or 8 mouse species (total number of conserved sites for each track were 336, 494 and 603). Additionally, some functionally
annotated sites, like POLRMT binding sites, were also mutational colspots. The last track indicates all potential methylation sites i.e.
GpC  sequence  context  (n = 23),  which  can  be  utilized  to  potentially  determine  novel  protein-binding  sites.  ETASs = extended
termination associated sequences,  OriH = origin of  replication of H-strand,  CSBs = conserved sequence blocks,  LSP = L-strand
transcription promoter, TFAM = mitochondrial transcription factor A, POLRMT = mitochondrial RNA polymerase, HSP = H-strand
transcription promoter. c) The average variant frequency of liver or brain samples was grouped according to the level of conservation
of a site: non-conserved sites were the ones harboring colored bar in all three classes in  b)  (n = 274), whereas the other groups
represent specific gap sites of each class in b), i.e. conserved sites only in rodents (n = 336), conserved sites in mice/rats which were
not already in rodents (n = 158) and those sites showing conservation only in mice (n = 109). Significantly lower average variant
frequency was observed in both liver and brain samples at the most conserved sites i.e. gap regions in rodents or mice/rats in  b).
** p<0.01, *** p<0.001, post-hoc Tukey Honest Significant Difference of 1-way ANOVA.
Table 4.4. Comparison of variant distribution over the entire mtDNA genome
and control  region.  Percentages  of  each  variant  type  were  calculated  from
unique and total variant loads which were calculated by dividing the unique or
total variant read count by the number of aligned bases in question i.e. variant
loads  were  normalized  to  the  base  composition  of  the  region.  Each  row
represents the reference base and columns the variant base, total column shows
the  total  distribution  of  variants  on  each  reference  base.  Transitions  are
highlighted with grey background.
Unique variant load proportions, 
mtDNA
Total variant load proportions, 
mtDNA
→ A C G T Tot. → A C G T Tot.
A - 2.81 18.17 7.58 28.56 A - 3.30 15.89 6.71 25.09
C 0.89 - 0.60 19.45 20.94 C 0.60 - 0.39 22.06 23.05
G 18.77 1.63 - 1.08 21.48 G 19.64 1.12 - 0.71 21.47
T 4.00 22.65 2.38 - 29.03 T 3.04 24.71 1.83 - 29.58
Unique variant load proportions, 
control region
Total variant load proportions, control
region
→ A C G T Tot. → A C G T Tot.
A - 2.46 27.01 5.64 35.11 A - 3.25 25.15 4.20 32.60
C 0.14 - 0.06 17.64 17.84 C 0.11 - 0.04 19.83 19.98
G 11.59 0.13 - 0.28 12.00 G 10.42 0.08 - 0.14 10.64
T 4.31 30.28 0.45 - 35.04 T 4.70 31.51 0.59 - 36.80
Discussion
To summarize, mtDNA-seq was successfully applied to produce detailed
variant profile of the entire mtDNA genome of MKO mice. The detailed
characterization  showed,  that  MKO  mice  indeed  are  a  true  in  vivo
mtDNA saturation mutagenesis model, and for the first time, the variant
detection was possible at high sensitivity. Moreover, comparison of the
new  results  to  previous  PCS  results  not  only  further  confirmed  the
reliability  of  mtDNA-seq,  but  also  extended  the  previous  study  by
showing that despite the extremely low-frequency detection threshold,
the same mutational coldspots were still observed at OriL. Similarly, as
noted before with less sensitive methods, also control region harbored
major mutational coldspots.
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Detailed  control  region  variant  profile  revealed  alignment  of  highly
conserved  or  functionally  important  regions  to  mutational  coldspots.
This  supported  the  hypothesis  that  regions  essential  for  mtDNA
replication  and  replication-associated  transcription  are  sensitive  to
variation  as  it  likely  affects  the  replication  efficiency,  thus  mutated
mtDNA molecules  do  not  proliferate  to  the  levels  above  the  variant
detection threshold. For example,  POLRMT binding site  (Posse et  al.
2014), although not evolutionarily very conserved except at LSP site,
was fully a mutational coldspot supporting that the POLRMT interacts
sequence specifically with the DNA at the transcription initiation site
(Gaspari  et  al.  2004;  Posse  et  al.  2014).  On  the  other  hand,  TFAM
binding site seem to be dispensable,  although it  is  suggested to bind
sequence specifically to activate promoter-specific transcription (Fisher
& Clayton 1988; Fisher et  al.  1992; Posse et  al.  2014).  However,  as
TFAM is capable of binding mtDNA also in a non-sequence-specific
manner,  this  observation  is  not  that  surprising.  Probably,  specific
POLRMT binding without sequence-specific TFAM binding is crucial
for replication initiation by providing primer for POLG.
The functionally annotated ETAS sites,  of  which ETAS I  also highly
conserved, were also mutational coldspots (also noted by Rovio 2006).
Doda et al. (1981) suggested that certain sequence motifs identified near
the end points of various 7S DNA molecules would be important signals
for  termination  of  mouse  mtDNA synthesis.  They  proposed  that  the
primary sequence or a secondary structure arrests the replication process
(Doda et al. 1981). Only two out of the four predicted motifs were also
mutational coldspots, whereas the mapped 3' ends of 7S DNA molecules
were  coldspots. More  recently,  ETAS I  and  CSB I  regions,  both
harboring  a  sequence  motif  ATGN9CAT  (in  human  and  in  mouse
mtDNA, partially overlapping with the findings of Doda et al. 1981),
were suggested to be important for transcription termination from HSP
and LSP, respectively,  and the ETAS region also for formation of 7S
DNA in humans (Jemt et al. 2015). However, the mouse mtDNA control
region harbors in total four of such motifs and only the one on CSB I
was a significant mutational coldspot. Thus, it is likely that more precise
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or shorter sequence motifs are required, and as suggested also by Jemt et
al. (2015), it is likely that other factors than these sequence motifs alone
are involved in these key processes. A 48-kDa yet-to-be-isolated protein
is  known  to  bind  at  ETAS  region  in  cows,  probably  involved  in
replication termination and formation of D-loop structure (Madsen et al.
1993), however, such protein has not yet been identified in human nor in
mice (Gustafsson et al. 2016).
Variant and conservation profiles also seemed to retain the GC-content
of the control region. The longest coldspots and conserved regions were
on D-loop, which is also more G-rich in comparison to other control
region  sites  (Sbisà  et  al.  1997;  Larizza  et  al.  2002).  It  has  been
suggested, that D-loop region, and especially G-rich motifs, would be
important  in  anchoring  the  mtDNA to  the  mitochondrial  membrane
(Jackson et  al.  1996; Larizza et  al.  2002).  Moreover,  although triple-
stranded  structure  formation  i.e.  D-loop  region  is  well-known,  its
function  still  requires  clarification:  it  is  suggested  to  prime  mtDNA
replication, serve as a dNTP pool or a regulator to avoid replication fork
collisions (reviewed by Nicholls & Minczuk 2014).
Another G-rich region is located at CSB II, which was also a mutational
coldspot. It is a known site for formation of stable RNA-DNA hybrid,
which  is  suggested  to  be  involved  in  mtDNA  transcription  and
replication  as  well  as  D-loop  stabilization  via  formation  of  G-
quadruplex structures (Xu & Clayton 1996; Wanrooij P.H. et al. 2012).
Recent  in  vitro  study  of  human  mtDNA  suggested  that  length
heterogeneity of the G-tracts changes stability of the G-quadruplex and
thus modulates  the  transcription termination and replication initiation
efficiencies  (Tan  et  al.  2016).  Furthermore,  it  was  shown in  another
human  and  mouse  mtDNA  in  vitro study  that  POLRMT  pauses  at
several  sites,  especially  at  G-quadruplex  structure,  and  mitochondrial
transcription  elongation  factor  (TEFM)  is  required  to  enhance  the
transcription  elongation,  thus,  TEFM  was  suggested  as  a  potential
regulator of mtDNA replication (Posse et al. 2015).
The above-mentioned cases are just a few examples on how the variant
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profile of the entire mtDNA genome may be utilized in further research.
The  data  set  produced  in  this  project  enables  formation  of  new
hypotheses  or  may  represent  in  vivo results  to  support  existing
hypotheses,  and  it  may  serve  as  a  resource  for  the  search  of  novel
protein-binding sites or other  functional  elements.  In  the end, it  may
provide  crucial  information  of  mtDNA replication  and  replication-
associated transcription mechanisms.
4.3.2 Clarification  of  developmental  stage  and  mechanism  of
purifying selection of mitochondrial DNA
In  mammals,  mitochondria  are  transmitted  maternally  as,  upon
fertilization, the sperm mtDNA is eliminated (Shitara et al. 2000, Luo et
al. 2013;  Pyle et al. 2015). During the early stages of embryogenesis,
mtDNA  is  not  replicated,  but  instead  the  ~105 maternal  mtDNA
molecules  are  efficiently  diluted  during  cell  divisions  (reviewed  by
Stewart & Larsson 2014) (Fig. 4.18, pre-natal bottleneck). Only a tiny
subset of the maternal pool of mtDNA molecules is segregated to form
the primordial germ cells (PGC), and once the mtDNA replication is re-
initiated at the embryonic day ~7.5 (E7.5), mtDNA molecules will be
multiplied exponentially.  As a result of this mitochondrial bottleneck,
and potentially rapid proliferation of some mtDNA molecules but not
the others, the proportion of different mtDNA molecules can fluctuate
drastically  between  the  cells.  However,  as  reviewed  by  Stewart  &
Larsson  (2014)  there  is  still  no  consensus  when  the  mitochondrial
bottleneck exactly takes place – some groups argue that the amount of
mtDNA is  extremely  low  at  early  PGCs  explaining  the  bottleneck,
others claim the amount of mtDNA to be much higher and that  only
subset of the mtDNA molecules would be replicated, yet another group
suggests the occurrence of another replicative burst after birth to form
the mature oocytes (post-natal bottleneck).
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Figure 4.18. Mitochondrial bottleneck.  During embryogenesis, the number of
mtDNA molecules per cell (green line) is diluted because very minimal mtDNA
replication (pink line) takes place while cells are dividing until embryonic day
~7.5 (E7.5). By E7.5, primordial germ cells are segregated (purple dots) and
mtDNA replication is re-initiated. A very small number of mtDNA molecules are
extensively replicated (pre-natal bottleneck) in the developing embryo to form
oogonia (purple dots). After birth, another replicative burst takes place (post-
natal bottleneck) to form the mature oocytes and, through atresia, only small
amount of mature oocytes are left. The illustration is based on Wai et al. (2008),
Cree et al. (2009), Poulton et al. (2010) and Stewart & Larsson (2014).
Purifying selection has been shown to affect the mtDNA transmission.
Stewart et al. (2008a) utilized the homozygote mtDNA mutator mice as
founders for female lineages. By Sanger sequencing of 190 N2 to N6
generation  mice,  they  observed  a  rapid  purifying  selection  against
deleterious variants. Under a neutral model, one would expect to see an
equal distribution of the variants at any mtDNA site in early generations.
Indeed, transmission of variants on tRNA and rRNA, as well as on third
codon  position  of  protein  coding  sites  (i.e.  likely  neutral  variants)
followed this expectation. However, the variant loads on the first and
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second codon positions (i.e. potentially amino acid changing, deleterious
mutations) were significantly lower in comparison to the variant load on
the  third  codon  position.  Such  a  variant  profile  is  considered  as  a
hallmark  of  purifying  selection.  Their  observations  suggested  that
during the formation of subsequent generations the deleterious variants
are selectively lost, even if they would be rare and below any functional
threshold level (Stewart et al. 2008a). The exact molecular mechanism
and developmental stage when this selective pressure occurs are still not
understood.
In this project,  MKO mice were utilized as founders (F1) for female
mouse lineages (N1–N3,  Fig. 4.19). This breeding scheme allows only
variants introduced by the founder mother to be transmitted to the next
generations  without  a  background  variant  load.  Furthermore,  the
previous study utilized insensitive Sanger sequencing, and thus, only the
detection  of  high-frequency  variants  from  N2  generation  on  was
possible. Here, the sensitive mtDNA-seq approach enables, for the first
time, efficient detection and following of transmitted variants through
the  generations,  moreover,  the  variants  are  also  detectable  from  N1
generation mice. Thus, this project  aims to clarify the developmental
stage and mechanisms of germ line mtDNA purifying selection.
Mitochondrial bottleneck is the most effective factor in mtDNA 
transmission
The preliminary samples were obtained from two female lineages (two
F1 mothers).  Per  N1–N3 generation,  a  mother  with a  littermate  was
dissected to obtain in total four liver samples per generation of which
N1s  were  obtained  by  the  mitochondrial  extraction  kit  method  (see
discussion in  Chapter 4.2.2) and the other samples with mtDNA-seq
(single-end). To increase the power, mice from two more lineages were
sequenced with the improved dual mtDNA-seq approach, however, the
results presented here, are based only on the preliminary samples as the
sequencing  of  the  other  samples  was  delayed  due  to  the  previously
discussed artefacts (Chapter 4.2.2).
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Figure 4.19.  Breeding scheme to segregate  maternally  transmitted mtDNA
variants  into  female  mouse  lineages.  The  breeding  scheme  illustrates
generation of female mouse lineages carrying maternally transmitted mtDNA
variants. The founder MKO (F1, PolgAD257A/KO) mouse is generated by crossing a
heterozygote mtDNA mutator mouse (PolgAWT/D257A) male and a hemizygote WT
female  (PolgAWT/KO).  Thus,  F1  does  not  inherit  mtDNA  variants,  but  is
introducing them for the first time. To study the transmission of mtDNA, mtDNA
variants can be segregated to female lineages by breeding F1 mice with WT
males  and  selecting  for  WT (PolgAWT/KO)  female  offspring  (N1).  These  mice
inherit subset of the maternal pool of variable mtDNA molecules, but do not
introduce more mtDNA variants. Further breedings with WT males produce N2
and  N3  generation  females  (PolgAWT/KO or  PolgAWT/WT).  Each  offspring
generation is expected to harbor the same total load of maternally transmitted
mtDNA variants  (illustrated by  colored  mitochondria)  –  only  the  number  of
different  mtDNA variants  decreases,  but  the  same  variants  are  observed  at
higher  frequencies,  i.e.  clonally  expanded,  in  the  later  generations.  The
illustration is based on Stewart et al. (2008a).
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The N1 generation mice harbored median of 1836 variants, which was
approximately 10x less than what had been observed for MKO mice
(Chapter 4.3.1, same genotype as founder F1 mice, but the specific F1
mice  forming  the  female  lineages  used  in  this  project  were  not
sequenced). In comparison to N1 generation mice, approximately 8x and
16x less variants were observed in N2 and N3 generation mice (249 and
112,  respectively,  Fig.  4.20a,b).  As  expected,  the  total  variant  loads
were at similar levels in all generations (Fig. 4.20c). This was due to
clonal expansion of the maternally transmitted mtDNA variant subset,
also  noted  as  increasing  median  allele  frequencies  in  the  later
generations (Fig. 4.20d).
In  order  to  compare  the  mtDNA-seq  data  to  the  previous  results
obtained by Sanger sequencing (Stewart et al. 2008a), a similar figure
revealing  the  hallmark  of  purifying  selection  was  plotted.  First  the
varian counts were normalized to the genome element length and then
plotted as proportion of all variants in question (Fig. 4.21). The figure
represents neutral variants i.e. tRNA and rRNA (RNA) and variants on
each codon position (CP) of protein-coding regions, which were further
separated  into  two  classes  according  to  the  variant  effect  i.e.
synonymous  or  non-synonymous  variants.  Variants  on  other  regions
(intergenic  bases,  OriL  or  control  region)  were  excluded  from  this
analysis  as  non-informative.  For  comparison,  the same plot  was  also
produced from MKO mice presented in Chapter 4.3.1.
Expectedly,  the  variant  profile  of  MKO  mice  showed  uniform
distribution of the variants over the different genome sites (Fig. 4.21,
left-most plot). Similarly, when considering the mtDNA-seq results of
N1 to N3 generation mice without any hard-coded AF thresholds, the
variants were quite uniformly distributed over the different genome sites
(Fig. 4.21, middle column of plots). However, there was a mild trend of
purifying selection notable by the N3 generation mice: the amount of
likely  deleterious,  amino-acid  changing  variants  (mainly  non-
synonymous variants  on CP1 and CP2) was less  than the amount of
neutral variants (RNA or synonymous variants on CP3) in comparison
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to  MKO,  N1 or  N2 generation  mice.  These  were  slightly  surprising
results, because the previous study showed a strong purifying selection
already by N2 generation mice (Stewart et al. 2008a).
A likely  explanation  for  the  difference  between mtDNA-seq  and  the
earlier results (Stewart  et al.  2008a) is that  in Sanger sequencing the
variant  detection  threshold  is  very  high  (AF  ~30 %,  Hancock  et  al.
2005),  thus  it  detects  only  the  highly  clonally  expanded  variants,
whereas  mtDNA-seq  is  far  more  sensitive  method.  For  better
comparability  to  the  earlier  study  (Stewart  et  al.  2008a),  the  variant
results obtained here by mtDNA-seq were filtered by setting minimum
AF to 5 % (Fig. 4.21, right-most column of plots). Using any higher AF
thresholds  was  not  meaningful,  since  the  number  of  high-frequency
variants was already very low at  AF 5 % threshold in N1 generation
mice  (Fig.  4.20d).  Now  with  the  minimum  AF  5 %  threshold,  the
hallmark  of  purifying  selection  became  observable  even  in  N1
generation mice and was even more emphasized by N3 generation mice.
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Figure  4.20.  Variant  loads  and  frequencies  in  female  lineages  carrying
maternally transmitted mtDNA variants.  Variant counts (a) as well as unique
variant loads (b) decreased from N1 to N3 generation of mice, whereas total
variant load (c) was almost at equal level in each mouse generation because the
maternally transmitted mtDNA variants were clonally expanded as also noted
by increased  median allele  frequencies  from N1 to N3 generation  mice  (d).
Samples are from two lineages, two littermates from each generation of both
lineages. In  d), total number of variants for each generation in plotting order
were N1: 7376, 5556, 650, 1086, 7, 4, 73; N2: 1015, 745, 92, 166, 0, 1, 11; and
N3: 423, 296, 43, 80, 0, 0, 4.
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Figure 4.21. Proportion of mutations on different genome elements in different mice
generations.  The proportions of each variant type was compared between the N1 to N3
generations and MKO mice (same genotype as female lineage founders F1, however, F1s
were not sequenced) was plotted for comparison. The hallmark of purifying selection, i.e.
decreased number of  variants  on first  and second codon positions (CP1 and CP2)  in
comparison to neutral mutations on RNAs or on third codon position (CP3) was mildly
visible in N2 and N3 generations (column-wise, germ line) when all mtDNA-seq results
were considered (no hard-coded AF threshold). If hard-coded minimum allele frequency
(AF) thresholds was set to AF >= 5 %, the decrease in number of deleterious variants in
comparison to neutral variants became more visible between generations (column-wise).
When the results were considered within the generation (row-wise, somatic), the hallmark
of purifying selection was observed strongly already in N1 generation. This suggested that
purifying selection takes place during the embryogenesis,  whereas random drift  is the
most effective factor in germ line mtDNA variant transmission. The plot was produced
using preliminary data from only two mouse lineages (each generation N1 to N3 n = 4)
and the MKO mice data from Chapter 4.3.1 (MKO n = 6). The unique variant counts per
element  were  first  divided  by  the  element  size  (tRNA = 1501  bp,  rRNA = 2357  bp,
CP1 = 3803 bp, CP2 and 3 = 3800 bp) and then proportion of all variants in question
were compared. Total number of observed variants were in order tRNA, rRNA and CPs
non-synonymous and synonymous: for MKO 9161, 14989, 21914, 2187, 25717, 0, 3357,
23332, for N1 no threshold 650, 1086, 1584, 81, 1764, 0, 359, 1768 and AF 5 % 10, 21,
12, 3, 22, 0, 2, 34, for N2 no threshold 92, 166, 199, 13, 226, 0, 38, 269 and AF 5 % 15,
32, 24, 3, 26, 0, 4, 38, and for N3 no threshold 43, 80, 71, 2, 82, 0, 22, 119 and AF 5 % 17,
36, 13, 2, 23, 0, 9, 39.
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Discussion
One of the major challenges in the field of mitochondrial biology is to
understand  how  exactly  the  heteroplasmic  mtDNA  variants  are
transmitted  to  the  offspring  and,  in  the  case  of  pathogenic  mtDNA
mutations, how the transmission could be prevented. It is well known,
that the mtDNA variant allele frequencies may rapidly shift within just a
few generations  (Hauswirth & Laipist  1982).  Often an asymptomatic
mother,  not  even  known  to  be  a  carrier  of  a  pathogenic  mtDNA
mutation, may have an affected child  (Kang et al. 2016). Furthermore,
the study by Kang et al. (2016) is only one of the many examples, that
some pathogenic mtDNA mutations may often be present at very high
levels (AF ~70 %), yet the symptoms only occur when the pathogenic
mutation  is  expanded  to  even  much  higher  levels.  This  behavior  of
mtDNA transmission  is  well  explained  by  the  random  genetic  drift
model  (Wonnapinij  et  al.  2008) and  the mitochondrial  bottleneck.  In
addition to the mitochondrial bottleneck, Stewart et al. (2008a) showed
a strong purifying selection of mtDNA, and also  Fan et al. 2008 have
shown how severe mtDNA mutation was eliminated within four mice
generations  whereas  less  pathogenic  mutation  was  retained.  These
results indicated that mtDNA purifying selection takes place in the germ
line.
Several reviews over the years  (Stewart et al. 2008b; Cree et al. 2009;
Poulton et al. 2010; Stewart & Larsson 2014; Stewart & Chinnery 2015)
have discussed the possible mechanisms for mtDNA transmission and
selection,  which  may  take  place  on  molecule,  organelle,  cellular  or
organism level. Jenuth et al. (1997) showed that in some tissues mtDNA
variants follow random drift model, whereas in others there is selection
of  mtDNA.  They  suggested  that  this  may  be  due  to  replicative
advantages  of  one  mtDNA molecule  over  another,  different  turnover
rates or selection at a cellular level by altered respiratory chain function
(Jenuth et al. 1997). The mtDNA selection in the germ line has been
suggested to be an active process, in which defective components are
identified and removed or it can be a competition, in which the fittest
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component will contribute the most to the next generation (Stewart et al.
2008b, Poulton et al. 2010).
Here,  these  preliminary  results  were  in  line  with  the  previous  study
(Stewart et al. 2008a) showing a strong purifying selection in the N3
generation  mice,  however,  similar  variant  profile  was  only  mildly
present in N2 generation mice (Fig. 4.21). If mtDNA-seq results without
hard-coded AF threshold filtering were considered, the variant  profile
resembled  more  neutral  model,  especially  for  N1  generation  mice.
Intriguingly,  when  only  high-frequency  variants  (AF  >=5 %)  were
considered, the hallmark of purifying selection became visible also in
N1 generation mice. These new, more sensitive results suggest that any
variant may be transmitted from the mother to the offspring, but only the
less  deleterious  variants  are  able  to  clonally  expand  during  the
development.  Thus,  it  can  be  hypothesized  that  the  mitochondrial
bottleneck and random drift are the most effective factors considering
the germ line mtDNA transmission. 
The purifying selection seems to take place during the embryogenesis,
observable  already  at  very  low  AF 5 %.  The  homozygote  mtDNA
mutator  mouse  has  been  found  to  show  a  mosaic  respiratory  chain
deficiency  (Trifunovic  et  al.  2004)  i.e.  only  some  cells  are  highly
defected  harboring  high  levels  of  the  deleterious  mtDNA mutation
whereas other cells are normal. Similar mosaicism can be assumed to be
present also in these MKO descendants, thus individual cell may show a
high variant  load but  the total  variant  load  of  the tissue is  low.  The
selection could then occur on the cellular or organellar level such that
proliferation of a highly defected cell/organelle is hampered. On cellular
level,  defected  cells  could  be  eliminated  by  apoptosis,  whereas  on
organellar  level,  defects  could  lead  to  changes  in  mitochondrial
membrane potential, which in turn would affect the protein import into
mitochondria  and  eventually  the  mtDNA  replication  efficiency  (as
reviewed by Stewart & Chinnery 2015).
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4.3.3 Effects of mitochondrial DNA variants on mitochondrial RNA
processing
Mitochondrial  RNA  processing  has  peculiar  characteristics  in
comparison to nuclear RNA. As already briefly mentioned (Fig. 4.11b),
mtDNA is transcribed into two near-genome-length transcripts – one for
the  H-strand  and  another  for  the  L-strand.  Interestingly,  most  of  the
mRNAs are flanked by tRNAs (Fig. 1.1),  and according to so called
tRNA  punctuation  model  (Ojala  et  al.  1981),  precursor  mtRNA
transcripts are spliced into mRNAs, tRNAs and rRNAs in order to form
the  mature  RNA products.  Two  main  protein  complexes  have  been
identified, RNase P and RNase Z, which are responsible of the 5' end
and  3'  end  endonucleolytic  cleavage  of  the  polycistronic  RNAs,
respectively. However, several sites (e.g. 5' end of COI), do not fit into
the tRNA punctuation model and also nearby sequence contexts do not
seem  to  function  as  recognition  signals  for  the  cleavage  enzymes.
Furthermore, all the other involved proteins or exact mechanism details
how  mature  mtRNA products  are  formed,  are  still  not  known  (as
reviewed by van Haute et al. 2015).
Recently,  Stewart  et al.  (2015) studied human tumor sequencing data
and compared the relative variant levels detected in mtDNA and mtRNA
(Stewart  et  al.  2015).  Most  of  the  variants  occurred,  expectedly,  at
similar  allele  frequencies  in  both  mtDNA  and  mtRNA.  However,
handful of variants showed a clear allelic mismatch. Surprisingly, these
outlier variants were mainly on tRNAs. Such observation was intriguing
since in normal RNA-seq the poly-A enrichment step or size selection
should eliminate the presence of small tRNAs in the sequenced RNA
pool  and  detection  of  tRNA variants  is  not  expected.  Those  tRNA
regions  also  showed  higher  coverage  pattern  in  the  variant  carrying
samples than in other samples. This lead to a hypothesis that a variant is
potentially disrupting the secondary structure of the tRNA, which would
hamper the mtRNA processing and yield to mRNA products, which are
still attached to the flanking tRNA sequences (Fig. 4.22).
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Figure 4.22. Model for mitochondrial RNA precursor transcript processing.
Most of the mitochondrial mRNAs are flanked with tRNAs and near-genome-
length precursor transcripts are processed by splicing out the flanking tRNAs to
form  mature,  poly-adenylated  (pA)  mitochondrial  RNA  (mtRNA)  products.
Analysis of variants from human tumor sequencing data of mtDNA and mtRNA
(Stewart  et  al.  2015)  revealed  mismatches  in  the  allele  frequencies;  several
tRNA variants  were  observed  at  high-frequency  levels  although  the  variant
frequency was much less in the corresponding mtDNA. In poly-A-enriched RNA
pool,  it was not expected to detect short tRNAs at all,  yet,  the tRNA variant
carrying samples (red) showed high coverage on the tRNA in comparison to
non-variant samples (grey). The hypothesis was that a certain variant on tRNA
disrupts the tRNA secondary structure in comparison to normal tRNA. Altered
tRNA  structure  hampers  the  cleavage  process  leading  to  accumulation  of
precursor transcripts, which is detected as high coverage on the variant tRNA
region.
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The aim of this project is to continue the human tumor study with the
MKO mouse model, utilizing the N1–N3 mouse generations (introduced
in  Chapter  4.3.2),  which  would  harbor  high-frequency,  clonally
expanded  variants.  Study  on  mouse  samples  allows  more  detailed
molecular  characterization  of  the  hypothesized  mtRNA  processing
defects.  The research idea was tested in  a  preliminary experiment  in
which mtDNA from N1 and N2 generation mice were sequenced by
amplicon  sequencing  with  non-tagged  primers  and  mtRNA  by
directional total RNA-seq. Amplicon sequencing is preferred method for
this kind of project, since that method is significantly faster regarding
the hands-on time and the expected variants are of high-frequency (AF
>>0.5 %), thus, reliable detection is straightforward from the amplicon
sequencing data. Furthermore, PCR-errors do not pose a great risk of
false-positive  results  since  any  variant  of  interest  is  expected  to  be
observed in both mtDNA and mtRNA. Although, this already eliminates
the risk of observing variants originating from the amplicon primers, the
use  of  the  tagged  primers  for  future  experiments  (as  discussed  in
Chapter  4.2.2)  is  still  recommended  in  order  to  eliminate  any
unnecessary bias.
With high RNA-seq depth (five Gbases), it was indeed possible to detect
~10–1000x coverage on tRNAs. The final variant results were filtered to
contain only those variants shared by the mtDNA and mtRNA within a
mouse sample.  It  was possible to detect  two variants  showing allelic
mismatch between the mtDNA and mtRNA (Fig. 4.23a), of which one
was on mt-tRNAs (Fig. 4.23b). The observed allelic mismatches were,
unfortunately,  at  relatively  low  levels,  e.g.  3902.C>T  variant  on
tRNA M, was observed at AF 4 % and 30 % in mtDNA and mtRNA,
respectively. Furthermore, no real alterations in mtRNA coverage of the
mutated sample were observed in comparison to other samples which
did  not  harbor  the  variant  in  question  and  were  thus  considered  as
controls.
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Figure  4.23.  Comparison  of  variant  allele  frequencies  between  mitochondrial  DNA and  RNA.  a)  Variant  allele  frequencies
observed for common mtDNA and mtRNA variants were compared by plotting the AF values from both source materials against each
other. This revealed mild outliers i.e. variants showing allelic mismatch at lower mtDNA AF levels (<5 %). b) In order to understand
the variant site and significance of the allelic mismatch, the allelic mismatch was calculated as log2-fold-change of mtRNA variant AF
over mtDNA variant AF and plotted over the mtDNA genome positions. This comparison did not only reveal the two significant
outliers on tRNA M and COI, but also showed that variants – although not showing high allelic mismatch – were detected on many
tRNA regions (shaded areas). These were probably normal processing intermediates carrying variants which do not disrupt the
mtRNA processing.
Discussion
Based on these preliminary data, the project might have potential and
amplicon sequencing approach seem to fit well for the aim. However, in
order to detect more significant allelic mismatches, and thus, potentially
also greater alterations in mtRNA coverages,  it  is advisable to use at
least N3 – or even N4 – generation mice. These mice will have fewer
but highly clonally expanded variants, which increases the potential of
such mutations to show up as allelic mismatches. For example, in the
human tumor data, the variants showing allelic mismatches were present
in mtDNA at AF ~20–70 % and at AF ~100 % in mtRNA (Stewart et al.
2015),  whereas  in  N1  and  N2  generation  mice  mtDNA the  variants
showing allelic mismatch were at AF <5 %. In the purifying selection
project (Chapter 4.3.2), mtDNA-seq samples from N3 generation mice
harbored even AF ~80 % variants, whereas maximum AF values were
only  55 %  and  28 %  for  N2  and  N1  generation  mice  variants,
respectively.  Those  results  suggest,  that  already  N3  generation  mice
could  be  more  suitable  samples  for  detection  of  potential  allelic
mismatch of the mtDNA and mtRNA variants.
For detection of alterations in RNA coverages, wild-type mouse RNA
could be used as a better, true control. Now, similar to the human tumor
study, the control  samples were the other highly mutated N1 and N2
generation mice samples, which did not carry the particular variant in
question.  However,  the  high  load  of  neighbouring  variants  in  such
control samples could in theory affect the coverage profile, and usage of
pure WT samples would be a cleaner approach. Although, with N3 or
N4 generation mice, the number of variants is much lower and also their
suitability as controls could be investigated. Additionally, with RNA-seq
one  should  consider  that  the  coverage  might  drastically  depend  on
differences in expression levels between e.g. tissues or age groups.
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5 CONCLUSIONS AND FUTURE PROSPECTS
5.1 Optimization of the mitochondrial DNA extraction 
and sequencing method for extremely low-
frequency mitochondrial DNA variant detection
The main findings of the method optimization were:
• Many  mitochondria  enrichment  methods  yield  in  significant
nuclear DNA contamination in the extracted mtDNA.
• Treatment of enriched liver and brain mitochondria with DNase
I is highly efficient method to diminish nDNA contamination,
thus only two Gbase of paired-end sequencing reads are enough
to  obtain  ~40000–60000x  depth  over  the  entire  mtDNA
genome.
• In order  not to waste sequencing data or  introduce bias,  de-
duplication should not be included into the data analysis and
reads should be aligned directly to mtDNA reference genome
with an approach considering the circularity of the genome.
• For good quality  mtDNA sample,  sensitive variant  calling is
possible  without  hard-coded allele  frequency thresholds  well
beyond the sequencing platform error rates, as low as AF 0.05–
0.1 %.
• Extremely  low-frequency  variant  detection  is  susceptible  for
slight  changes  in  the  sample  preparation  and  sequencing
protocols, but precision is increased by utilizing dual indices
and potentially by adding EDTA to the sonication step or repair
enzymes to the library preparation PCR step.
The final  optimized workflow to detect  rare variants from mtDNA is
illustrated in Figure 5.1.
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For reliable, extremely rare variant detection, it is important to obtain
high-quality mtDNA sample pure from nDNA contamination. Although,
the experimentation with different methods was not optimally designed
due to financial constrains (e.g. such that similar samples or treatments
would  have  been  used  with  all  methods),  mtDNA-seq  (i.e.  simple
differential  centrifugation  combined  with  DNase  I  treatment  of  the
enriched mitochondria) consistently yielded to very pure, good quality,
high-yield  mtDNA fractions  with  minimal  hands-on  time  and  low
sample  preparation  costs.  Traditionally  used  gradient-based
mitochondria enrichment methods alone also yielded in relatively pure
mtDNA  fractions  when  experienced  lab  personnel  performed  the
enrichment. Furthermore, commercial mitochondria isolation kit might
be useful for difficult or precious tissue samples, such as heart.
Here,  the projects utilized only big tissues – liver and brain – which
easily  lead  to  high-yield  mtDNA samples.  Originally,  the  required
minimum DNA amount for standard Illumina library preparation was
100  ng  (Max  Planck  Genome  Centre  Cologne).  The  DNA  input
requirement  is  a  prohibitive  factor  in  applying  the  method  for  e.g.
human tissue biopsies, where the sample amount may be very limited.
Figure 5.1. Final optimized workflow for extraction of highly pure mtDNA
and detection of extremely rare variants.
The protocol for mtDNA extraction is based on simple differential centrifugation
enrichment of mitochondria (mitos), which are treated with DNase I in order to
remove almost all contaminating nuclear DNA (nDNA). DNA is extracted with
chloroform  (without  phenol  to  avoid  unnecessary  risk  of  introducing  DNA
damage)  and  treated  extensively  with  RNase  A.  Highly  pure  mtDNA  is
fragmented in the presence of EDTA in order to diminish the risk of introducing
oxidative damage to DNA. DNA fragments are ligated to adapters with dual
indexing approach and sequenced in paired-end mode to enable de-multiplexing
based on both indices in order to exclude between-sample cross-contamination.
Reads are trimmed for high quality and aligned to normal and split reference
genomes  in  order  to  rescue  coverage  and  variant  detection  at  the  junction
region  of  the  circular  genome.  Variant  calling  does  not  include  stringent
filtering and the most effective filter is the strand-bias filtering allowing reliable
variant detection even below allele frequency (AF) of 0.05 %. (Figure is on the
next page.) 
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However, as the sequencing library preparation kits are constantly being
developed as  well  as the practices  in the sequencing centers,  already
during these thesis projects, the required DNA input was decreased to 50
ng. This allowed also sequencing of the smaller yield samples, such as
heart, and the input DNA amounts will probably be improved to even
lower levels in the future. Yet, this development should be cautiously
followed, since Costello et al. (2013) suggested that decrease in input
amount from 3 µg to 100 ng without proper adaptation of the sonication
parameters caused significant increase in oxidative damage of the DNA
(Costello et al. 2013).
Another possibility for low-yield samples could be a low-input library
preparation  kit,  which  is  based  on  simultaneous  enzymatic
fragmentation and adapter ligation. This should also be carefully tested
with controls,  since the fragmentation method is completely different
and could cause unexpected artefacts in extremely rare variant detection.
Moreover,  with the ever  decreasing DNA input  amounts,  one  should
consider the fact that the sequencing library is always representing only
a subsample of the original pool of mtDNA molecules. If the original
mtDNA was  already  a  low-yield  sample,  and  only  extremely  low
amount of that is used for the library preparation, even two subsampling
bottlenecks will  be applied and  any effect  of  a  random artefact  may
become magnified and seen as unintended bias in extremely rare variant
detection results.
On the other hand, PCR-free library preparation currently requires 2.5
µg of input DNA (MP-GC), which is reachable with liver mtDNA-seq
samples. It would be an interesting comparison to mtDNA-seq variant
results, although the PCR-free library preparation includes four cycles
of  PCR  to  normalize  the  pool  of  ssDNA and  dsDNA molecules  to
dsDNA. However, the starting pool of mtDNA molecules would be 50x
larger  and  PCR cycles  are  only  half  of  what  is  applied  to  standard
library preparation. This should at least diminish the detection of library
preparation  artefacts;  however,  as  indicated  by  Illumina,  it  could
actually increase the index hopping and thus lead to detection of cross-
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contaminating variants (Illumina 2017).
Different mtDNA enrichment methods were compared by their variant
profiles. Although, the experimental design was suboptimal (due to the
relatively high costs, only single samples or no WT controls were tested
by some methods), the results seemed to favor non-amplification based
enrichment. Together with the sample preparation optimization results,
mtDNA-seq was concluded as the most optimal in comparison to other
methods. However, major artefact observed during the experiments was
GC>TA variants – a known signature of oxidative damage (Shibutani et
al.  1991).  Simultaenously  with  artefactual  GC>TA  variants,  also
between-sample cross-contamination suddenly increased to intolerable
levels.  The  simple  solution  was  to  switch  to  paired-end  sequencing
mode and de-multiplex the reads based on both indices instead of just
one, as suggested already in 2012 by Kircher et al. Furthermore, it was
shown  that  trimming  or  alignment  strategy  can  easily  introduce
unintended  bias  to  the  coverage  profile.  Thus,  a  dual  alignment  and
variant  calling  strategy  was  applied  in  order  to  enhance  the  variant
detection  at  the  junction  region  of  the  circular  mtDNA genome –  a
highly  important  approach  for  projects  focusing  on  mtDNA control
region variant profile.
The key  finding of  the  data  analysis  optimization for  extremely  rare
mtDNA variant  detection  was  that  the  removal  of  any  hard-coded
variant  allele  frequency  thresholds  from  the  variant  calling  with
LoFreq* did not lead to significant amounts of false positive results.
Almost  all  studies  utilizing  standard  Illumina  sequencing  for  variant
detection  set  a  hard-coded  AF  threshold  because  of  relatively  high
”sequencing platform error rate”. Here, it was shown with the spike-in
mtDNA-seq samples, that from a high-quality, high-coverage mtDNA
sample, LoFreq* is capable of detecting variants with high precision as
low as AF <0.05 %. These results clearly stress the impact of the DNA
sample quality to the variant detection accuracy. Nevertheless, a major
drawback of  mtDNA-seq  is  that  the  extremely  rare  variant  detection
may be highly sensitive to even slight changes in the sample preparation
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protocol or in the sequencing platform. Thus, it is advisable to carefully
follow the  protocol  and  always  include  WT control  samples  in  each
sequencing run in order to quickly notice unexpected artefacts. It also
seems, that with a high-quality DNA sample, it is possible to reliably
detect  variants well  beyond the sequencing platform error  rate.  Here,
only LoFreq* was used. However, it would be interesting to utilize the
spike-in samples to compare different variant calling models and their
performance  in  comparison  to  LoFreq*,  especially  the  recently
developed  VarDict,  which  was  recently  suggested  to  outperform
LoFreq* (Sandmann et al. 2017).
As predicated by Lou et al. (2013), when the aim is to develop even
more sensitive variant detection methods, potentially more artefacts will
be discovered and these issues need to be tackled. Yet, the development
of the data analysis approaches is relatively slow in comparison to how
fast  the  technology  evolves.  The  above-mentioned  oxidative  damage
likely induced during standard sequencing library preparation is a good
sample case. Moreover, the switch to patterned flow cell usage has been
recently noted to increase index hopping (Illumina 2017, Sinha et  al.
2017) supporting the usage of dual  indices  as a standard method for
sensitive applications like low-frequency variant detection. Yet, another
recently  arised  concern  is  increased  duplicate  read  formation  in  the
patterned flow cells (Wingett 2017, accessed 07/2017). These are just a
few examples of how updates and technology advancements may bring
along unintended bias. Now that high-throughput sequencing is already
a routine method and the hype has mostly calmed down, more solid and
properly controlled, peer-reviewed research is required to address and
acknowledge  the  existing  and  newly  introduced  caveats  and  find
solutions  –  before  rushing  into  new  applications  with  stretched
sensitivity thresholds e.g. extremely low-frequency variant detection or
single-cell sequencing.
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5.2 Mitochondrial  biology  research  questions
addressed by mtDNA-seq
The optimized mtDNA-seq protocol was succesfully applied to address
several  mitochondrial  biology  research  questions.  The  new  results
obtained  within  these  thesis  projects  extend  the  previous  studies
regarding the variant  profile of  the entire  mtDNA genome,  purifying
selection of mtDNA as well as processing of the polycistronic mtRNA
transcripts.
5.2.1 Creation of variant profile of the entire mitochondrial genome 
and identification of regions essential for replication and 
replication-associated transcription
The main findings of the project were:
• The mtDNA mutator  mouse is a  true saturation mutagenesis
model and, with AF <0.05 % variant detection threshold, show
>90 % of the genome positions to harbor a variant.
• Liver and brain mtDNA samples show similar  trend in their
variant profiles.
• Control region harbor significant mutational coldspots, which
align with evolutionarily conserved regions.
• Detailed  variant  profile  serves  as  a  valuable  resource  for
studies  focusing  on  mtDNA  replication  and  transcription
mechanisms.
Because no methods to  transfect  mammalian mtDNA exists,  mtDNA
mutator  mouse  is  one  of  the  only  in  vivo  models  for  mtDNA
mutagenesis.  With  mtDNA-seq  it  was  possible  to  obtain  uniform
coverage  over  the  entire  mtDNA genome  and  even  to  represent  the
linear,  truncated  mtDNA  molecules  and  control  region  multimers
(Trifunovic et al. 2004, Williams et al. 2010). The variant profiles were
highly similar between the liver and brain mtDNA samples. The only
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difference  was  that  brain  mtDNA seemed  to  harbor  fewer  variants,
which can be explained by the fact that more replication is ongoing in
the mitotic liver than in the post-mitotic brain tissue. The results were
well  in  line  with  the  previous  PCS  results,  despite  the  completely
different technologies used. Also similar to previous studies, but now
with  extremely  sensitive  variant  detection,  significant  mutational
coldspots were observed at OriL and control regions, suggesting their
importance on mtDNA replication process. This hypothesis was further
supported by the alignment of the evolutionarily highly conserved sites
with the coldspots.
The data set presented here is an extremely valuable for mtDNA biology
research,  especially  for  studies  focusing  on  mechanisms  of  mtDNA
replication and replication-associated transcription or identification and
characterization  of  yet-unknown  proteins  involved  in  mtDNA
maintenance. The variant profile will be complemented with an in vivo
methylation assay (as in Rebelo et al. 2009 and Terzioğlu et al. 2013) to
reveal  potential  protein-binding  sites  by  observing  protection  from
methylation  at  GpC  sequence  context.  Non-methylated  bases  are
converted  to  Ts  in  bisulfite  treatment  and  will  be  detected  as  C>T
variants by pyrosequencing of short amplicons over the GpC-sites at the
control  region  (Fig.  4.15b,  lowest  track).  Furthermore,  some  of  the
coldspots and variant positions located in the CSB II and III (Fig. 5.2)
will  be  tested  in  in  vitro transcription  assay.  In  such  experiments,
synthetic DNA strands, each containing a single variant, are used as a
template for transcription and treated with RNase A. Those transcripts
resistant to the RNase A treatment, likely form stable RNA-DNA hybrid
required for replication initiation (Wanrooij P. et al. 2012). Differences
in  hybrid  stability  could  reveal  those  bases  essential  for  replication-
associated transcription and support  the hypothesis  that  coldspots are
required  for  efficient  replication  of  the  mtDNA.  The  publication  is
aimed  as  a  resource  for  other  researchers  to  create  or  narrow down
hypotheses and to better target their studies, e.g. the data set may be
utilized as a source material  to form bait sequences for the search of
ETAS-binding proteins.
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Figure 5.2. Sites to be tested in an in vitro transcription assay.  The lowest
track illustrates the sequence content of the conserved sequence blocks (CSB II
and III) and the target sites to be tested in an in vitro transcription assay. In this
assay,  DNA strands are  synthesized to  contain a single  variant  each (target
bases  are  marked  with  colors:  yellow = observed  variant  sites  and  blue  =
observed coldspots) and used as templates for transcription reactions, which are
then treated with RNase A. If the sample is resistant to the RNase A treatment, it
would indicate formation of a stable RNA-DNA hybrid. Differences in the RNA-
DNA hybrid stability between the different variant templates could reveal those
bases  essential  for  the  hybrid  formation,  thus,  essential  for  the  mtDNA
replication efficiency. Here, the hypothesis is that DNA templates harboring a
variant at the sites observed to be variable (yellow) should form stable RNA-
DNA hybrids,  whereas  DNA templates  harboring  a  variant  at  the  observed
coldspots (blue) should show poor RNA-DNA hybrid stability. The experimental
design and the actual experiments are carried out by our collaborators, PhD
Viktor  Posse  and  Prof.  Claes  Gustafsson  at  the  University  of  Gothenburg,
Sweden. The dashed grey lines highlight the CSB regions over the other tracks.
Other tracks are as in Figure 4.15b.
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5.2.2 Clarification of developmental stage and mechanism of 
purifying selection of mitochondrial DNA
 The main findings of the preliminary results:
• Strong purifying selection takes place already in N1 generation
mice when considering only high-frequency variants.
• Low  levels  of  potentially  deleterious  mtDNA mutations  are
transmitted even to N3 generation mice.
Only mild purifying selection was observed when rare mtDNA variants
were considered, but the hallmark of purifying selection became visible
already  in  N1  generation  mice  if  only  high-frequency  variants  were
considered. Furthermore, if considering all results (without a minimum
AF threshold), the hallmark of purifying selection was mild even in N3
generation mice. These data suggest that even deleterious mutations are
transmitted  to  the  offspring,  however,  such  mutations  are  not  highly
clonally expanded.
One original aim of this project was to apply the mtDNA-seq also to
different  stage  embryos  or  even  to  oocytes  in  order  to  gain  deeper
understanding  on the  developmental  stage  of  the  purifying selection.
However,  all  attempts  to  obtain  highly  pure  mtDNA from  N2  E14
embryos (in addition to mtDNA-seq, also ExoV treatment or extraction
of  the  mtDNA bands  from  agarose  gel  was  experimented  but  not
discussed within this thesis) failed. Furthermore, RCA did not turn out
as a successful  method for extremely low-frequence variant  detection
neither did amplicon sequencing. Thus, the future challenge to establish
an  effective  mtDNA enrichment  method  for  embryos  remains  to  be
solved.  On  the  other  hand,  the  results  showed  only  mild  difference
between N1 and N2 generation mice, thus sequencing of different stage
embryos  in  between  these  generations  would  not  add  up  much
information, if any. More interesting would be variant  profiles of N1
E7.5 and E14 embryos.
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For the final conclusions, the additional data from two more lineages
should be  included  into the analysis  as  here  only two lineages were
analyzed.  Furthermore,  in  addition  to  simply  plotting  the  relative
amounts of variants on different genome elements, there are multitude
of  other  analysis  options:  e.g.  the  distribution  of  variants  on  certain
amino acids (e.g.  hydrophobic vs. hydrophilic) could be compared to
reveal whether certain type of mutations are more tolerated than others,
detailed characterization of the variant  distribution on different codon
bases to detect whether certain codon compositions are preferred, follow
up  of  individual  variants  within  the  lineage  to  observe  the  variant
frequency fluctuations along the line or between litters and whether it
follows any pattern, e.g. in case of tRNA variants. Moreover, here, the
data were analyzed such that two samples per family was considered.
However,  as  a  lot  more  mice  have  been  sequenced  than  what  was
included into such analysis, more power can be obtained by including
all sequenced samples and the confounding problem of variable number
of  sequenced  littermates  can  be  eliminated  by  counting  each  variant
only once per relative mice per generation.
5.2.3 Effects of mitochondrial DNA variants on mitochondrial RNA 
processing
The main findings of the preliminary results:
• Amplicon sequencing is suitable approach for a study focusing
on high-frequency (AF >1 %) mtDNA variants.
• N1 and N2 generation mice do not show high alleleic mismatch
between mtDNA and mtRNA variants.
The  preliminary  results  suggested  that  when  searching  for  variants
potentially causing mtRNA processing defects visible by RNA-seq, the
variant likely has to be present in relatively high fraction of the mtDNA
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(AF >20 %).  Thus,  it  would be  advisable  to  continue  the project  by
utilizing later generation of mice – at least N3 or even N4 generation. As
these  mice  carry  less  variants,  the  number  of  mice  required  for  the
project  is  likely substantially increased.  As the same mouse breeding
scheme was utilized in the purifying selection project, mtDNA-seq data
from  N2  and  N3  generation  mice  could  be  utilized  to  screen  for
prevalence  of  high-frequency  tRNA variants  and  their  transmission.
During the purifying selection project, also tissue samples were stored,
thus  the  mtDNA-seq  results  can  be  used  to  select  interesting  N3
generation tissue samples for a pilot RNA-seq experiment.
Moreover,  recently  Kuznetsova  et  al.  (2017)  utilized  circular  RNA
sequencing  (Chu  et  al.  2015) to  characterize  unprocessed  RNA
molecules (Kuznetsova et al. 2017). In that method, the RNA molecules
are  first  circlized  by  intramolecular  ligation  and  only  then  reverse
transcribed with adapter-containing random primers. This way the 5' and
3' end information of the RNA molecule is preserved in comparison to
traditionally  prepared  RNA-seq  libarary  (Kuznetsova  et  al.  2017).
Furthermore, this method allows also simultaneous sequencing of small
RNA products, e.g. mature tRNAs carrying post-transcriptionally added
CCA at 3' end (Kuznetsova et al. 2017). 
Although  the  computational  steps  of  circular  RNA-seq  are  more
complex than in standard RNA-seq, it seems preferable method for this
project. The human tumor study was limited to poly-A-enriched RNAs,
whereas  here  only  ribosome depleted  RNA was  used.  Thus,  circular
RNA-seq  would  provide  more  complete  picture  of  the  RNA pool.
Moreover, detection of CCAs may provide highly valuable information
on whether the variant harboring tRNAs are actually ever processed to
the mature form or not. This data may aid in planning the molecular
characterization experiments or interpreting  in silico tRNA secondary
structure predictions.
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5.3 Summary
Within this thesis, mtDNA extraction from mouse liver and brain tissues
was  optimized  such  that  extremely  pure  mtDNA can  be  obtained  in
comparison  to  traditional  mitochondria  enrichment  methods.  High-
quality  mtDNA  samples  were  used  to  optimize  cheap  and  fast
sequencing protocol for extremely rare mtDNA variant detection. The
analysis steps were improved to account for the characteristics of the
small, circular mtDNA genome, and the final validation of the protocol
was  shown  with  spike-in  samples.  Observation  and  elimination  of
artefactual  variants  raised  recommendations  that  standard  sequencing
library preparation practices should include a repair step and sequencing
in  paired-end  mode  with  dual  indices,  although,  only  R1  should  be
utilized for the extremely low-frequency variant detection.
The mtDNA-seq approach was successfully applied to address different
research questions in mitochondrial biology: A detailed mtDNA variant
profile was created to aid the research focusing on mtDNA replication
and transcription mechanisms. The method enabled sensitive detection
of mtDNA variants in early mouse generations and will help to clarify
the timing and mechanism of mtDNA purifying selection. Finally, the
variant  data sets  can be combined with RNA-seq experiments of  the
collected  tissues  in  order  to  study  mitochondrial  RNA processing.
Detailed  knowledge  on  the  key  processes  involved  in  mtDNA
maintenance are in the end the basis for development of treatments for
mitochondrial disorders as well as measures to prevent transmission of
pathogenic mtDNA mutations.
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APPENDIX
Appendix 1. Difference between the standard mouse mitochondrial DNA
reference  genome  (C57Bl/6J,  NC_005089.1)  and  NZB  mitochondrial
DNA. The wild-type mouse strain used in these thesis projects (C57Bl/6N)
deviates from the reference genome (C57Bl/6J) at positions 4891.T>C and
9461.T>C, and some mice lines also at position 9027.G>A. The table lists
positions  at  which  C57Bl/6N  mice  carrying  mtDNA  from  NZB  strain
(mtNZB) deviates from the mtDNA reference genome. In total, there are 89
variants, of which one is common (position 9461.T>C) with the wild-type
mouse.
163
55 G A 8858 T C
716 A G 8864 C T
1353 A G 9137 A G
1519 G A 9152 T C
1590 G A 9391 A G
1822 T C 9461 T C
2201 T C 9530 C T
2340 G A 9581 C T
2525 C T 9599 A G
2766 A G 9985 G A
2767 T C 10547 C T
2798 C T 10583 A G
2814 T C 10952 C A
2840 C T 11843 G A
2934 C T 11846 C T
3194 T C 11933 A C
3260 A G 12353 C T
3422 T C 12575 T A
3467 T C 12695 A G
3599 T C 12835 T C
3692 A G 12890 A G
3932 G A 13004 G A
4123 C T 13444 C T
4276 G A 13612 T C
4324 T C 13689 C T
4408 G A 13781 A G
4706 A G 13782 T C
4732 C T 13837 A G
4771 T C 13983 A G
4885 A C 14186 T C
4903 T G 14211 G A
5463 G A 14363 A G
5552 T C 14642 G A
5930 G A 14738 C T
6041 T C 15499 T A
6407 C T 15549 C T
6470 A G 15578 A T
6575 C T 15588 C T
6620 G A 15603 C T
6785 G A 15657 T C
7411 A G 15917 C T
7870 G A 16017 A C
8439 A G 16268 A G
8467 T C 16272 T C
8568 C T
Genome position 
NC_005089.1
Reference base 
NC_005089.1
Variant base 
mtNZB
Genome 
position 
NC_005089.1
Reference base 
NC_005089.1
Variant base 
mtNZB
Appendix 2. Reference sequence of pAM1 plasmid. A pAM1 plasmid contains
the entire mouse mtDNA (deviating from the mouse mtDNA reference genome
[C57BL/6J,  NC_005089.1]  at  positions 4794.C>T,  9348.G>A,  9461.C>T,
10918.A>G and 12048.T>C)  restriction  digested with  HaeII  (restriction  site
RGCGCY, at position 2603), cloned into a 2.5-kb pACYC177 plasmid backbone
also restricted with HaeII.
>pAM1 | pACYC177_mtDNA
GTTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGA
AAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACT
TACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGAT
CGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGCAGCAATGGCAACAACGTT
GCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTG
CAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGC
GGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTAT
GGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCAT
ATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACC
AAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCTTAATAAGATGATCTTCTTGAGATCGTTTTGGTCT
GCGCGTAATCTCTTGCTCTGAAAACGAAAAAACCGCCTTGCAGGGCGGTTTTTCGAAGGTTCTCTGAGCTACCAACTCTT
TGAACCGAGGTAACTGGCTTGGAGGAGCGCAGTCACCAAAACTTGTCCTTTCAGTTTAGCCTTAACCGGCGCATGACTTC
AAGACTAACTCCTCTAAATCAATTACCAGTGGCTGCTGCCAGTGGTGCTTTTGCATGTCTTTCCGGGTTGGACTCAAGAC
GATAGTTACCGGATAAGGCGCAGCGGTCGGACTGAACGGGGGGTTCGTGCATACAGTCCAGCTTGGAGCGAACTGCCTAC
CCGGAACTGAGTGTCAGGCGTGGAATGAGACAAACGCGGCCATAACAGCGGAATGACACCGGTAAACCGAAAGGCAGGAA
CAGGAGAGCGCACGAGGGAGCCGCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCACTGATTT
GAGCGTCAGATTTCGTGATGCTTGTCAGGGGGGCGGAGCCTATGGAAAAACGGCTTTGCCGCGGCCCTCTCACTTCCCTG
TTAAGTATCTTCCTGGCATCTTCCAGGAAATCTCCGCCCCGTTCGTAAGCCATTTCCGCTCGCCGCAGTCGAACGACCGA
GCGTAGCGAGTCAGTGAGCGAGGAAGCGGAATATATCCTGTATCACATATTCTGCTGACGCACCGGTGCAGCCTTTTTTC
TCCTGCCACATGAAGCACTTCACTGACACCCTCATCAGTGCCAACATAGTAAGCCAGTATACACTCCGCTAGCGCTCTCA
ACTTAATTTATGAATAAAATCTAAATAAAATATATACGTACACCCTCTAACCTAGAGAAGGTTATTAGGGTGGCAGAGCC
AGGAAATTGCGTAAGACTTAAAACCTTGTTCCCAGAGGTTCAAATCCTCTCCCTAATAGTGTTCTTTATTAATATCCTAA
CACTCCTCGTCCCCATTCTAATCGCCATAGCCTTCCTAACATTAGTAGAACGCAAAATCTTAGGGTACATACAACTACGA
AAAGGCCCTAACATTGTTGGTCCATACGGCATTTTACAACCATTTGCAGACGCCATAAAATTATTTATAAAAGAACCAAT
ACGCCCTTTAACAACCTCTATATCCTTATTTATTATTGCACCTACCCTATCACTCACACTAGCATTAAGTCTATGAGTTC
CCCTACCAATACCACACCCATTAATTAATTTAAACCTAGGGATTTTATTTATTTTAGCAACATCTAGCCTATCAGTTTAC
TCCATTCTATGATCAGGATGAGCCTCAAACTCCAAATACTCACTATTCGGAGCTTTACGAGCCGTAGCCCAAACAATTTC
ATATGAAGTAACCATAGCTATTATCCTTTTATCAGTTCTATTAATAAATGGATCCTACTCTCTACAAACACTTATTACAA
CCCAAGAACACATATGATTACTTCTGCCAGCCTGACCCATAGCCATAATATGATTTATCTCAACCCTAGCAGAAACAAAC
CGGGCCCCCTTCGACCTGACAGAAGGAGAATCAGAATTAGTATCAGGGTTTAACGTAGAATACGCAGCCGGCCCATTCGC
GTTATTCTTTATAGCAGAGTACACTAACATTATTCTAATAAACGCCCTAACAACTATTATCTTCCTAGGACCCCTATACT
ATATCAATTTACCAGAACTCTACTCAACTAACTTCATAATAGAAGCTCTACTACTATCATCAACATTCCTATGGATCCGA
GCATCTTATCCACGCTTCCGTTACGATCAACTTATACATCTTCTATGAAAAAACTTTCTACCCCTAACACTAGCATTATG
TATGTGACATATTTCTTTACCAATTTTTACAGCGGGAGTACCACCATACATATAGAAATATGTCTGATAAAAGAATTACT
TTGATAGAGTAAATTATAGAGGTTCAAGCCCTCTTATTTCTAGGACAATAGGAATTGAACCTACACTTAAGAATTCAAAA
TTCTCCGTGCTACCTAAACACCTTATCCTAATAGTAAGGTCAGCTAATTAAGCTATCGGGCCCATACCCCGAAAACGTTG
GTTTAAATCCTTCCCGTACTAATAAATCCTATCACCCTTGCCATCATCTACTTCACAATCTTCTTAGGTCCTGTAATCAC
AATATCCAGCACCAACCTAATACTAATATGAGTAGGCCTGGAATTCAGCCTACTAGCAATTATCCCCATACTAATCAACA
AAAAAAACCCACGATCAACTGAAGCAGCAACAAAATACTTCGTCACACAAGCAACAGCCTCAATAATTATCCTCCTGGCC
ATCGTACTCAACTATAAACAACTAGGAACATGAATATTTCAACAACAAACAAACGGTCTTATCCTTAACATAACATTAAT
AGCCCTATCCATAAAACTAGGCCTCGCCCCATTCCACTTCTGATTACCAGAAGTAACTCAAGGGATCCCACTGCACATAG
GACTTATTCTTCTTACATGACAAAAAATTGCTCCCCTATCAATTTTAATTCAAATTTACCCGCTACTCAACTCTACTATC
ATTTTAATACTAGCAATTACTTCTATTTTCATAGGGGCATGAGGAGGACTTAACCAAACACAAATACGAAAAATTATAGC
CTATTCATCAATTGCCCACATAGGATGAATATTAGCAATTCTTCCTTACAACCCATCCCTCACTCTACTCAACCTCATAA
TCTATATTATTCTTACAGCCCCTATATTCATAGCACTTATACTAAATAACTCTATAACCATCAACTCAATCTCACTTCTA
TGAAATAAAACTCCAGCAATACTAACTATAATCTCACTGATATTACTATCCCTAGGAGGCCTTCCACCACTAACAGGATT
CTTACCAAAATGAATTATCATCACAGAACTTATAAAAAACAACTGTCTAATTATAGCAACACTCATAGCAATAATAGCTC
TACTAAACCTATTCTTTTATACTCGCCTAATTTATTCCACTTCACTAACAATATTTCCAACCAACAATAACTCAAAAATA
ATAACTCACCAAACAAAAACTAAACCCAACCTAATATTTTCCACCCTAGCTATCATAAGCACAATAACCCTACCCCTAGC
CCCCCAACTAATTACCTAGAAGTTTAGGATATACTAGTCCGCGAGCCTTCAAAGCCCTAAGAAAACACACAAGTTTAACT
TCTGATAAGGACTGTAAGACTTCATCCTACATCTATTGAATGCAAATCAATTGCTTTAATTAAGCTAAGACCTCAACTAG
ATTGGCAGGAATTAAACCTACGAAAATTTAGTTAACAGCTAAATACCCTATTACTGGCTTCAATCTACTTCTACCGCCGA
AAAAAAAAAATGGCGGTAGAAGTCTTAGTAGAGATTTCTCTACACCTTCGAATTTGCAATTCGACATGAATATCACCTTA
AGACCTCTGGTAAAAAGAGGATTTAAACCTCTGTGTTTAGATTTACAGTCTAATGCTTACTCAGCCATTTTACCTATGTT
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CATTAATCGTTGATTATTCTCAACCAATCACAAAGATATCGGAACCCTCTATCTACTATTCGGAGCCTGAGCGGGAATAG
TGGGTACTGCACTAAGTATTTTAATTCGAGCAGAATTAGGTCAACCAGGTGCACTTTTAGGAGATGACCAAATTTACAAT
GTTATCGTAACTGCCCATGCTTTTGTTATAATTTTCTTCATAGTAATACCAATAATAATTGGAGGCTTTGGAAACTGACT
TGTCCCACTAATAATCGGAGCCCCAGATATAGCATTCCCACGAATAAATAATATAAGTTTTTGACTCCTACCACCATCAT
TTCTCCTTCTCCTAGCATCATCAATAGTAGAAGCAGGAGCAGGAACAGGATGAACAGTCTACCCACCTCTAGCCGGAAAT
CTAGCCCATGCAGGAGCATCAGTAGACCTAACAATTTTCTCCCTTCATTTAGCTGGAGTGTCATCTATTTTAGGTGCAAT
TAATTTTATTACCACTATTATCAACATGAAACCCCCAGCCATAACACAGTATCAAACTCCACTATTTGTCTGATCCGTAC
TTATTACAGCCGTACTGCTCCTATTATCACTACCAGTGCTAGCCGCAGGCATTACTATACTACTAACAGACCGCAACCTA
AACACAACTTTCTTTGATCCCGCTGGAGGAGGGGACCCAATTCTCTACCAGCATCTGTTCTGATTCTTTGGGCACCCAGA
AGTTTATATTCTTATCCTCCCAGGATTTGGAATTATTTCACATGTAGTTACTTACTACTCCGGAAAAAAAGAACCTTTCG
GCTATATAGGAATAGTATGAGCAATAATGTCTATTGGCTTTCTAGGCTTTATTGTATGAGCCCACCACATATTCACAGTA
GGATTAGATGTAGACACACGAGCTTACTTTACATCAGCCACTATAATTATCGCAATTCCTACCGGTGTCAAAGTATTTAG
CTGACTTGCAACCCTACACGGAGGTAATATTAAATGATCTCCAGCTATACTATGAGCCTTAGGCTTTATTTTCTTATTTA
CAGTTGGTGGTCTAACCGGAATTGTTTTATCCAACTCATCCCTTGACATCGTGCTTCACGATACATACTATGTAGTAGCC
CATTTCCACTATGTTCTATCAATGGGAGCAGTGTTTGCTATCATAGCAGGATTTGTTCACTGATTCCCATTATTTTCAGG
CTTCACCCTAGATGACACATGAGCAAAAGCCCACTTCGCCATCATATTCGTAGGAGTAAACATAACATTCTTCCCTCAAC
ATTTCCTGGGCCTTTCAGGAATACCACGACGCTACTCAGACTACCCAGATGCTTACACCACATGAAACACTGTCTCTTCT
ATAGGATCATTTATTTCACTAACAGCTGTTCTCATCATGATCTTTATAATTTGAGAGGCCTTTGCTTCAAAACGAGAAGT
AATATCAGTATCGTATGCTTCAACAAATTTAGAATGACTTCATGGCTGCCCTCCACCATATCACACATTCGAGGAACCAA
CCTATGTAAAAGTAAAATAAGAAAGGAAGGAATCGAACCCCCTAAAATTGGTTTCAAGCCAATCTCATATCCTATATGTC
TTTCTCAATAAGATATTAGTAAAATCAATTACATAACTTTGTCAAAGTTAAATTATAGATCAATAATCTATATATCTTAT
ATGGCCTACCCATTCCAACTTGGTCTACAAGACGCCACATCCCCTATTATAGAAGAGCTAATAAATTTCCATGATCACAC
ACTAATAATTGTTTTCCTAATTAGCTCCTTAGTCCTCTATATCATCTCGCTAATATTAACAACAAAACTAACACATACAA
GCACAATAGATGCACAAGAAGTTGAAACCATTTGAACTATTCTACCAGCTGTAATCCTTATCATAATTGCTCTCCCCTCT
CTACGCATTCTATATATAATAGACGAAATCAACAACCCCGTATTAACCGTTAAAACCATAGGGCACCAATGATACTGAAG
CTACGAATATACTGACTATGAAGACCTATGCTTTGATTCATATATAATCCCAACAAACGACCTAAAACCTGGTGAACTAC
GACTGCTAGAAGTTGATAACCGAGTCGTTCTGCCAATAGAACTTCCAATCCGTATATTAATTTCATCTGAAGACGTCCTC
CACTCATGAGCAGTCCCCTCCCTAGGACTTAAAACTGATGCCATCCCAGGCCGACTAAATCAAGCAACAGTAACATCAAA
CCGACCAGGGTTATTCTATGGCCAATGCTCTGAAATTTGTGGATCTAACCATAGCTTTATGCCCATTGTCCTAGAAATGG
TTCCACTAAAATATTTCGAAAACTGATCTGCTTCAATAATTTAATTTCACTATGAAGCTAAGAGCGTTAACCTTTTAAGT
TAAAGTTAGAGACCTTAAAATCTCCATAGTGATATGCCACAACTAGATACATCAACATGATTTATCACAATTATCTCATC
AATAATTACCCTATTTATCTTATTTCAACTAAAAGTCTCATCACAAACATTCCCACTGGCACCTTCACCAAAATCACTAA
CAACCATAAAAGTAAAAACCCCTTGAGAATTAAAATGAACGAAAATCTATTTGCCTCATTCATTACCCCAACAATAATAG
GATTCCCAATCGTTGTAGCCATCATTATATTTCCTTCAATCCTATTCCCATCCTCAAAACGCCTAATCAACAACCGTCTC
CATTCTTTCCAACACTGACTAGTTAAACTTATTATCAAACAAATAATGCTAATCCACACACCAAAAGGACGAACATGAAC
CCTAATAATTGTTTCCCTAATCATATTTATTGGATCAACAAATCTCCTAGGCCTTTTACCACATACATTTACACCTACTA
CCCAACTATCCATAAATCTAAGTATAGCCATTCCACTATGAGCTGGAGCCGTAATTACAGGCTTCCGACACAAACTAAAA
AGCTCACTTGCCCACTTCCTTCCACAAGGAACTCCAATTTCACTAATTCCAATACTTATTATTATTGAAACAATTAGCCT
ATTTATTCAACCAATGGCATTAGCAGTCCGGCTTACAGCTAACATTACTGCAGGACACTTATTAATACACCTAATCGGAG
GAGCTACTCTAGTATTAATAAATATTAGCCCACCAACAGCTACCATTACATTTATTATTTTACTTCTACTCACAATTCTA
GAATTTGCAGTAGCATTAATTCAAGCCTACGTATTCACCCTCCTAGTAAGCCTATATCTACATGATAATACATAATGACC
CACCAAACTCATGCATATCACATAGTTAATCCAAGTCCATGACCATTAACTGGAGCCTTTTCAGCCCTCCTTCTAACATC
AGGTCTAGTAATATGATTTCACTATAATTCAATTACACTATTAACCCTTGGCCTACTCACCAATATCCTCACAATATATC
AATGATGACGAGACGTAATTCGTGAAGGAACCTACCAAGGCCACCACACTCCTATTGTACAAAAAGGACTACGATATGGT
ATAATTCTATTCATCGTCTCGGAAGTATTTTTCTTTGCAGGATTCTTCTGAGCGTTCTATCATTCTAGCCTCGTACCAAC
ACATGATCTAGGAGGCTGCTGACCTCCAACAGGAATTTCACCACTTAACCCTCTAGAAGTCCCACTACTTAATACTTCAG
TACTTCTAGCATCAGGTGTTTCAATTACATGAGCTCATCATAGCCTTATAGAAGGTAAACGAAACCACATAAATCAAGCC
CTACTAATTACCATTATACTAGGACTTTACTTCACCATCCTCCAAGCTTCAGAATACTTTGAAACATCATTCTCCATTTC
AGATGGTATCTATGGTTCTACATTCTTCATGGCTACTGGATTCCATGGACTCCATGTAATTATTGGATCAACATTCCTTA
TTGTTTGCCTACTACGACAACTAAAATTTCACTTCACATCAAAACATCACTTCGGATTTGAAGCCGCAGCATGATACTGA
CATTTTGTAGACGTAGTCTGACTTTTCCTATACGTCTCCATTTATTGATGAGGATCTTACTCCCTTAGTATAATTAATAT
AACTGACTTCCAATTAGTAGATTCTGAATAAACCCAGAAGAGAGTAATTAACCTGTACACTGTTATCTTCATTAATATTT
TATTATCCCTAACGCTAATTCTAGTTGCATTCTGACTCCCCCAAATAAATCTGTACTCAGAAAAAGCAAATCCATATGAA
TGCGGATTCGACCCTACAAGCTCTGCACGTCTACCATTCTCAATAAAATTTTTCTTGGTAGCAATTACATTTCTATTATT
TGACCTAGAAATTGCTCTTCTACTTCCACTACCATGAGCAATTCAAACAATTAAAACCTCTACTATAATAATTATAGCCT
TTATTCTAGTCACAATTCTATCTCTAGGCCTAGCATATGAATGAACACAAAAAGGATTAGAATGAACAGAGTAAATGGTA
ATTAGTTTAAAAAAAATTAATGATTTCGACTCATTAGATTATGATGATGTTCATAATTACCAATATGCCATCTACCTTCT
TCAACCTCACCATAGCCTTCTCACTATCACTTCTAGGGACACTTATATTTCGCTCTCACCTAATATCCACATTACTATGC
CTGGAAGGCATAGTATTATCCTTATTTATTATAACTTCAGTAACTTCCCTAAACTCCAACTCCATAAGCTCCATACCAAT
CCCCATCACCATCTTAGTTTTCGCAGCCTGCGAAGCAGCTGTAGGACTAGCCCTACTAGTAAAAGTTTCAAACACGTACG
GAACAGATTACGTCCAAAATCTCAACCTACTACAATGCTAAAAATTATTCTTCCCTCACTAATGCTACTACCACTAACCT
GACTATCAAGCCCTAAAAAAACCTGAACAAACGTAACCTCATATAGTTTTCTAATTAGTTTAACCAGCCTAACACTTCTA
TGACAAACCGACGAAAATTATAAAAACTTTTCAAATATATTCTCCTCAGACCCCCTATCCACACCATTAATTATTTTAAC
AGCCTGATTACTGCCACTAATATTAATAGCTAGCCAAAACCACCTAAAAAAAGATAATAACGTACTACAAAAACTCTACA
TCTCAATACTAATCAGCTTACAAATTCTCCTAATCATAACCTTTTCAGCAACTGAACTAATTATATTTTATATTTTATTT
GAAGCAACCTTAATCCCAACACTTATTATTATTACCCGATGAGGGAACCAAACTGAACGCCTAAACGCAGGGATTTATTT
165
CCTATTTTATACCCTAATCGGTTCTATTCCACTGCTAATTGCCCTCATCTTAATCCAAAACCATGTAGGAACCCTAAACC
TCATAATTTTATCATTCACAACACACACCTTAGACGCTTCATGATCTAACAACTTACTATGGTTGGCATGCATAATAGCA
TTTCTTATTAAAATACCATTATATGGAGTTCACCTATGACTACCAAAAGCCCATGTTGAAGCTCCAATTGCTGGGTCAAT
AATTCTAGCAGCTATTCTTCTAAAATTAGGTAGTTACGGAATAATTCGCATCTCCATTATTCTAGACCCACTAACAAAAT
ATATAGCATACCCCTTCATCCTTCTCTCCCTATGAGGAATAATTATAACTAGCTCAATCTGCTTACGCCAAACAGATTTA
AAATCACTAATCGCCTACTCCTCAGTTAGCCACATAGCACTTGTTATTGCATCAATCATAATCCAAACTCCATGAAGCTT
CATAGGAGCAACAATACTAATAATCGCACATGGCCTCACATCATCACTCCTATTCTGCCTAGCAAACTCCAACTACGAAC
GGATCCACAGCCGTACTATAATCATGGCCCGAGGACTTCAAATGGTCTTCCCACTTATAGCCACATGATGACTGATAGCA
AGTCTAGCTAATCTAGCTCTACCCCCTTCAATCAATCTAATAGGAGAATTATTCATTACCATATCATTATTTTCTTGATC
AAACTTTACCATTATTCTTATAGGAATTAACATTATTATTACAGGTATATACTCAATATACATAATTATTACCACCCAAC
GCGGCAAACTAACCAACCATATAATTAACCTCCAACCCTCACACACACGAGAACTAACACTAATAGCCCTTCACATAATT
CCACTTATTCTTCTAACTACCAGTCCAAAACTAATTACAGGCCTGACAATATGTGAATATAGTTTACAAAAAACATTAGA
CTGTGAATCTGACAACAGGAAATAAACCTCCTTATTCACCAAGAAAGATTGCAAGAACTGCTAATTCATGCTTCCATGTT
TAAAAACATGGCTTTCTTACTTTTATAGGATAATAGTAATCCATTGGTCTTAGGAACCAAAAACCTTGGTGCAAATCCAA
ATAAAAGTAATCAATATTTTCACAACCTCAATCTTATTAATCTTCATTCTTCTACTATCCCCAATCCTAATTTCAATATC
AAACCTAATTAAACACATCAACTTCCCACTGTACACCACCACATCAATCAAATTCTCCTTCATTATTAGCCTCTTACCCC
TATTAATATTTTTCCACAATAATATAGAATATATAATTACAACCTGGCACTGAGTCACCATAAATTCAATAGAACTTAAA
ATAAGCTTCAAAACTGACTTTTTCTCTATCCTGTTTACATCTGTAGCCCTTTTTGTCACATGATCAATTATACAATTCTC
TTCATGATATATACACTCAGACCCAAACATCAATCGATTCATTAAATATCTTACACTATTCCTGATTACCATGCTTATCC
TCACCTCAGCCAACAACATATTTCAACTTTTCATTGGCTGAGAAGGGGTGGGAATTATATCTTTCCTACTAATTGGATGA
TGGTACGGACGAACAGACGCAAATACTGCAGCCCTACAAGCAATCCTCTATAACCGCATCGGAGACATCGGATTCATTTT
AGCTATAGTTTGATTTTCCCTAAACATAAACTCATGAGAACTTCAACAGATTATATTCTCCAACAACAACGACAATCTAA
TTCCACTTATAGGCCTATTAATCGCAGCTACAGGAAAATCAGCACAATTTGGCCTCCACCCATGACTACCATCAGCAATA
GAAGGCCCTACACCAGTTTCAGCACTACTACACTCAAGTACAATAGTAGTTGCAGGAATTTTCCTACTGGTCCGATTCCA
CCCCCTCACGACTAATAATAACTTTATTTTAACAACTATACTTTGCCTCGGAGCCCTAACCACATTATTTACAGCTATTT
GTGCTCTCACCCAAAACGACATCAAAAAAATCATTGCCTTCTCTACATCAAGCCAACTAGGCCTGATAATAGTGACGCTA
GGAATAAACCAACCACACCTAGCATTCCTACACATCTGTACCCACGCATTCTTCAAAGCTATACTCTTTATATGCTCTGG
CTCAATCATTCATAGCCTGGCAGACGAACAAGACATCCGAAAAATAGGAAACATCACAAAAATCATACCATTCACATCAT
CATGCCTAGTAATCGGAAGCCTCGCCCTCACAGGAATACCATTCCTAACAGGGTTCTACTCAAAAGACCTAATTATTGAA
GCAATTAATACCTGCAACACCAACGCCTGAGCCCTACTAATTACACTAATCGCCACTTCTATAACAGCTATGTACAGCAT
ACGAATCATTTACTTCGTAACAATAACAAAACCGCGTTTTCCCCCCCTAATCTCCATTAACGAAAATGACCCAGACCTCA
TAAACCCAATCAAACGCCTAGCATTCGGAAGCATCTTTGCAGGATTTGTCATCTCATATAATATTCCACCAACCAGCATT
CCAGTCCTCACAATACCATGATTTTTAAAAACCACAGCCCTAATTATTTCAGTATTAGGATTCCTAATCGCACTAGAACT
AAACAACCTAACCATAAAACTATCAATAAATAAAGCAAATCCATATTCATCCTTCTCAACTTTACTGGGGTTTTTCCCAT
CTATTATTCACCGCATTACACCCATAAAATCTCTCAACCTAAGCCTAAAAACATCCCTAACTCTCCTAGACTTGATCTGG
TTAGAAAAAACCATCCCAAAATCCACCTCAACTCTTCACACAAACATAACCACTTTAACAACCAACCAAAAAGGCTTAAT
TAAATTGTACTTTATATCATTCCTAATTAACATCATCTTAATTATTATCTTATACTCAATTAATCTCGAGTAATCTCGAT
AATAATAAAAATACCCGCAAACAAAGATCACCCAGCTACTACCATCATTCAAGTAGCACAACTATATATTGCCGCTACCC
CAATCCCTCCTTCCAACATAACTCCAACATCATCAACCTCATACATCAACCAATCTCCCAAACCATCAAGATTAATTACT
CCAACTTCATCATAATAATTAAGCACACAAATTAAAAAAACCTCTATAATCACCCCCAATACTAAAAAACCCAAAATTAA
TCAGTTAGATCCCCAAGTCTCTGGATATTCCTCAGTAGCTATAGCAGTCGTATATCCAAACACAACCAACATCCCCCCTA
AATAAATTAAAAAAACTATTAAACCTAAAAACGATCCACCAAACCCTAAAACCATTAAACAACCAACAAACCCACTAACA
ATTAAACCTAAACCTCCATAAATAGGTGAAGGCTTTAATGCTAACCCAAGACAACCAACCAAAAATAATGAACTTAAAAC
AAAAATATAATTATTCATTATTTCTACACAGCATTCAACTGCGACCAATGACATGAAAAATCATCGTTGTAATTCAACTA
CAGAAACACCTAATGACAAACATACGAAAAACACACCCATTATTTAAAATTATTAACCACTCATTCATTGACCTACCTGC
CCCATCCAACATTTCATCATGATGAAACTTTGGGTCCCTTCTAGGAGTCTGCCTAATAGTCCAAATCATTACAGGTCTTT
TCTTAGCCATACACTACACATCAGATACAATAACAGCCTTTTCATCAGTAACACACATTTGTCGAGACGTAAATTACGGG
TGACTAATCCGATATATACACGCAAACGGAGCCTCAATATTTTTTATTTGCTTATTCCTTCATGTCGGACGAGGCTTATA
TTATGGATCATATACATTTATAGAAACCTGAAACATTGGAGTACTTCTACTGTTCGCAGTCATAGCCACAGCATTTATAG
GCTACGTCCTTCCATGAGGACAAATATCATTCTGAGGTGCCACAGTTATTACAAACCTCCTATCAGCCATCCCATATATT
GGAACAACCCTAGTCGAATGAATTTGAGGGGGCTTCTCAGTAGACAAAGCCACCTTGACCCGATTCTTCGCTTTCCACTT
CATCTTACCATTTATTATCGCGGCCCTAGCAATCGTTCACCTCCTCTTCCTCCACGAAACAGGATCAAACAACCCAACAG
GATTAAACTCAGATGCAGATAAAATTCCATTTCACCCCTACTATACAATCAAAGATATCCTAGGTATCCTAATCATATTC
TTAATTCTCATAACCCTAGTATTATTTTTCCCAGACATACTAGGAGACCCAGACAACTACATACCAGCTAATCCACTAAA
CACCCCACCCCATATTAAACCCGAATGATATTTCCTATTTGCATACGCCATTCTACGCTCAATCCCCAATAAACTAGGAG
GTGTCCTAGCCTTAATCTTATCTATCCTAATTTTAGCCCTAATACCTTTCCTTCATACCTCAAAGCAACGAAGCCTAATA
TTCCGCCCAATCACACAAATTTTGTACTGAATCCTAGTAGCCAACCTACTTATCTTAACCTGAATTGGGGGCCAACCAGT
AGAACACCCATTTATTATCATTGGCCAACTAGCCTCCATCTCATACTTCTCAATCATCTTAATTCTTATACCAATCTCAG
GAATTATCGAAGACAAAATACTAAAATTATATCCATGTCTTGATAGTATAAACATTACTCTGGTCTTGTAAACCTGAAAT
GAAGATCTTCTCTTCTCAAGACATCAAGAAGAAGGAGCTACTCCCCACCACCAGCACCCAAAGCTGGTATTCTAATTAAA
CTACTTCTTGAGTACATAAATTTACATAGTACAACAGTACATTTATGTATATCGTACATTAAACTATTTTCCCCAAGCAT
ATAAGCTAGTACATTAAATCAATGGTTCAGGTCATAAAATAATCATCAACATAAATCAATATATATACCATGAATATTAT
CTTAAACACATTAAACTAATGTTATAAGGACATATCTGTGTTATCTGACATACACCATACAGTCATAAACTCTTCTCTTC
CATATGACTATCCCCTTCCCCATTTGGTCTATTAATCTACCATCCTCCGTGAAACCAACAACCCGCCCACCAATGCCCCT
CTTCTCGCTCCGGGCCCATTAAACTTGGGGGTAGCTAAACTGAAACTTTATCAGACATCTGGTTCTTACTTCAGGGCCAT
CAAATGCGTTATCGCCCATACGTTCCCCTTAAATAAGACATCTCGATGGTATCGGGTCTAATCAGCCCATGACCAACATA
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ACTGTGGTGTCATGCATTTGGTATCTTTTTATTTTGGCCTACTTTCATCAACATAGCCGTCAAGGCATGAAAGGACAGCA
CACAGTCTAGACGCACCTACGGTGAAGAATCATTAGTCCGCAAAACCCAATCACCTAAGGCTAATTATTCATGCTTGTTA
GACATAAATGCTACTCAATACCAAATTTTAACTCTCCAAACCCCCCACCCCCTCCTCTTAATGCCAAACCCCAAAAACAC
TAAGAACTTGAAAGACATATAATATTAACTATCAAACCCTATGTCCTGATCAATTCTAGTAGTTCCCAAAATATGACTTA
TATTTTAGTACTTGTAAAAATTTTACAAAATCATGTTCCGTGAACCAAAACTCTAATCATACTCTATTACGCAATAAACA
TTAACAAGTTAATGTAGCTTAATAACAAAGCAAAGCACTGAAAATGCTTAGATGGATAATTGTATCCCATAAACACAAAG
GTTTGGTCCTGGCCTTATAATTAATTAGAGGTAAAATTACACATGCAAACCTCCATAGACCGGTGTAAAATCCCTTAAAC
ATTTACTTAAAATTTAAGGAGAGGGTATCAAGCACATTAAAATAGCTTAAGACACCTTGCCTAGCCACACCCCCACGGGA
CTCAGCAGTGATAAATATTAAGCAATAAACGAAAGTTTGACTAAGTTATACCTCTTAGGGTTGGTAAATTTCGTGCCAGC
CACCGCGGTCATACGATTAACCCAAACTAATTATCTTCGGCGTAAAACGTGTCAACTATAAATAAATAAATAGAATTAAA
ATCCAACTTATATGTGAAAATTCATTGTTAGGACCTAAACTCAATAACGAAAGTAATTCTAGTCATTTATAATACACGAC
AGCTAAGACCCAAACTGGGATTAGATACCCCACTATGCTTAGCCATAAACCTAAATAATTAAATTTAACAAAACTATTTG
CCAGAGAACTACTAGCCATAGCTTAAAACTCAAAGGACTTGGCGGTACTTTATATCCATCTAGAGGAGCCTGTTCTATAA
TCGATAAACCCCGCTCTACCTCACCATCTCTTGCTAATTCAGCCTATATACCGCCATCTTCAGCAAACCCTAAAAAGGTA
TTAAAGTAAGCAAAAGAATCAAACATAAAAACGTTAGGTCAAGGTGTAGCCAATGAAATGGGAAGAAATGGGCTACATTT
TCTTATAAAAGAACATTACTATACCCTTTATGAAACTAAAGGACTAAGGAGGATTTAGTAGTAAATTAAGAATAGAGAGC
TTAATTGAATTGAGCAATGAAGTACGCACACACCGCCCGTCACCCTCCTCAAATTAAATTAAACTTAACATAATTAATTT
CTAGACATCCGTTTATGAGAGGAGATAAGTCGTAACAAGGTAAGCATACTGGAAAGTGTGCTTGGAATAATCATAGTGTA
GCTTAATATTAAAGCATCTGGCCTACACCCAGAAGATTTCATGACCAATGAACACTCTGAACTAATCCTAGCCCTAGCCC
TACACAAATATAATTATACTATTATATAAATCAAAACATTTATCCTACTAAAAGTATTGGAGAAAGAAATTCGTACATCT
AGGAGCTATAGAACTAGTACCGCAAGGGAAAGATGAAAGACTAATTAAAAGTAAGAACAAGCAAAGATTAAACCTTGTAC
CTTTTGCATAATGAACTAACTAGAAAACTTCTAACTAAAAGAATTACAGCTAGAAACCCCGAAACCAAACGAGCTACCTA
AAAACAATTTTATGAATCAACTCGTCTATGTGGCAAAATAGTGAGAAGATTTTTAGGTAGAGGTGAAAAGCCTAACGAGC
TTGGTGATAGCTGGTTACCCAAAAAATGAATTTAAGTTCAATTTTAAACTTGCTAAAAAAACAACAAAATCAAAAAGTAA
GTTTAGATTATAGCCAAAAGAGGGACAGCTCTTCTGGAACGGAAAAAACCTTTAATAGTGAATAATTAACAAAACAGCTT
TTAACCATTGTAGGCCTAAAAGCAGCCACCAATAAAGAAAGCGTTCAAGCTCAACATAAAATTTCAATTAATTCCATAAT
TTACACCAACTTCCTAAACTTAAAATTGGGTTAATCTATAACTTTATAGATGCAACACTGTTAGTATGAGTAACAAGAAT
TCCAATTCTCCAGGCATACGCGTATAACAACTCGGATAACCATTGTTAGTTAATCAGACTATAGGCAATAATCACACTAT
AAATAATCCACCTATAACTTCTCTGTTAACCCAACACCGGAATGCCTAAAGGAAAGATCCAAAAAGATAAAAGGAACTCG
GCAAACAAGAACCCCGCCTGTTTACCAAAAACATCACCTCTAGCATTACAAGTATTAGAGGCACTGCCTGCCCAGTGACT
AAAGTTTAACGGCCGCGGTATCCTGACCGTGCAAAGGTAGCATAATCACTTGTTCCTTAATTAGGGACTAGCATGAACGG
CTAAACGAGGGTCCAACTGTCTCTTATCTTTAATCAGTGAAATTGACCTTTCAGTGAAGAGGCTGAAATATAATAATAAG
ACGAGAAGACCCTATGGAGCTTAAATTATATAACTTATCTATTTAATTTATTAAACCTAATGGCCCAAAAACTATAGTAT
AAGTTTGAAATTTCGGTTGGGGTGACCTCGGAGAATAAAAAATCCTCCGAATGATTATAACCTAGACTTACAAGTCAAAG
TAAAATCAACATATCTTATTGACCCAGATATATTTTGATCAACGGACCAAGTTACCCTAGGGATAACAGCGCAATCCTAT
TTAAGAGTTCATATCGACAATTAGGGTTTACGACCTCGATGTTGGATCAGGACATCCCAATGGTGTAGAAGCTATTAATG
GTTCGTTTGTTCAACGATTAAAGTCCTACGTGATCTGAGTTCAGACCGGAGCAATCCAGGTCGGTTTCTATCTATTTACG
ATTTCTCCCAGTACGAAAGGACAAGAGAAATAGAGCCACCTTACAAATAAGCGCTCAAAGATGCAGGGGTAAAAGCTAAC
CGCATCTTTACCGACAAGGCATCCGGCAGTTCAACAGATCGGGAAGGGCTGGATTTGCTGAGGATGAAGGTGGAGGAAGG
TGATGTCATTCTGGTGAAGAAGCTCGACCGTCTTGGCCGCGACACCGCCGACATGATCCAACTGATAAAAGAGTTTGATG
CTCAGGGTGTAGCGGTTCGGTTTATTGACGACGGGATCAGTACCGACGGTGATATGGGGCAAATGGTGGTCACCATCCTG
TCGGCTGTGGCACAGGCTGAACGCCGGAGGATCCTAGAGCGCACGAATGAGGGCCGACAGGAAGCAAAGCTGAAAGGAAT
CAAATTTGGCCGCAGGCGTACCGTGGACAGGAACGTCGTGCTGACGCTTCATCAGAAGGGCACTGGTGCAACGGAAATTG
CTCATCAGCTCAGTATTGCCCGCTCCACGGTTTATAAAATTCTTGAAGACGAAAGGGCCTCGTGATACGCCTATTTTTAT
AGGTTAATGTCATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGT
TTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAG
GAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACC
CAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGC
GGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGT
ATTATCCCGT
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Appendix 3. Exact commands for the mtDNA-seq data analysis steps.
################################ mtDNA-seq data analysis workflow ################################
#### TRIMMING ####
# Read trimming for minimum length, quality and TruSeq adapters 
flexbar -n 16 -r /path/to/reads1.fastq.gz -t output_prefix -f i1.8 -j -z GZ -q 
28 -m 50 -ao 10 -at 1 -ae ANY > file.log.txt 
##############################################################################################
#### ALIGNMENT to the NORMAL REFERENCE GENOME ####
# Create index for the reference genome (required only once) 
bwa index -p reference reference.fa 
# bwa mem alignment 
bwa mem -t 15 -P -T 19 -B 3 -L 5,4 /path/to/reference/reference 
/path/to/reads1_flexbar.fastq.gz > reads1.sam 
# Sorting and indexing 
samtools view -Sbu reads1.sam | samtools sort - -T reads1.sorted -o 
reads1.sorted.bam ; samtools index reads1.sorted.bam 
# Quality filter only mapped reads for further processing 
samtools view -bq 1 reads1.sorted.bam > reads1.accepted.bam 
samtools index reads1.accepted.bam 
##############################################################################################
#### ALIGNMENT to the SPLIT REFERENCE GENOME ####
## Create the split reference genome (required only once) ## 
# Create variables 
split_genome=reference_split.fa 
single_line=reference_singleline.fa 
split_data=reference_split.data 
# Transform the reference fasta file to contain the sequence as a single line 
header=$(cat /path/to/reference.fa | grep '>') 
cat /path/to/reference.fa | grep -v '>' | tr -d '\n' > $single_line 
# Calculate the length of the input reference genome sequence to determine the cutting position 
half_split=$(cat $single_line | awk 'BEGIN {junc=0} junc=int(length($0)/2) 
{print junc}') 
half_split1=$(echo $half_split | awk '{print $0+1}') 
full_len=$(cat $single_line | awk 'BEGIN {len=0} len=length($0) {print len}') 
paste <(echo $half_split) <(echo $half_split1) <(echo $full_len) > $split_data 
# Take the genome halves according to the calculated positions 
gen_start=$(cat $single_line | cut -c1-$half_split) 
gen_end=$(cat $single_line | cut -c${half_split1}-$full_len) 
# Combine the halves in correct order and restore the fasta format 
gen_split=$(paste <(echo $gen_end) <(echo $gen_start) | tr -d '\t') 
paste <(echo $header) <(echo $gen_split) | tr '\t' '\n' > $split_genome 
#### 
# Create index for the reference genome (required only once) 
bwa index -p reference_split reference_split.fa 
# bwa mem alignment 
bwa mem -t 15 -P -T 19 -B 3 -L 5,4 /path/to/reference/reference_split 
/path/to/reads1_flexbar.fastq.gz > reads1_junction.sam 
# Sorting and indexing 
samtools view -Sbu reads1_junction.sam | samtools sort - -T 
reads1_junction.sorted -o reads1_junction.sorted.bam 
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samtools index reads1_junction.sorted.bam 
#################################################################################################
#### FILTERING the ALIGNED READS ### #
# Quality filter only uniquely aligned reads for further processing (bwa mem mapping quality 0 indicates multimapping
reads) 
samtools view -bq 1 reads1.sorted.bam > reads1.accepted.bam 
samtools index reads1.accepted.bam 
samtools view -bq 1 reads1_junction.sorted.bam > reads1_junction.accepted.bam 
samtools index reads1_junction.accepted.bam 
#################################################################################################
#### CALCULATE the COVERAGE ####
# For the normal reference alignment 
bedtools genomecov -d -ibam reads1.accepted.bam -g reference.fa > coverage.txt 
# For the split reference alignment 
bedtools genomecov -d -ibam reads1_junction.accepted.bam -g reference_split.fa >
coverage_junction.txt 
## Combine the coverages to represent the entire mtDNA genome ## 
# Take the middle and end points of the split junction genome for extracting correct lines 
mid_point=$(cat reference_split.data | awk '{print $2}') 
end_point=$(cat reference_split.data | awk '{print $3}') 
# Middle part of the normal coverage file 
cat coverage.txt | awk -v endpoint="$end_point" '$2 > 200 && $2 < endpoint - 200
{print}' > coverage.middle 
# Re-coordinate the junction region and take only -200 and +200 
cat coverage_junction.txt | awk -v midpoint="$mid_point" -v 
endpoint="$end_point" 'BEGIN {OFS = "\t"; pos = 0; test = 0; res = 0} {pos = $2;
test = pos - midpoint; if(test <= 0) res = endpoint + test; else res = test; $2 
= res; print}' | sort -nk2 | awk -v endpoint="$end_point" '$2 <=200 || $2 >= 
endpoint - 200 {print}' > coverage.junction_replacement 
# Merge the middle and junction regions into a final result file 
cat $normal_middle $junction_replacement | sort -nk2 > coverage_final.txt 
################################################################################################
####LoFreq* VARIANT CALLING #### 
# First set the indel qualities for using --call-indels 
lofreq indelqual --dindel --ref reference.fa --out reads1.indelqual.bam 
reads1.accepted.bam 
lofreq indelqual --dindel --ref reference_split.fa --out 
reads1_junction.indelqual.bam reads1_junction.accepted.bam 
samtools index reads1.indelqual.bam 
samtools index reads1_junction.indelqual.bam 
# Variant calling including indels 
lofreq call-parallel --pp-threads 20 -f reference.fa -o reads1.nofilter.vcf -N 
-B -q 30 -Q 30 --call-indels --no-default-filter reads1.indelqual.bam 
lofreq call-parallel --pp-threads 20 -f reference_split.fa -o 
reads1_junction.nofilter.vcf -N -B -q 30 -Q 30 --call-indels --no-default-filter
reads1_junction.indelqual.bam 
# Filtering the results if >85% of variant reads are on single strand 
lofreq filter --no-defaults --snvqual-thresh 70 --indelqual-thresh 70 --sb-incl-
indels -B 60 -i reads1.nofilter.vcf -o reads1.sbfiltered.vcf 
lofreq filter --no-defaults --snvqual-thresh 70 --indelqual-thresh 70 --sb-incl-
indels -B 60 -i reads1_junction.nofilter.vcf -o reads1_junction.sbfiltered.vcf 
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## Combine the original and junction region results for the junction region ## 
# Read in the mid and end points of the split genome junction region 
mid_point=$(cat reference_split.data | awk '{print $2}') 
end_point=$(cat reference_split.data | awk '{print $3}') 
# Re-coordinate the variants and take only -200 and +200 region 
cat reads1_junction.sbfiltered.vcf | awk '/#CHROM/ {flag = 1; next} flag 
{print}' | awk -v midpoint="$mid_point" -v endpoint="$end_point" 'BEGIN {OFS = 
"\t"; pos = 0; test = 0; res = 0} {pos = $2; test = pos - midpoint; if(test <= 
0) res = endpoint + test; else res = test; $2 = res; print}' | sort -nk2 | awk 
-v endpoint="$end_point" '$2 <= 200 || $2 >= endpoint - 200 {print}' > 
junction_replacement.vars 
# Intermediate vcf header 
cat reads1.sbfiltered.vcf | awk '/#/ {print}' > 
reads1.sbfiltered_junction_combined.vcf 
# Take middle part of the original alignment variant calls 
cat reads1.sbfiltered.vcf | awk '/#CHROM/ {flag = 1; next} flag {print}' | awk 
-v endpoint="$end_point" '$2 > 200 && $2 < endpoint - 200 {print}' > 
reads1.middle.vars 
# Combine junction replacement and original middle, sort and append to the original vcf header 
cat reads1.middle.vars junction_replacement.vars | sort -nk2 >> 
reads1.sbfiltered_junction_combined.vcf 
# Final junction fixed file for snv and indel separation 
# Separate snvs only and indels only to different files for downstream analysis 
lofreq filter --no-defaults --only-snvs -i 
reads1.sbfiltered_junction_combined.vcf -o reads1.snvs.vcf 
lofreq filter --no-defaults --only-indels -i 
reads1.sbfiltered_junction_combined.vcf -o reads1.indels.vcf 
#################################################################################################
#### snpEff FINAL FILTERING of the VARIANT RESULTS #### 
## Make sure the snpEff config file uses mitochondrial codons for annotations (required only once)
cd ~
mkdir snpEff_data
# Modify snpEff.config file
# data.dir = ~/snpEff_data/
# Fix mitochondrial codon table usage in the .config file to the wanted genome version:
## Original rows in snpEff.config
## GRCm38.82.genome : Mus_musculus
## GRCm38.82.reference : ftp://ftp.ensembl.org/pub/release-82/gtf/
# Add MT.codonTable in between:
## GRCm38.82.genome : Mus_musculus 
## GRCm38.82.MT.codonTable: Vertebrate_Mitochondrial
## GRCm38.82.reference : ftp://ftp.ensembl.org/pub/release-82/gtf/
###
# Filter variants for minimum number of supporting reads in total and on both strands
cat reads1.snvs.vcf | java -jar /software/snpEff/4.2/SnpSift.jar filter 
"( (DP*AF >= 15) & (DP4[2] >= 3) & (DP4[3] >= 3) )" > reads1.filtered.vcf
# Filter variants for mouse strain specific and highly strand biased variants
cat reads1.filtered.vcf | java -jar /software/snpEff/4.2/SnpSift.jar filter 
"( (SB < 1000) & (POS != 4891) & (POS != 9461) & (POS != 9027) )" > 
reads1.pos_filtered.vcf
# Annotate the file
java -jar /software/snpEff/4.2/snpEff.jar -config ~/snpEff.config -no-downstream
-no-upstream -noStats -v GRCm38.82 reads1.pos_filtered.vcf > reads1.ann.vcf
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# -classic produces reference and alternative codon triplets and different amino acid change format than newer ANN
(default) annotation
java -jar /software/snpEff/4.2/snpEff.jar eff -config ~/snpEff.config -classic 
-no-downstream -no-upstream -noStats -v GRCm38.82 reads1.pos_filtered.vcf > 
reads1.eff.vcf 
## Separate genome regions 
# tRNAs (contain also protein_coding rows from overlapping region) 
cat reads1.ann.vcf | java -jar /software/snpEff/4.2/SnpSift.jar filter 
"ANN[*].BIOTYPE has 'Mt_tRNA'" | 
/software/snpEff/4.2/scripts/vcfEffOnePerLine.pl > reads1.ann.trna_tmp.vcf 
# Re-filter to have only tRNA rows and modify the final output columns 
cat reads1.ann.trna_tmp.vcf | java -jar /software/snpEff/4.2/SnpSift.jar filter 
"ANN[*].BIOTYPE has 'Mt_tRNA'" | java -jar /software/snpEff/4.2/SnpSift.jar 
extractFields - -s "\t" -e "NA" CHROM "ANN[*].BIOTYPE" "ANN[*].GENE" POS REF ALT
QUAL DP DP4[0] DP4[1] DP4[2] DP4[3] AF SB "ANN[*].EFFECT" "ANN[*].IMPACT" 
"ANN[*].HGVS_C" "ANN[*].HGVS_P" "ANN[*].CDS_POS" "ANN[*].CDS_LEN" 
"ANN[*].AA_POS" "ANN[*].AA_LEN" "ANN[*].GENEID" "ANN[*].ERRORS" | sed '1d' | sed
'1iCHROM\tANN_BIOTYPE\tANN_GENE\tPOS\tREF\tALT\tQUAL\tDP\tDP4_REF_fw\tDP4_REF_rv
\tDP4_ALT_fw\tDP4_ALT_rv\tAF\tSB\tANN_EFFECT\tANN_IMPACT\tANN_HGVSc\tANN_HGVSp\t
ANN_CDSPOS\tANN_CDSLEN\tANN_AAPOS\tANN_AALEN\tANN_GENEID\tANN_ERRORS' > 
reads1.ann.trna.vcf 
# rRNAs 
cat reads1.ann.vcf | java -jar /software/snpEff/4.2/SnpSift.jar filter 
"ANN[*].BIOTYPE has 'Mt_rRNA'" | java -jar /software/snpEff/4.2/SnpSift.jar 
extractFields - -s "\t" -e "NA" CHROM ANN[0].BIOTYPE ANN[0].GENE POS REF ALT 
QUAL DP DP4[0] DP4[1] DP4[2] DP4[3] AF SB ANN[0].EFFECT ANN[0].IMPACT 
ANN[0].HGVS_C ANN[0].HGVS_P ANN[0].CDS_POS ANN[0].CDS_LEN ANN[0].AA_POS 
ANN[0].AA_LEN ANN[0].GENEID ANN[0].ERRORS | sed '1d' | sed 
'1iCHROM\tANN_BIOTYPE\tANN_GENE\tPOS\tREF\tALT\tQUAL\tDP\tDP4_REF_fw\tDP4_REF_rv
\tDP4_ALT_fw\tDP4_ALT_rv\tAF\tSB\tANN_EFFECT\tANN_IMPACT\tANN_HGVSc\tANN_HGVSp\t
ANN_CDSPOS\tANN_CDSLEN\tANN_AAPOS\tANN_AALEN\tANN_GENEID\tANN_ERRORS' > 
reads1.ann.rrna.vcf 
# Control region 
cat reads1.ann.vcf | java -jar /software/snpEff/4.2/SnpSift.jar intervals 
~/scripts_master/ctrl_region_bases.txt | java -jar 
/software/snpEff/4.2/SnpSift.jar extractFields - -s "\t" -e "NA" CHROM 
ANN[0].BIOTYPE ANN[0].GENE POS REF ALT QUAL DP DP4[0] DP4[1] DP4[2] DP4[3] AF SB
ANN[0].EFFECT ANN[0].IMPACT ANN[0].HGVS_C ANN[0].HGVS_P ANN[0].CDS_POS 
ANN[0].CDS_LEN ANN[0].AA_POS ANN[0].AA_LEN ANN[0].GENEID ANN[0].ERRORS | sed 
'1d' | sed 
'1iCHROM\tANN_BIOTYPE\tANN_GENE\tPOS\tREF\tALT\tQUAL\tDP\tDP4_REF_fw\tDP4_REF_rv
\tDP4_ALT_fw\tDP4_ALT_rv\tAF\tSB\tANN_EFFECT\tANN_IMPACT\tANN_HGVSc\tANN_HGVSp\t
ANN_CDSPOS\tANN_CDSLEN\tANN_AAPOS\tANN_AALEN\tANN_GENEID\tANN_ERRORS' > 
reads1.ann.ctrl.vcf 
# OriL region 
cat reads1.ann.vcf | java -jar /software/snpEff/4.2/SnpSift.jar intervals 
~/scripts_master/OriL_region_bases.txt | java -jar 
/software/snpEff/4.2/SnpSift.jar extractFields - -s "\t" -e "NA" CHROM 
ANN[0].BIOTYPE ANN[0].GENE POS REF ALT QUAL DP DP4[0] DP4[1] DP4[2] DP4[3] AF SB
ANN[0].EFFECT ANN[0].IMPACT ANN[0].HGVS_C ANN[0].HGVS_P ANN[0].CDS_POS 
ANN[0].CDS_LEN ANN[0].AA_POS ANN[0].AA_LEN ANN[0].GENEID ANN[0].ERRORS | sed 
'1d' | sed 
'1iCHROM\tANN_BIOTYPE\tANN_GENE\tPOS\tREF\tALT\tQUAL\tDP\tDP4_REF_fw\tDP4_REF_rv
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\tDP4_ALT_fw\tDP4_ALT_rv\tAF\tSB\tANN_EFFECT\tANN_IMPACT\tANN_HGVSc\tANN_HGVSp\t
ANN_CDSPOS\tANN_CDSLEN\tANN_AAPOS\tANN_AALEN\tANN_GENEID\tANN_ERRORS' > 
reads1.ann.oril.vcf 
# Protein_coding 
cat reads1.ann.vcf | java -jar /software/snpEff/4.2/SnpSift.jar filter 
"ANN[*].BIOTYPE has 'protein_coding'" | java -jar 
/software/snpEff/4.2/SnpSift.jar extractFields - -s "\t" -e "NA" CHROM 
ANN[0].BIOTYPE ANN[0].GENE POS REF ALT QUAL DP DP4[0] DP4[1] DP4[2] DP4[3] AF SB
ANN[0].EFFECT ANN[0].IMPACT ANN[0].HGVS_C ANN[0].HGVS_P ANN[0].CDS_POS 
ANN[0].CDS_LEN ANN[0].AA_POS ANN[0].AA_LEN ANN[0].GENEID ANN[0].ERRORS | sed 
'1d' | sed 
'1iCHROM\tANN_BIOTYPE\tANN_GENE\tPOS\tREF\tALT\tQUAL\tDP\tDP4_REF_fw\tDP4_REF_rv
\tDP4_ALT_fw\tDP4_ALT_rv\tAF\tSB\tANN_EFFECT\tANN_IMPACT\tANN_HGVSc\tANN_HGVSp\t
ANN_CDSPOS\tANN_CDSLEN\tANN_AAPOS\tANN_AALEN\tANN_GENEID\tANN_ERRORS' > 
reads1.ann.protein_tmp.vcf 
# Add codon position as a number to protein variants 
# Calculate whether the variant is on 1st, 2nd or 3rd codon position for coding genes based on ANN_CDSpos column 
sed '1d' reads1.ann.protein_tmp.vcf | cut -f 19 | while read i; do 
 if [ -z $i ]; then 
  echo "NA" 
 elif [ $(($i % 3)) == 1 ]; then 
  echo "1" 
 elif [ $(($i % 3)) == 2 ]; then 
  echo "2" 
 elif [ $(($i % 3)) == 0 ]; then 
  echo "3" 
 fi 
done | sed '1iCODON_POS' > codon_position.tmp 
# Codons and amino acid change from EFF annotation for protein coding 
cat  reads1.eff.vcf  |  java  -jar  /software/snpEff/4.2/SnpSift.jar  filter
"ANN[*].BIOTYPE  has  'protein_coding'"  |  java  -jar
/software/snpEff/4.2/SnpSift.jar extractFields - -s "\t" -e "NA" "EFF[0].CODON"
"EFF[0].AA"  |  sed  '/^#/d;s/\//\t/g'  |  sed
'1iEFF_CODONREF\tEFF_CODONALT\tEFF_HGVSp' > protein.eff.tmp 
# Combine everything to full protein coding tab-delimited file 
paste reads1.ann.protein_tmp.vcf codon_position.tmp protein.eff.tmp > 
reads1.ann.protein.vcf
# Combine all per element files into a full genome tab-delimited file to be used for mutation load calculations 
sed -e '2,${/^CHROM/d' -e '}' reads1.ann.*.txt | sed '/^CHROM/ s/
$/\tCODON_POS\tEFF_CODONREF\tEFF_CODONALT\tEFF_HGVSp/' > reads1.ann.MT.vcf
#################################################################################################
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